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SUMMARY.
The targeting and processing of proricin, a 
precursor form of the highly cytotoxic castor bean lectin, 
ricin, was studied in this thesis. Targeting signals are 
present on plant seed storage protein precursors which first 
direct them into the ER-lumen (signal peptides) and then sort 
them to the protein bodies. Computer analysis of the 35aa 
residue N-terminal presequence of preproricin identified two 
residues as being likely sites of signal peptidase cleavage. 
Using site-directed mutagenesis, chimeric genes were 
constructed between the N-terminal region of preproricin and 
npt2. Expression of one such chimera in rabbit reticulocyte 
lysate (containing microsomal membranes) showed that the first 
22aa N-terminal residues of preproricin function as a signal 
peptide. The ricin/npt2 chimeras were then transiently 
expressed in tobacco protoplasts in order to determine whether 
the 35aa preproricin presequence contained any vacuolar 
targeting information. Evidence is presented which suggests 
that this region is not responsible for targeting proricin to 
the protein bodies.
Recombinant proricin was synthesised by injection of 
proricin transcripts into Xenopus oocytes. Proricin synthesised 
in this way possessed lectin activity but did not depurinate 
mammalian ribosomes, indicating that the A chain domain has no 
RNA N-glycosidase activity when in the context of the 
precursor. In order to demonstrate the conversion of an 
inactive enzyme precursor to an active mature enzyme (the 
conversion of proricin to ricin), an assay was designed to 
purify the proricin processing enzyme from the protein bodies 
of dry castor bean seeds. Radiolabelled proricin was made in 
vitro by expression of proricin transcripts in wheat germ 
lysate. This was then used as a substrate to identify 
processing activity present in protein body extracts from dry 
castor bean seeds. Processing of the 63kD labelled proricin 
polypeptide to products of 30kD was observed by SDS-PAGE 
analysis and fluorography of assay samples. However, the levels 
of enzyme activity in the dried seed were too low to enable 
purification of the proricin processing enzyme. Therefore, an 
alternative strategy was designed to enable in vitro 
proteolytic cleavage of proricin. Site-directed mutagenesis was 
used to design proricin linkers encoding a recognition sequence 
for either Factor Xa or thrombin. Proricin clones containing 
these mutant linkers were expressed in E.coli. wheat germ 
lysate and a Xenopus egg-cell free extract"! When expressed in 
Xenopus egg cell-free extract, the proricin mutants were shown 
to have lectin activity, indicating that the B chain domain was 
biologically active. Evidence for Factor Xa-specific cleavage 
of proricin with a mutated linker is presented.
xviii

1.1 SUMMARY
Since its identification by Stillmark in 1888 as a 
protein extract from castor beans that caused 
erythroagglutination, ricin has had a highly profiled and 
diverse history. Its name has cropped up in connection with 
therapeutic agents designed to fight cancer and in the more 
sinister field of international espionage: the murder of the 
Bulgarian dissident, Markov, in London in 1979 was thought to 
have been caused by a ricin-tipped umbrella.
Ricin can perhaps best be defined as the highly cytotoxic 
7S lectin that accumulates in the seeds of the castor bean, 
Ricinus communis. This description covers the three features of 
ricin which account for its widespread scientific appeal; 
namely, it is a potent toxin, a sugar-binding lectin and, as it 
accumulates in the seed, it can easily be obtained in large 
amounts. As will be discussed in this introduction, ricin is 
initially synthesised as a preproprotein and the object of this 
study was to examine the post-translational targeting and 
processing of this precursor.
The introduction has therefore been divided as follows. 
Plant seed storage proteins will first be considered with 
particular attention being paid to the subclass of the 7S 
lectins, into which ricin falls. This first section will 
concentrate on their synthesis as preproproteins, post- 
translational modifications and subcellular sites of storage, 
as these are of particular relevance to this work. In section
1.3 a general scheme for the intracellular vesicular routing of 
proteins will be proposed, based largely on pioneering work in 
animal and yeast systems. The areas in which plants now appear 
to differ from this scheme will be discussed. Finally, ricin 
will be described in detail before this introduction section is 
completed with a summary of the aims of this work.
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1.2 PLANT SEED STORAGE PROTEINS
1.2.1 INTRODUCTION
In addition to supplying the genetic information 
necessary for the successful development of a new plant, parent 
spermatophytes (seed plants) must also lay down reserves within 
the seeds. These reserves must include a source of energy, 
organically-fixed nitrogen, pre-formed carbon chains and 
minerals: all of which will enable the germinating progeny to 
survive until their root and photosynthetic systems are 
sufficiently developed to sustain further growth.
The reserves commonly found in seeds are carbohydrates, 
proteins, lipids and phytins (a source of metal ions and 
phosphorus). The storage proteins are a major component of 
these reserves and may account for up to 80% of the total 
protein in mature cells. They are a source of organically-fixed 
nitrogen, having a high content of arginine, 
asparagine/aspartate and glutamine/glutamate residues - for 
example, these residues constitute 36% of the amino acid 
residues in the legumin storage protein from soybean, Glycine 
max (see Wilson, 1986).
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1.2.2 CLASSIFICATION OF PLANT STORAGE PROTEINS
In 1924, Osborne defined a tetrapartite classification 
scheme for plant storage proteins that was based on their 
relative solubilities in different solvents. The four groups 
were as follows;
ALBUMINS - soluble in H2O at neutral/slightly acidic pH
GLOBULINS - soluble in salt solutions
GLUTELINS - soluble in strongly acidic or basic solutions
PROLAMINS - soluble in ethanol (aqueous alcohol)
Generally speaking, glutelins and prolamins are the major 
storage proteins in monocotyledonous plants (monocots.) whereas 
dicotyledonous plants (dicots.) have globulins as their primary 
storage proteins. Exceptions to this rule include oat, whose 
major storage proteins are globulins (see Higgins, 1984), and 
the castor bean, that store 2S albumins as a significant source 
of organically-fixed nitrogen and sulphur.
Due to their commercial importance, the storage proteins 
of cereals and legumes have been the most widely studied 
monocot. and dicot. storage proteins respectively.
1.2.3 STORAGE PROTEINS OF CEREALS
In cereals the endosperm is the major seed storage 
tissue. Prolamins are the major group of proteins in cereals 
such as barley, wheat, maize and sorghum, where they can 
account for 80 to 100Z of the protein in the endosperm protein 
bodies (Pernollet, 1978). Rice, however, stores predominantly 
glutelins. Oats have both glutelins and globulins as storage 
protein.
1.2.4 STORAGE PROTEINS OF DICOTS.
The main storage tissue in legumes is the cotyledonary 
tissue, though in plants with a developed endosperm, this may 
be the site of storage protein deposition. The globulins found
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in legume cotyledons fall into two types; the 11S legumins and 
the 7S N-glycosylated vicilins. The relative amounts of these 
two types of globulins varies between different species.
(i) Legumins
As illustrated by their high average sedimentation 
coefficient legumins are large molecules, consisting of 6 
heterodimers held together by non-covalent forces. Each 
heterodimer is made up of a large 40kD acidic subunit and small 
20kD basic subunit, covalently attached by a single inter-chain 
disulphide bridge. Many different isoforms of both the acidic 
and basic subunits exist as the legumins are encoded by a
multi-gene family. However, Staswick £t jil (1981) showed that 
the association of the a- and b- isoforms of the soybean 
legumin, glycinin, was non-random and it is now known that this 
is because they are initially synthesised as a single 60kD 
precursor (see Nielsen, 1984) which is later processed to its 
mature two-chain form, after the formation of the disulphide 
bond.
Storage proteins of the legumin type have been identified 
in non-leguminous dicots, and include the 11S globulin from
pumpkin (see Akazawa and Hara-Nishimura, 1985). The monocot. 
seed globulin from oat also resembles the 11S legumins and 
contains acidic and basic subunits that are synthesised as a 
single polypeptide precursor (Brinegar and Peterson, 1982).
(ii) Vicilins
As mentioned above, vicilins are N-glycosylated. This co- 
translational modification occurs as the protein is
translocated into the lumen of the ER. Differential
oligosaccharide processing of these glycan residues partly 
explains the complex pattern of vicilin forms within a single 
plant species. Sun et al (1974) and Thanh and Shibasaki (1978) 
have shown that vicilin from Phaseolus vulgaris (phaseolin) and 
Glycine max respectively contain three major
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subunits (a, a' and B) ranging from 40-60kD in size. Badenoch- 
Jones e_t aj. (1981) have shown that at least 10 subunits of pea 
vicilin can be distinguished. However, Chrispeels £t a^ (1982) 
have demonstrated that 4 subunits (with molecular weights of 
75, 70, 50 and 49kD) are initially synthesised and the six
smallest subunits arise by specific proteolysis of the 49/50kD 
subunits.
All vicilins described to date are from the Leguminosae 
family, with the exception of acalin A from cotton (see Wilson,
1986).
(ill) Convicilin
Croy et al^  (1980) have isolated a third type of storage 
globulin from pea. Convicilin is a 290kD tetrameric protein - 
each subunit having a molecular weight of 71kD.
(iv) Albumins
In addition to the globulins, 7S lectins and 2S albumins 
are present in significant quantity in some plant species. They 
may be considered to be storage proteins as they contain 
organically-fixed nitrogen, accumulate during seed development, 
and are rapidly degraded during germination.
(▼) 7S Lectins (see review by Gtzler, 1985: Sharon & Lis, 1989)
The 7S lectins can generally be classified as plant 
storage proteins in that they accumulate during seed
development, they have an amino acid composition containing 
relatively high proportions of fixed nitrogen and are rapidly 
degraded during germination. They are also, as we shall see, 
initially synthesised as preproprotein precursors, transported 
along the same intracellular routes and are deposited in the 
same organelles as other plant storage proteins. However, these 
proteins do not simply act as stores of organically-fixed 
nitrogen. They belong to a diverse class of proteins called 
lectins, found in all classes and families of organisms and 
which are classified functionally by their ability to bind to
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carbohydrate moieties (Sharon and Lis, 1989). Lectins are also 
multi-valent (each molecule can bind more than one sugar 
molecule) and this property results in agglutination when 
intact cells and lectins are mixed together, since all cells 
have a 'sugar coating' of glycoproteins, glycolipids or 
polysaccharide. Lectins can be sub-divided into six specificity 
groups according to the monosaccharide that is the best 
competitive inhibitor of erythroagglutination.
A number of roles have been proposed to explain their 
widespread presence in plants: to date lectins have been found 
in more than 1000 plant species (reviewed by Gztler, 1986). 
However, Chrispeels and Raikhel (1991) have most recently used 
the examples of the Phaseolus lectins and the chitin-binding 
lectins to propose a common ancestory and role for this family 
of seed proteins in dicots and monocots respectively. They 
propose that their primary function is in plant defence, by for 
example, discouraging predation by animals (feeding studies 
have attributed the toxicity of many seeds to their lectin 
contents) or limiting hyphal growth upon fungal penetration of 
the plant cells and release of lectins from ruptured vacuoles.
The most abundant source of lectins are the 7S lectins in 
mature seeds and particularly in the seeds of the Leguminosae 
where they can constitute up to 10Z of the total protein 
(Pusztai e£ a^ L, 1979). Typically legume lectins exist as 
tetramers with subunits of 25-35kD. The subunits may or may not 
be identical. For example, Concanavalin A (ConA) from the 
jackbean, Canavalia ensifortnis t is assembled from a single 
25.5kD subunit, whereas pea lectin (and other lectins from the 
Vicieae tribe) is composed of two non-identical subunits of 
17kD & 6kD (Trowbridge, 1974) and is termed a two-chain lectin. 
There is a high degree of protein sequence homology between all 
the legume lectins, but this homology is not immediately 
apparent. For example, for correct alignment the B chain of the
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two chain lectins must be placed alongside the amino-terminus 
of the single chain lectins, followed by the A chain. On the 
other hand, Hemperely and Cunningham (1983) used the term 
'circular homology' to describe how the primary amino acid 
sequences of the lectins from the Dioclea tribe align with 
those of the one and two chain lectins. These apparently 
cryptic homology patterns are a consequence of different post- 
translational modifications of the lectin precursors and are 
discussed below in 1.2.6.
Other 7S lectins include the lectins from Abrus pretorius 
and Ricinus communis (see review by Olsnes and Pihl, 1982). In 
both species there are two closely related lectins: a 
heterodimeric cytotoxin (abrin and ricin) and a relatively non­
toxic tetrameric agglutinin which resembles a dimerised form of 
the toxin. In these lectins, only one of the two non-identical 
subunits has sugar-binding properties (the B chain): the other 
subunit is the toxic moeity (A chain) and will be discussed in 
more detail in section 1.4.
Lectins frequently exist in a number of different 
isoforms, termed isolectins, which can arise from expression of 
more than one gene within a lectin gene family. For example, 
phytohaemagglutinin (PHA) from Phaseolus vulgaris contains both 
erythro-binding (PHA-E) and leuco-binding (PHA-L) subunits 
encoded by two closely-linked genes (Hoffman and Donaldson, 
1985) which can assemble randomly to form 5 isolectins. Most 7S 
lectins are glycoproteins, an exception being the mature form 
of ConA, although even this is initially synthesised as a 
glycoprotein (Herman, Shannon and Chrispeels, 1985).
(vi) 2S Albumins
Youle and Huang (1982) identified three low-molecular- 
weight albumins, all with apparent molecular weights of 12kD, 
in the endosperm of castor bean seeds. The amino acid 
composition of these 2S albumins reveals a 30% content of
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glutamate residues and 8.52 cysteine (see Wilson, 1986) 
suggesting that these are important stores of nitrogen and 
sulphur in the castor bean.
Other 2S-albumins include the napins isolated from 
rapeseed, Brassica napus (Lonnerdal and Janson, 1972). The cDNA 
sequence of these proteins reveals that they too are 
synthesised as a single polypeptide precursor (Crouch et al, 
1983).
The 2S albumins, protease inhibitors, prolamins, alpha- 
amylase- and trypsin-inhibitors from cereals have 3 homologous 
domains (see Kreis et al, 1985) and it is believed that they 
all arose from a common ancestral gene.
1.2.5 SUBCELLULAR SITE OF STORAGE PROTEIN DEPOSITION -
THE PROTEIN BODIES
Numerous immunocytochemical and cell fractionation 
studies have identified the site of storage protein deposition 
within a cell to be the single-membrane-bound organelles, 
termed aleurone grains or protein bodies (reviewed by 
Pernollet, 1978). In dicots, they range between 1 and 22 um in 
diameter. Pernollet (1978) identified three types of protein 
bodies defined by their internal morphology: those with a 
homogeneous, granular internal morphology; those with phytin 
globoids; and, as in the case of the well-characterised protein 
bodies of the castor bean, those that contain both globoids and 
crystalloid inclusions (Youle and Huang, 1976: Tully and 
Beevers, 1976). Gifford and Bewley (1983) showed that these 
crystalloid inclusions contain deposits of 11S globulin, the 
major storage protein of the castor bean.
As many dicot. storage proteins are glycosylated it has 
been possible to propose a common route of intracellular 
transport for these proteins from the ER lumen, via the the 
Golgi apparatus to the protein bodies (defined here as the
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secretory pathway). This is because oligosaccharide side chains 
are modified post-translationally in an orderly and uni­
directional way: each of the various modification enzymes 
involved has been localised to a particular vesicular 
compartment along the secretory pathway (see review by 
(Cornfield and (Cornfield, 1985). The oligosaccharide side chains 
of glycoproteins therefore provide a biochemical 'footprint' 
of their route through the cell. In this way, Chrispeels 
(1983ab) showed that PHA passed through the Golgi apparatus en 
route to the protein bodies in developing Phaseolus seeds. 
Immunocytochemical data of Greenwood and Chrispeels (1985) in 
Phaseolus supports this observation, as does that of Herman 
and Sharon (1984 & 1985) who showed that the Golgi apparatus 
was involved in the transport to the protein bodies of the 
lectins alpha-galactosidase haemagglutinin in soybean and ConA 
in jackbean.
However, the transport of monocot storage proteins to the 
protein bodies is far from clear. There is evidence from 
studies of prolamin deposition in maize and wheat to suggest 
that protein bodies arise from budding of the endoplasmic 
reticulum (ER) (Larkins and Hurkman, 1978: Parker, 1982). This 
would imply that some monocot storage proteins may not pass 
along the secretory pathway en route to pre-existing protein 
body organelles but instead, accumulate in regions of the ER 
which delimit and bud to form 'de novo' protein bodies. 
However, this work is open to criticism as cross-contamination 
of fractions or misinterpretation of immunocytochemical data 
when considered in isolation is possible. One factor which has 
hindered work in this area is that most monocot storage 
proteins are not glycosylated and therefore their intracellular 
route cannot be traced biochemically as it has been for the 
dicot proteins. Indirect evidence is now available in support 
of this secretory pathway-independent route for monocot storage
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proteins from the expression of zeins and alpha-gliandins in 
Xenopus oocytes (Wallace et ¿1, 1988s Simon £t al, 1990). In 
both studies the prolamins became aggregated and remained in 
the ER. However, Simon and co-workers found that the closely- 
related gamma-gliandin was efficiently secreted from the 
oocytes. This data may be interpreted to imply that there is 
not a single (common) route of protein storage in monocots, or 
it may be argued that the proteins simply behave differently 
when expressed in a heterologous system.
Chrispeels and Tague (1990) choose to distinguish between 
the two types of protein bodies described above by terming them 
'ER-derived vesicles' and 'protein storage vacuoles'. However, 
for the purpose of this thesis, the general term 'protein 
bodies' will be used as it is now generally accepted that all 
protein bodies in dicots are both derived from, and the 
progenitor of, the large central vacuole (Bollini and
Chrispeels, 1979: Nishimura and Beevers, 1978).
1.2.6 SYNTHESIS AS PREPROPROTEINS
A common feature of many of the storage proteins is that 
they are synthesised as precursors, or 'preproproteins'.
Lord and Robinson (1986) distinguish between two 
different proteolytic processing steps that lead to the mature 
protein. The first is the co-translational cleavage of the N- 
terminal signal peptide that directs the storage protein into 
the lumen of the endoplasmic reticulum (ER) (see next section 
for more detail). The second step involves endoproteolytic 
cleavage(s) of the segregated protein to yield its mature form.
Evidence that this second modification step occurs in the 
protein bodies, the site postulated for the processing of pea 
storage proteins by Chrispeels e£ ¿1 (1982), has been presented 
for the the 11S globulins from pumpkin (Hara-Nishimura and 
Nishimura, 1987). They isolated an enzyme activity from
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vacuoles of developing pumpkin cotyledons which was able to 
process their storage protein precursors iji vitro. They also 
found that 11S globulin precursors were cleaved to their mature 
sizes after incubation with an extract from castor bean seeds, 
suggesting that this activity may be present in different 
species.
A common feature of these protein body-localised 
processing events is the observation that cleavage of the 
precursor polypeptide backbone usually occurs on the carboxyl 
side of an asparagine residue (Higgins, 1984).
(i) Legumin processing
Study of cDNA sequences available for many storage 
proteins illustrates that proteolytic processing does not 
always involve a single cleavage of the polypeptide precursor. 
In the case of the legumin-like proteins there is removal of a 
linking peptide that lies between the mature polypeptides in 
the proprotein. In the legumin precursor from pea, processing 
involves the removal of a 6aa residue linker (Boulter, 1984) 
whereas glycinin precursor from soybean loses a 4aa residue 
linker (Nielsen, 1984). In each case the carboxy-terrainal 
residue of the linker is an asparagine residue. It should be 
added that a 12aa residue carboxy-terminal peptide is also lost 
from the basic subunit of soybean (Nielsen, 1984). In this case 
an asparagine-specific endoprotease is not thought to be 
involved.
(ii) Vicilin processing
The vicilin-like precursors undergo different degrees of 
proteolytic processing. For example, a 4aa residue carboxy- 
terminal propeptide is thought to be cleaved from beta- 
phaseolin, a subunit of vicilin from Phaseolus (Sandro 
Vitale, personal communication). On the other hand, the 50kD 
subunit of pea vicilin can be processed at two internal sites 
to release subunits of 19kD, 13.5kD and 12-14kD. Processing at
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only one of these sites will result in subunits of intermediate 
size (see Boulter, 1984: reviewed by Lord and Robinson, 1986). 
The processing sites in the 50kD subunit have been shown to lie 
on the carboxyl side of an asparagine. In vicilin isoforms that 
do not have an asparagine residue in either of these positions 
cleavage does not occur at that position. This explains the 
apparent partial processing of the 50kD subunit and the fact 
that both the full-length and intermediately-sized subunits 
constitute a significant proportion of the mature vicilin.
(ill) Lectin processing
Asparagine -specific cleavages are also observed in the 
processing of some legume 7S lectins. Amino acid sequencing of 
the two-chain lectins from the Vicieae tribe of legumes reveals 
that proteolytic cleavage of the prolectin molecule in each 
case occurs on the carboxyl side of an asparagine residue 
(summarised by Yarwood et _al, 1988). However, there are 
examples of single chain lectins in this tribe. The protein 
sequences of a single chain lectin from Lathyrus sphaericus 
(Richardson, Yarwood and Rouge, 1987) and two single chain 
isolectins from Lathyrus nissolia (Yarwood et al, 1988) 
identifies an asparagine residue in a position equivalent to 
the Asparagine residue lying on the carboxyl side of the 
cleavage site in the two chain lectins. One explanation for the 
absence of cleavage at this site in the single chain Viciae 
lectins is that the L.sphaericus and L.nissolia species lack an 
asparagine -specific processing enzyme. An alternative 
suggestion made by Yarwood and co-workers was based on the 
observation that in the precursors of two chain lectins, the 
asparagine at the cleavage site formed part of a putative 
asparagine-linked glycosylation signal (i.e. Asn-X-Thr/Ser:see 
section 1.3.4). No such signal was present in the sequences of 
the single-chain lectins at this position. As this region of 
the protein precursor must be accessible for a processing
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enzyme to cleave the polypeptide backbone of the two-chain 
Vicieae lectins, it is reasonable to suggest that it is near 
the surface and is glycosylated. In their mature form, however, 
the two chain lectins are not glycosylated at this asparagine 
residue and so Yarwood e_t ^1 propose that a deglycosylation 
event at this site might be a prerequisite for endoproteolytic 
processing of the Vicieae lectins. They therefore proposed that 
a glycosylation/deglycosylation may be a pre-requisite for 
endoproteolytic processing of the two chain lectins.
In support of this the complex processing of the single 
chain lectin ConA from jackbean is known to involve such a 
glycosylation/deglycosylation step which is followed (sometime 
later) by four asparagine -specific cleavages and a unique 
polypeptide ligation event (Carrington et al, 1985: Bowles jet 
al, 1986: reviewed by Bowles and Pappin, 1988). Also the 
derived protein sequence from pea seed lectin cDNA (Higgins et 
al, 1983) reveals the asparagine residue at the end of its 6aa 
linker as being a potential site for asparagine-linked 
glycosylation. However, to date there is no direct evidence 
that shows a link between glycosylation and endoproteolytic 
processing.
Lectins are not proteolytically processed in every case. 
For example, there is no evidence for the proteolytic 
processing of PHA in the protein bodies of Phaseolus.
(iv) 2S albumins
From the predicted amino acid sequence of napin precursor, 
Crouch et aJL (1983) suggested that there is a 21aa residue N- 
terminal signal peptide followed by a region of 38aa residues 
that has a net negative charge, before the start of the mature 
small subunit. They also proposed that there is a 20aa residue 
linker between the small and large subunits which again has a 
net negative charge. Both of these regions are thought to be 
cleaved from the proprotein in the protein bodies. None of
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these proteolytic events however, appear to involve a peptide 
bond cleavage on the carboxyl side of asparagine.
1.2.7 SUMMARY
It is clear that many storage proteins are formed as 
preproprotein precursors which become N-glycosylated and are 
finally sequestered and processed to their mature form in the 
protein bodies. In many cases there is a role for a protein 
body-localised class of asparagine-specific endoprotease(s) in 
the removal of propeptides. The ability of a protein body 
soluble matrix fraction isolated from one species to process a 
storage protein precursor from another species suggests that 
this processing machinery may be highly conserved. However, 
very little else is known about this processing step and no 
asparagine-specific enzymes have, to the author's knowledge, 
been characterised.
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1.3 INTRACELLULAR TRAFFICKING OF NEWLY-SYNTHESISED PROTEINS
1.3.1 INTRODUCTION
As has been shown, seed storage proteins are made as 
preproprotelns that are sequestered in the ER before being 
transported to the protein bodies. What route they follow and 
what distinguishes them from other synthesised proteins will 
now be discussed.
Many of the steps involved in the intracellular routing 
of proteins were initially elucidated by studying animal and 
yeast systems. Only recently have similar studies in plants 
begun to reveal many common features and show that much of the 
transport machinery is conserved throughout the eukaryotes.
1.3.2 MEMBRANE TRANSLOCATION AS A FIRST STEP IN
COMPARTMENTALISATION
(i) The Paradox
Order is imposed within a cell by the segregation of 
proteins necessary for a specific reaction within membrane- 
bound compartments: this may be the periplasmic space of E.coli 
or, in the case of the eukaryotic cell, by segregation within 
organelles. Boundaries are maintained by the impermeability of 
water soluble proteins to the membrane lipid bilayer. However, 
an apparent paradox arises when considering that, with the 
exception of a relatively few proteins encoded and expressed 
within mitochondria and chloroplasts, all proteins share a 
common site of synthesis, that is on cytosolic ribosomes. 
Therefore, the proteins destined for organellar locations must 
at some stage cross an apparently impermeable membrane barrier.
But what distinguishes membrane-segregated from cytosolic 
proteins?
(11) Topogenic signals
The signal hypothesis was first proposed by Blobel and
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Dobberstein (1975), who suggested that secretory proteins had 
specific signals which interacted with specific receptors on 
the membrane of the endoplasmic reticulum (ER). Blobel later 
generalised the signal hypothesis (Blobel, 1980) by using the 
term 'intracellular protein topogenesis' to include the 
targeting of proteins across other intracellular membranes. He 
proposed that topogenic sequences within the protein are 
recognised by specific receptors on the target membrane, during 
(co-translational) or shortly after (post-translational) their 
synthesis. The last statement takes into account the 
observations jLn vitro that ER translocation of secretory 
proteins is closely linked to translation whereas proteins 
targeted to other organelles (e.g. mitochondria and 
chloroplasts) can be imported post-translationally. For a 
recent review of membrane targeting signals see Von Heijne 
(1990).
(ii) Translocation-competent state.
Zimmerman and Meyer (1986) suggested that an essential 
property of any protein that is translocated is that is must be 
in an 'unfolded state' - that is, a polypeptide with secondary 
but no tertiary structure. They concluded that factors that 
prevent or promote protein 'unfolding' form components of the 
translocation systems.
In light of the observations that preproalphafactor from 
yeast and human glucose transporter can cross the ER membrane 
post-translationally, Schatz (1986) proposed that the more 
commonly observed tight coupling between synthesis and 
translocation of secretory proteins was merely an operational 
one to ensure that proteins were not allowed to fold before 
translocation. Walter and Lingappa (1986) favour this view of 
ribosome-dependent versus ribosome-independent translocation 
as reflecting the requirements of the maintenance of a 
'translocation competent state'.
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Wiech et ¿1 (1990) have recently collated these theories 
and define a translocation competent state as meaning that the 
protein must be water-soluble, possess secondary but no 
tertiary structure, and interact with cytosolic 'chaperones'. 
This last term has been used to describe proteins that affect 
the folding of others without playing any part in their final 
structure (see Ellis and Hemmingsen, 1989). The signal 
recognition particle (see below) and members of the heat shock 
protein family (hsp70) (Chirico et al, 1988) act as such 
chaperones in the translocation of proteins across the ER 
lumen.
1.3.3 TRANSLOCATION ACROSS THE ER MEMBRANE
The translocation across the ER membrane has been 
reviewed by Walter and Lingappa (1986) and, more recently, by 
Pugsley (1990). Walter and Lingappa suggest that the two 
questions to be addressed when considering ER translocation 
are:
(i) how is the target membrane recognised, and
(ii) once targeted to the membrane surface, how is the
protein translocated across the membrane?
(1) Recognition of Target membrane.
Proteins destined for the secretory pathway are 
distinguished by the presence of signal peptides. These signals 
are discrete N-terminal extensions that are cleaved from the 
mature protein during translocation (for review of signal 
peptides see von Heijne, 1990). They have very little or no 
amino acid (primary) sequence homology but comparison of many 
known signal peptides has elucidated three functional domains: 
a positively-charged amino-terminus, or n-region; a hydrophobic 
h-region; and a carboxy-terminal c-region which contains polar 
residues and contains the signal peptide cleavage site (von
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Heijne, 1985). The n- and h-regions are known to be involved in 
membrane targeting - the hydrophobic core forming an alpha 
helix. The c-region often contains alpha-helix breaking 
residues such as glycine and proline, and residues at positions 
-3 and -1 relative to the cleavage site tend to be small and 
uncharged. All plant storage proteins synthesised as 
preproproteins carry N-terminal extensions that fit this 
description.
The signal peptide interacts with a cytosolic factor, 
the signal recognition particle (SRP). SRP, an 11S small 
cytoplasmic ribonucleoprotein, was purified by Walter and 
Blobel (1980) and consists of a 7S RNA component and 6 
polypeptide chains. During protein synthesis, SRP recognises 
the signal peptide as it emerges from the ribosome, binds to 
the nascent chain and arrests further polypeptide elongation. 
Krieg et a_i (1986) showed that the 54kD monomeric polypeptide 
of SRP contained the signal peptide binding site. Sequencing of 
cDNA encoding the 54kD protein (Bernstein et al, 1989: Romish 
et al, 1989) has revealed a methionine-rich binding pocket 
which may accommodate the hydrophobic signal sequence. The 
deduced amino acid sequence also reveals a potential 6TP 
binding site. Pugsley (1990) suggests that GTP 
binding/hydrolysis at this site may affect the affinity of SRP 
for the signal peptide.
The SRP/nascent polypeptide/ribosome complex then 
interacts with another characterised protein factor, the SRP 
receptor (Walter and Blobel, 1981) or docking protein (Meyer et 
al. 1982). This is a heterodimeric integral membrane protein 
consisting of a 69kD trans-membrane alpha chain and a 30kD beta 
chain. A hydrophilic cytosolic domain of the alpha subunit 
strongly resembles a nucleotide binding site and Walter and 
Lingappa (1986) suggest that the RNA component of SRP may 
interact with this domain.
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At this stage the ribosome binds to the membrane in a 
functional way. Meyer's group have recently purified a 180 kD 
integral ER membrane protein which binds to ribosomes and that 
they propose is the ribosome binding factor (unpublished).
The next step in the translocation process is the GTP- 
mediated release of the SRP from the signal peptide (Connolly 
and Gilmore, 1989). This allows the recycling of SRP, its 
receptor and the resumption of peptide elongation. A second 
membrane protein, identified by Weidmann e_t ¿1 (1987) and 
termed the Signal Sequence Receptor (SSR), (see also Walter,
1987) binds the signal peptide and may be involved in the 
release of the SRP from the signal peptide (reviewed by 
Rapoport, 1990).
(ii) Translocation of the nascent peptide.
Although signal peptides are hydrophobic and can insert 
into lipid monolayers (Cornell et al, 1989), the mature portion 
of the protein is unlikely to pass through the lipid bilayer. 
Instead, integral membrane proteins are thought to assemble to 
form a channel, or translocon, through which the protein is 
translocated (see Pugsley, 1990). The SSR mentioned above may 
form part of this translocon (Rapoport, 1990).
Plant storage preproprotein precursors can be 
translocated across mammalian membranes and the involvement of 
the SRP in this translocation has been demonstrated using 
globulin precursors from Vicia faba (Bassuner e£ al, 1984). 
This suggests that similar mechanisms are involved in the 
targeting to and translocation across the plant cell ER 
membrane although there is no direct data on the plant 
components themselves.
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1.3.4 CO-TRANSLATIONAL MODIFICATIONS.
As the nascent polypeptide emerges into the lumen of the 
ER, co-translational cleavage of signal peptide and core 
asparagine-linked glycosylation takes place catalysed by the 
membrane-associated hexameric signal peptidase and a glycosyl- 
transferase complex respectively. The glycosylated asparagine 
residue forms part of a tripartite recognition sequence, Asn-X- 
Ser/Thr (where X can be any amino acid), in animals and higher 
plants. The glycan, composing 3 glucose, 9 mannose and 2 N- 
acetylglucosamine residues, is transferred from a lipid donor 
to the side chain of the asparagine. Sequential modifications 
of the oligosaccharides occurs both in the ER lumen and in the 
Golgi (reviewed by Kornfield and Kornfield, 1985).
1.3.5 PROTEIN FOLDING IN ER.
(i) Disulphide bridge forestion.
The oxidising environment of the ER lumen promotes the 
spontaneous formation of disulphide bridges between intra- and 
inter-chain cysteine residues. A soluble ER resident protein, 
Protein Disulphide Isomerase (PDI), has been identified 
(Freedman, 1984). It catalyses the formation of productive 
disulphide bridges by lowering the activation energy of 
reactions involving free thiol groups and/or disulphide chain 
exchanges. Its ability to catalyse the formation of the correct 
disulphide bridges within a newly-synthesised protein was 
illustrated by Bulleid and Freedman (1988). They observed that 
the wheat storage protein, gamma gliadin, could be imported 
into PDI-depleted microsomes but was not correctly disulphide 
bonded. Addition of purified PDI to the microsomes during their 
preparation resulted in the correctly folded form of the 
protein.
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(ii) The involvement of Binding Protein.
Another resident ER protein that has an effect on the 
folding and assembly of proteins is the binding protein (BiP). 
This protein binds tightly to ATP, shows great homology with 
the hsp70 chaperone family, and is likely to act in a similar 
way (Munro and Pelham, 1986). A simple functional model for BiP 
is that it acts as a reversible detergent which binds 
hydrophobic residues exposed on the surface of misfolded 
monomers or unassembled oligomeric subunits. The binding of BiP 
shields the hydrophobic regions, and thus avoids protein 
precipitation. This interaction could be reversed by the 
hydrolysis of BiP-bound ATP, which may also provide the energy 
necessary for correct folding or assembly. Munro and Pelham
(1986) showed that BiP (from S.cerevisiae) bound to immobilised 
immunoglobulin heavy chain could be released upon the addition 
of ATP but not ADP, indicating that hydrolysis of the high 
energy phosphate bond is the driving force for dissociation. In 
plants, a BiP homologue has been reported in tomato (see 
Pelham, 1989)
1.3.6 PROTEIN EXPORT PROM ER.
Proteins destined for compartments other than the ER 
(lysosome/plant vacuole, secretory vesicles, or those destined 
for extracellular secretion) exit the ER and pass along the 
route of 'Biosynthetic Protein Transport* (Pfeffer and Rothman, 
1987) . Pfeffer and Rothman propose that the pathway for 
biosynthetic protein transport is constitutive, non-selective 
and unidirectional. Proteins deposited in the ER lumen are 
transported to the Golgi and then to the cell surface in a 
series of transport steps involving the budding and fusion of 
transport vesicles from a donor to an acceptor organellar 
compartment. They use the term 'bulk flow' to describe the 
constitutive, non-selective nature of the protein trafficking.
22
They also review evidence which suggests that the cytosolic 
factors involved in vesicle trafficking are conserved in all 
eukaryotes. A feature of the vesicles is that they are coated 
on their cytosolic face but the coat does not contain clathrin. 
Clathrin is involved in receptor-mediated endocytosis and, 
therefore, Pfeffer and Rothman suggest that the distinction 
between clathrin and non-clathrin coating may represent the 
difference between selective and non-selective transport.
A consequence of the bulk flow secretory pathway is that 
proteins whose destinations are not the extracellular medium, 
such as resident ER/Golgi proteins and those destined for the 
lysosomes/plant vacuole, require signals to retard them or 
direct them away from this pathway. Pfeffer and Rothman suggest 
that these need not be contiguous blocks (such as the signal 
peptide) and may instead be represented by 'signal patches' 
formed as the protein assembles into its tertiary and 
quaternary structures.
Evidence that the same route of biosynthetic protein 
transport exists in plants was first shown by the observation 
that many seed storage proteins are glycosylated and the 
protein-borne oligosaccharides contain Golgi-specific 
modifications (Chrispeels, 1983ab). Also Greenwood and 
Chrispeels (1985) observed immunocytochemical localisation of 
phaseolin and phytohaemagglutinin in the ER and Golgi of 
developing bean cotyledons.
Recent evidence that transport along this pathway is by 
default has been provided by the work of Dorel ejt al, (1989), 
Iturriaga et jil (1989), and Denecke et al (1989). Dorel £t al 
(1989) expressed a chimeric gene, containing the promoter and 
signal peptide coding sequence of a vacuolar seed protein fused 
to the coding sequence of a cytosolic seed albumin, in 
transgenic tobacco. They found that the chimera was correctly 
expressed and glycosylated but was not associated with any
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organellar fraction. They concluded that the chimera had been 
secreted though this was not directly demonstrated. More 
convincing evidence was provided by Iturriaga ej: al (1989) and 
Denecke e£ al (1989) who both fused genes for known signal 
peptides onto marker enzymes and expressed them in tobacco. 
Denecke and his colleagues used electroporation of protoplasts 
and transient expression assays to show the secretion of the 
marker enzymes from the transformed protoplasts into the 
medium.
1.3.7 CONTROL OF ER EXPORT (see review by Pelham, 1989)
Given that export from the ER can occur at a similar rate 
to bulk flow (Welland et al, 1987s Karrenbauer et al, 1990), 
what is the explanation for the observed variation in half­
times of secretion between exported proteins? Pfeffer and 
Rothman (1987) suggest two factors that may be involved. The 
first is that the rates of export reflect the variability in 
the rates of protein folding/assembly, as only correctly folded 
and assembled proteins are exported (reviewed by Rose and Dorns,
1988). For example, Vitale et al (1991) have expressed beta- 
phaseolin in Xenopus oocytes and found that only correctly 
assembled trimers were secreted. Furthermore, they observed 
that unassembled subunits were rapidly degraded in the ER. 
Secondly, the high surface area to volume ratio of the ER may 
result in the membrane acting as a absorption matrix. The rate 
of movement of exported proteins through the lumen would then 
be determined by the number and strength of their 
hydrophobic/electrostatic interactions with this matrix.
The final question to be addressed when considering 
export from the ER is the observed retention of resident 
luminal ER proteins. Munro and Pelham (1986) identified a 
conserved 4aa C-terminal sequence, lysine-aspartate-glutamate- 
leucine (KDEL), present on three major ER resident proteins;
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BiP, PDI and endoplasmin (grp94). They have subsequently shown 
that removal of this sequence from BiP leads to its slow 
secretion. In converse experiments the tetrapeptide sequence, 
fused to the C-terminus of a secretory protein, results in its 
retention in the ER (Munro and Pelham, 1986). This data 
suggests that KDEL functions as an ER retention signal. 
Interestingly, the sequencing of BiP from the yeast 
S.cerevisiae (Rose and Misra, 1989) revealed histidine-DEL 
(HDEL) which Dean and Pelham (1990) have recently shown to be 
the ER retention signal in this yeast species.
Many more ER resident proteins have now been examined and 
show a KDEL (or KDEL related) C-terminus (for a list see 
Pelham, 1989). In the higher plant proteins so far examined, 
BiP cloned from tomato appears to have a HDEL signal (see 
Pelham, 1989) whereas the auxin binding protein from Zea mays 
has a KDEL C-terminus (Inohara e_t al, 1990).
This ER retention signal is thought to interact with a 
specific receptor in a post-ER compartment which then returns 
the resident lumenal protein to the ER (Munro and Pelham, 1987: 
Warren, 1987). Putative KDEL receptors have been identified in 
animals and yeast. Using an anti-idiotypic antibody approach 
Vaux £t al (1990) identified a 72kD integral membrane protein 
which bound anti-anti-KDEL immunoglobulin and was concentrated 
in a post ER compartment. Pelham's group, on the other hand, 
used a genetic approach in S.cerevisiae and suggest that the 
ERD2 gene product, a 25kD protein with 7 predicted membrane- 
spanning domains, is the HDEL receptor (Lewis et al, 1990: 
Semenza et al, 1990). They have also isolated a human cDNA ERD2 
homologue indicating that this gene product is highly conserved 
(Lewis and Pelham, 1990).
The ability of plant systems to recognise and
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specifically retain KDEL-tagged proteins was recently shown by 
Herman ejt al, (1990). They used site-directed mutagenesis to 
modify the C-terminus of the legume vacuolar protein 
phytohaemagglutinin (PHA) such that the four terminal aa 
residues were K-D-E-L. When expressed in transgenic tobacco 
they found a significant proportion of the mutant localised in 
the ER. However, some of the PHA-KDEL was not retained. Their 
results, together with those of Zagouras and Rose (1989) who 
observed retardation (rather than retention) of two KDEL-tagged 
animal secretory proteins expressed in mammalian tissue culture 
cells, suggest that there are other factors responsible for 
efficient retention. Herman et al (1990) suggest that the 
reason for incomplete retention was that the KDEL signal was 
not being presented optimally on their PHA-KDEL chimera.
1.3.8 VACUOLAR TARGETING
It is now thought that the trans-Golgi network (TGN), a 
series of tubulo-vesicular extensions of the trans-Golgi, is 
the site where such sorting takes place (reviewed by Griffiths 
and Simons, 1986).
(i) Targeting to the Lysosome
The mannose-6-phosphate pathway in animals enables 
lysosomal enzymes to reach their correct sub-cellular 
destination (Kornfield and Mellmam, 1989). Lysosomal enzymes 
have an as yet uncharacterised signal which is recognised by a 
phosphotransferase localised in the early Golgi. Upon 
recognition, the enzyme phosphorylates the lysosomal protein on 
a mannose residue. This is then recognised by the mannose-6- 
phosphate receptor in the TGN (Gueze e± al, 1985) and targeted 
to the lysosome. The search for the phosphorylation signal (see 
Baranski et al, 1990) is underway.
(ii) Yeaat Vacuolar Targeting
Targeting to the yeast vacuole has also been
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investigated. Two vacuolar enzymes, carboxypeptidase Y (CPY) 
and proteinase A (PrA), are both synthesised as preproproteins. 
The N-terminal propeptide (a stretch of amino acid residues 
located immediately downstream of the signal peptide) was shown 
to contain vacuolar sorting information and fusion of this 
region from preproCPY (Johnson £t al, 1987: Vails e_t ill, 1987) 
or preproPrA (Klionsky £t al, 1988) to the yeast secretory 
protein invertase resulted in targeting of the fusion protein 
to the vacuole. Vails £t al (1990) have since restricted the 
vacuolar targeting signal to four contiguous amino acids within 
the propeptide of CPY - that is, glutamine-arginine-proline- 
leucine (QRPL). The large numbers of different cytosolic and 
membrane proteins involved in yeast vacuolar sorting is 
illustrated by the isolation and characterisaton of a host of 
sorting mutants which fall into 40 vacuolar protein sorting 
(VPS) complementation groups (Rothman et al, 1989).
(ill) Plant Vacuolar/Protein Body Targeting
The story in higher plants is much less clear. As Bowles 
(1990) points out, most studies on vacuolar trafficking to date 
have involved seed storage protein deposition in dicotyledons. 
These appear to follow the biosynthetic pathway as described 
above. Hoffman e£ al (1987) and Wilkins ejt al (1990) have both 
expressed monocot storage proteins in tobacco and showed that 
that they are correctly targeted to the vacuole. However, as 
discussed in Section 1.2 there is evidence to suggest that some 
monocot seed storage proteins may not pass along the 
biosynthetic pathway. Targeting of proteins to the vacuole in 
monocots therefore, remains unclear (see review by Bowles, 
1990).
(iv) Vacuolar/Protein Body targeting in dicotyledons.
As discussed earlier, sugar modifications specific for 
the late (trans-) Golgi appear on many glycosylated seed 
storage proteins suggesting that, as with animal (lysosomal)
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and yeast systems, targeting occurs in a late compartment along 
the biosynthetic transport pathway. However, treatment of 
developing cotyledons or seeds with the glycosylation inhibitor 
tunicamycin has shown that glycosylation is not required for 
the correct targeting of some seed storage proteins (Bollini ^t 
al, 1985: Lord, 1985b). More recently, site-directed 
mutagenesis has been used to remove the glycosylation signals 
present in PHA (Voelker et al, 1989). When this mutant was 
expressed in transgenic tobacco the non-glycosylated PHA mutant 
was correctly targeted to the protein bodies.
One protein whose intracellular transport is inhibited by 
tunicamycin treatment is the precursor form of the jackbean 
lectin, Concanavalin A (Faye and Chrispeels, 1987). However, 
the post-translational modifications of this lectin are 
complicated and Bowles (1990) suggests that the inhibition of 
glycosylation results in an active lectin species which binds 
to glycoproteins at the luminal face of the RER.
Correct tissue-specific expression, glycosylation and 
targeting to the protein bodies is observed when the plant 
storage proteins B-phaseolin (Sangupta-Gopalan et jil, 1985), 
PHA (Sturm et al, 1988) and pea vicilin (Higgins e_t _al, 1988) 
are expressed in the seeds of transgenic tobacco. Furthermore, 
the potato tuber vacuolar protein patatin was correctly 
glycosylated and transported to the vacuoles of transformed 
tobacco leaf protoplasts (Sonnewald et al, 1990). This is an 
interesting observation as vacuoles in parenchymal tissue are 
essentially lytic/lysosome-like compartments whereas the 
vacuolar-derived protein storage vesicles (protein bodies) are 
primarily storage compartments. This data therefore suggests a 
common mechanism for vacuolar sorting in different tissues and 
between different plant species.
Tague and Chrispeels (1987) have shown that when PHA is 
expressed in yeast it is correctly targeted to the vacuole.
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This suggests that there may be common mechanisms for vacuolar 
targeting in yeast and higher plants.
Expression of B-phaseolin in Xenopus laevis oocytes 
(Vitale et ajL, 1986), PHA in Chinese hamster ovary (COS) cells 
(Voelker et al, 1986) and B-phaseolin in a baculovirus-infected 
insect cells (Bustos et al, 1988) all lead to their secretion, 
indicating that different sorting mechanisms are involved 
between plants and animals, and contrasting with the apparently 
common mechanism of ER retention (see section 1.2.7 above).
(v) The search for a plant vacuolar targeting signal in yeast.
Following their successful vacuolar targeting of PHA in 
yeast (Tague and Chrispeels, 1987), Chrispeels and his 
colleagues fused portions of cDNA encoding the N-terminal 
regions of PHA to the secreted yeast protein invertase (Tague 
et al, 1990). They localised the vacuolar targeting information 
to a region representing residues 14 to 23 of mature PHA. They 
further defined the signal as being centred around a Glutamine 
residue at position 19. By comparison to other legume lectins, 
they showed that this glutamine residue was conserved and the 
residues in positions 19 to 22 showed similarity to the QRPL 
vacuolar targeting sequence described above (Vails e£ al, 
1990).
However, although mutation of this Glutamine 19 caused 
secretion of the PHA/invertase hybrids, it had no affect on the 
correct targeting of the complete PHA polypeptide when 
expressed in yeast. Thus it seems other regions in the mature 
PHA molecule may act as a targeting signal, possibly in synergy 
with the N-terminal propeptide.
(vi) Clathrin coated vesicle transport to vesicles.
Further evidence for receptor-mediated transport of plant 
proteins to the vacuole is provided by Harley and Beevers 
(1989). They showed that clathrin-coated vesicles were involved 
in the transport of pea lectin to the storage vacuoles in pea.
29
Clathrin is known to be involved in receptor-mediated vesicular 
trafficking (see review by Robinson and Depta, 1988).
(▼ii) Plant defence-related proteins
Both the wound induced proteinase inhibitors from tomato 
leaves (Graham et ¿1, 1985) and the basic isoforms of the
pathogen-induced B-l,3-glucanases from tobacco (Van den Bulcke 
et al, 1989) are targeted to the vacuole. Graham et a^ (1985) 
found that, in addition to a signal peptide, the primary 
translation product of the tomato proteinase inhibitor 
contained a 19aa residue N-terminal extension that was cleaved 
in the vacuole. On the other hand, the vacuolar forms of B-1,3- 
glucanase are synthesised in tobacco with a cleavable C- 
terminal propeptide (Shinshi e£ al, 1988). Do these extensions 
hold vacuolar targeting information?
In support of this, Reikhel and co-workers (Bednarek e_t 
al, 1990: Wilkins e£ al, 1990) have recently shown in monocots 
that barley lectin precursor contains a C-terminal extension 
which is necessary for vacuolar targeting.
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1.3.9 SUMMARY
It is clear that intracellular sorting in plant systems 
shares some common features and mechanisms with the well- 
characterised pathways in animals and yeasts. In particular, 
evidence now exists for common mechanisms of membrane 
insertion, ER retention and vesicular traffic. However, there 
appear to be some features unique to the Plant Kingdom - such 
as the oligosaccharide-independent targeting of proteins to the 
vacuole which is not necessarily mediated by an N-terminal 
sorting sequence. The nature and location of plant protein body 
and vacuolar targeting signals are currently poorly understood.
1.4 RICIN AND THE CASTOR BEAN
1.4.1 INTRODUCTION
Ricin is isolated from the seeds of the castor bean, 
Ricinus communis L. (family, Euphorbiaceae). The castor bean 
plant is grown in many countries as it is a hardy plant and a 
good source of oil; a dry seed typically contains lOOmg of 
lipid (Roberts and Lord, 1981a). The fruiting body is 3-4cm in 
diameter, spined and contains three seeds. Seeds are brown in 
colour with black flecks. The endosperm is the main storage 
organ and is the most prominent internal tissue - the 
cotyledons being poorly developed.
The protein bodies of the endosperm are the main sites of 
protein storage and their protein components have been well 
characterised (Youle and Huang, 1976: Tully and Beevers, 1976). 
They are divided into crystalloid and soluble matrix fractions. 
The crystalloid component consists of 11S globulins whereas the 
7S lectins and 2S albumins form the main part of the matrix. 
All of these storage proteins are disulphide-bonded 
heterodimers, initially synthesised as preproproteins and are 
transported along the secretory pathway en route to the protein 
bodies (Lord, 1985). Storage protein synthesis occurs at a late 
stage in seed development; maximal synthesis occurring at the 
time of testa development (Roberts and Lord, 1981a).
1.4.2 11S GLOBULINS.
The 11S globulins consist of a heterogenic group of 
closely-related non-glycosylated polypeptides which can account 
for up to 80Z of the protein storage reserve in the mature seed 
(Tully and Beevers, 1976). They are legumin-like, consisting of 
six non-covalently bound subunits, each subunit being a 
disulphide-linked heterodimer with a large, acidic A chain and 
a smaller, basic B chain (Gifford and Bewley, 1983). The A and
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B chains are synthesised as a single polypeptide. Cleavage of 
this precursor has been demonstrated Ln vitro using a matrix 
fraction from castor seed protein bodies as a source of 
processing activity (Fukasawa et al, 1988).
1.4.3 2S ALBUMINS.
The small 2S albumins are allergenic (Youle and Huang, 
1978) and are a major store of nitrogen and sulphur, containing 
a high proportion of glutamate and cysteine residues (see 
Wilson, 1986). A protein sequence has been determined for a 2S 
albumin and both cDNA and genomic clones have been isolated 
(Sharief and Li, 1982: Irwin, 1989). Analysis of the cDNA 
sequence reveals that the 2S albumins are synthesised as a 
single precursor, the two subunits being separated by a 3aa 
residue linker which terminates in asparagine. Irwin 
demonstrated the processing of the albumin precursor In vitro 
using a matrix fraction of protein bodies isolated from dried 
seeds. Irwin (1989) also presented evidence for a unique 
polycistronic mRNA species which encodes two closely-related 
albumin precursors.
1.4.4 7S LECTINS - RICIN
Ricin and Ricinus communis agglutinin (RCA) are the two 
closely-related lectins found in the matrix fraction of the 
castor seed protein bodies. Ricin (RCA II) is a 62kD monovalent 
lectin which agglutinates cells only weakly, but is one of the 
most cytotoxic proteins known. For instance, Balint (1974) 
comments that 1kg of purified ricin would be sufficient to kill
3.6 million people. It is a heterodimeric molecule with a 265aa 
residue A chain linked by a single disulphide bond to a 260aa 
residue B chain. Both chains contain two N-glycosylation 
recognition sequences (Asn-X-Ser/Thr). The A chain exists in 
both singly and doubly glycosylated forms: the composition of
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each oligosaccharide moiety being (N-acetylglucosamine)2  
(xylose)^(fucose)^(mannose) 3 (see Lord et al, 1987). The B- 
chain is glycosylated with two oligosaccharide groups composed 
solely of (N-acetylglucosamine) and (mannose) and it also 
contains four intra-chain disulphide bridges.
RCA (RCA I) is a divalent lectin with strong 
agglutinating properties. Structurally it is composed of two 
ricin-like heterodimers linked by non-covalent forces. Both A 
and B chains of RCA closely resemble their respective subunits 
in ricin and immuno cross-reactivity has been shown to exist. 
However, the RCA B chain contains a fucosylated oligosaccharide 
chain not present in ricin B chain (Lord and Harley, 1985).
The A chains of both lectins have RNA specific N- 
glycosidase activity which allows them to modify and thereby 
to inactivate eukaryotic 60s ribosomal subunits (see Section
1.4.5). The B chains contain one high affinity and one low 
affinity sugar binding site specific for galactose and N- 
acetylgalactosamine.
Whole ricin has been crystallised (Villafranca and 
Robertus, 1977) and the 3D structure determined (Montfort e£ 
al, 1987). A schematic representation is shown in Figure 1.4.4. 
An interesting feature of the B chain is that it is a bilobal 
structure - each domain containing a galactose binding site and 
two disulphide bridges. It is suggested that this is a result 
of successive gene duplications of an ancestral galactose­
binding peptide (Villafranca and Robertus, 1981).
Ricin and RCA can be purified from a crude seed 
homogenate by affinity chromatography on Sepharose 6B; the 
lectins being selectively retained by interaction with the 
beta-galactose residues exposed on the matrix. A number of 
different isolectin forms exist (Lin and Li, 1980) as a result 
of expression from small multi-gene families (Roberts et ¿1, 
1990).
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FIGURE 1.4.4 SCHEMATIC REPRESENTATION OF THE 3D STRUCTURE OF
RICIN AND RCA.
A/ Schematic representation of the castor bean 75- 
lectins, ricin and RCA. Ricin is a heterodimer with a 32kD A 
chain and 34kD B chain, linked by a single disulphide bond. 
Both chains are N-glycosylated. The A chain (effectomer) 
enzymatically modifies eukaryotic 60S ribosomes and the B chain 
(haptomer), with its two sugar binding sites, binds to most 
eukaryotic cells, making ricin a potent cytotoxin. RCA 
resembles a dimeric form of ricin, with two A' chains and two 
B' chains, the two A'B' pairs being held together by non- 
covalent forces. The tetrameric configuration of RCA makes it a 
strong cell agglutinator, as the B chains can bind to sugar 
residues exposed on the surfaces of different cells. RCA 
however, is relatively non-cytotoxic. (Figure reproduced by 
permission from J.M.Lord.)
B/ Diagramatic representation of the 3D structure of 
ricin elucidated by X-ray crystallography (Montfort £t al, 
1987). The amino-terminus of A chain (grey) and B chain (blue) 
is shown (NH2 ): the N-linked glycans are represented by 
hexagons: alpha-helices are represented as tubes and beta- 
sheets are shown by arrows. The A chain has both alpha-helical 
domains and beta-sheets. The B chain consists of two beta- 
sheeted domains, each containing a sugar-binding site, which 
have arisen as a result of gene duplication (Villafranca and 
Robertus, 1981).
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Complete cDNA clones for both ricin and RCA have 
been isolated and sequenced (Lamb et al, 1985: Roberts et alt 
1985). Amino acid predictions reveal that the A chains of the 
two lectins are 93% homologous and the B chains 84% homologous. 
Using clones derived from the ricin cDNA, soluble recombinant A 
and B chains have been synthesised separately in E.coli (O'Hare 
et al, 1988: Hussain et ¿1, 1989). However, the recombinant B 
chain is extremely unstable when synthesised in this 
unglycosylated form. In an endeavour to find an expression 
system capable of producing a stable recombinant B chain, B 
chain clones have also been expressed in yeast and Xenopus 
oocytes using the 35aa residues from the N-terminus of 
preproricin to direct the B chain into the ER lumen (Richardson 
et al, 1988ab). Unfortunately, the recombinant B chain made in 
yeast was not stable because it contained high mannose glycans 
added to the protein by yeast sugar modification enzymes which 
are dissimilar to those in higher eukaryotic organisms. 
However, the recombinant B chain synthesised in Xenopus oocytes 
appears to be both stable and biologically active.
Both lectins are synthesised as single-chain 
preproproteins that have a 35aa residue N-terminal extension 
and a 12aa residue linking peptide which separates the 
sequences of the mature A and B chains. The N-terminal 
extension contains a ER signal peptide which mediates the co- 
translational translocation of nascent preproproteins across 
the ER membrane (Roberts and Lord, 1981b). It is at this stage 
that signal peptide cleavage and core-glycosylation takes 
place. The proteins are disulphide bonded and transiently 
sequestered in the ER lumen (Butterworth and Lord, 1983). 
Direct evidence for the lectin precursors being transported 
along the protein biosynthetic (secretory) pathway involving 
Golgi-localised oligosaccharide modifications is available 
(Lord, 1985ab: Foxwell et al, 1985). Lord (1985b) also showed
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that the protein body targeting signal was not oligosaccharide- 
specific by showing the correct deposition of unglycosylated 
proricin in the protein bodies of tunicamycin-treated 
developing seeds.
Once sequestered in the protein bodies, proricin is 
processed by endoproteolytic removal of the 12aa residue linker 
(Harley and Lord, 1985). This linker terminates with an 
asparagine residue. Furthermore, the 35aa residue N-terminal 
extension of preproricin has a carboxy-terminal asparagine and, 
as will be shown, computer predictions strongly suggest that 
the whole extension is not removed by the signal peptidase in 
the ER. It is therefore likely that proteolytic processing also 
involves the removal of an N-terminal peptide.
1.4.5 RICIN - A TYPE II RIP
Ricin is part of a large family of toxic lectins 
termed Ribosome Inactivating Proteins (RIPs). Ricin A chain is 
the toxic moiety (effectomer) and it enzymatically inactivates 
60s ribosomal subunits thus inhibiting eukaryotic protein 
synthesis (Olsnes et al, 1975: reviewed by Olsnes and Pihl, 
1982). Protein initiation and elongation are inhibited in 
ribosomes pre-incubated with ricin (Osborn and Hartley, 1990). 
Its ability to arrest protein synthesis in rabbit reticulocyte 
lysates has been used in double message translation assays to 
allow characterisation of ricin A chain mutants in vitro (May 
et al, 1989).
The A chain is an RNA-specific N-glycosidase. It 
specifically depurinates a single adenine (A^24) in rat 28S 
rRNA (Endo and Tsurugi, 1987: Endo et al, 1987) (see Figure
1.4.5). The depurination makes the RNA sugar-phosphate backbone 
susceptible to mild base hydrolysis, a feature which has been 
exploited experimentally to diagnose A-chain catalysed 
modification of ribosomes. The reagent commonly used is acetic
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FIGURE 1.4.5 SITE OF ACTION OF RICIN ON RAT 28S rRNA.
The site of action of reduced ricin A chain on rat 
28s rRNA. The A chain specifically depurinates a single adenine 
nucleotide in the 28S rRNA component of 60S eukaryotic 
ribosomal subunits (position 4324 in rat 28srRNA). This 
depurination makes the sugar-phosphate backbone of the 28S rRNA 
susceptible to mild base hydrolysis. Treatment with acetic 
aniline for instance releases a 650 nucleotide fragment, which 
can be resolved by denaturing gel electrophoresis and is 
diagnostic for ricin-catalysed ribosomal modification.
(Figure reproduced by permission of J.Cook.)
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28S RNA
aniline (see May et _al, 1989). The residues Glu1^  and Arg1®0 
in ricin A chain are involved in its enzymatic activity 
(Frankel e£ al, 1990: Chaddock,J. personal communication). It 
is unclear from the published literature whether the precursor 
forms of ricin have RNA N-glycosidase activity. However, the A 
chain alone is not toxic to intact cells. The B chain has a 
mediating role in the cytotoxicity of ricin as it binds to 
glycoproteins bearing exposed galactose residues on the cell 
surface. The endocytosis of ricin has been extensively reviewed 
(see Lord (it _al, 1987) and further discussion is not relevant 
here.
RIPs have been identified in other plants and 
bacteria and fall into two categories: type one RIPs which are 
non-cytotoxic and resemble ricin A chain; and type two RIPs 
which are cytotoxic heterodimers resembling whole ricin.
1.4.6 RICIN AND IMMUNOTOX1NS
Their potent toxicity has made RIPs popular 
candidates for therapeutic purposes in selective cell 
destruction (reviewed by Lord et al, 1987). The term 
'immunotoxins' has been coined to describe conjugates of 
immunoglobulins (Igs) raised against epitopes on the surfaces 
of malignant cells coupled to RIP derivatives. Initial tissue 
culture studies suggested that Ig:whole ricin conjugates were 
toxic but non-specific since the B chain binds 
opportunistically to most cell types. Conversely, Ig:Ricin A 
chain conjugates had a high specificity but variable toxicity. 
The lack of cell specificity and higher toxicity with the 
Ig:whole ricin conjugates have been attributed to the B chain. 
The binding of the B chain to animal cell surfaces has been 
discussed. The higher toxicity may be the result of a 
potentiating activity of the B chain on the intracellular 
membrane translocation of the A chain into the cytosol.
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Current research therefore, is aimed at genetically 
engineering the B chain to remove the galactose binding sites 
but maintain its putative ability to potentiate the 
internalisation of the A chain. However, problems have arisen 
when trying to express the B chain or derived mutants. 
Glycosylation and the correct formation of the 4 intrachain 
disulphide bonds seem essential for solubility of the product 
(Richardson et al, 1989: Richardson ejt al, 1991). This is 
thought to be the reason that expression in the ER lumen of 
Xenopus laevis oocytes has proved to be the only successful 
heterologous system for this polypeptide to date. Once 
synthesised, the B chain requires stabilisation in solution by 
the presence of the A chain and galactose. It has therefore 
been considered for sometime that expression of the precursor 
form of ricin might be a better means of providing a soluble B 
chain, providing that a successful means of releasing the B 
chain from the A component is found.
1.4.7 SUMMARY
The castor bean seed storage proteins have been 
extensively studied and their subcellular sites of storage have 
been determined. In particular, the cytotoxic lectin, ricin, 
has been the focus of intense interest. Ricin cDNA, genomic and 
protein sequences have been reported. The three dimensional 
structure of mature ricin has also been determined. 
Biologically active recombinant ricin A chain has been 
successfully expressed and purified. The mode and site of 
action of this A chain on eukaryotic ribosomes has been 
investigated and its use in therapeutic agents has been 
documented. However, immunotoxins containing the A chain alone 
appear to have variable toxicity. Research in this field has 
now turned to look at the role of B chain in the 
internalisation of ricin into the cell. The B chain of ricin
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has been expressed in bacterial, yeast and animal heterologous 
systems with variable success. It appears glycosylation and 
correct intra-chain disulphide bond formation of the expressed 
B chain are required for its solubility. To date the only 
useful system found for the expression of B chain has been in 
Xenopus oocytes. Ricin B chain is also stabilised in solution 
in the presence of the A chain and therefore co-expression of 
the single chain ricin precursor (containing both A and B 
chains) may prove to be a way of successfully expressing 
soluble B chain.
As with many plant storage proteins, ricin is 
initially synthesised as a preproprotein. It shares many common 
features with other seed storage proteins and so provides a 
good model for studying both intracellular targeting (to the 
protein bodies) and post-translational processing of these 
proteins.
Ricin has an RNA-specific N-glycosidase activity. 
Many enzymes are initially synthesised as inactive zymogen 
precursors and require endoproteolytic processing (which often 
requires the removal of one or more propeptides). By studying 
the enzyme activities of preproricin before and after cleavage 
it may be possible to determine whether ricin activation occurs 
in a similar way.
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1.6 AIMS OF THE PROJECT
The alms of the work described here are summarised
below:
1. To determine the function of the N-terminal propeptide of 
proricin.
2. To determine the biological activities associated with 
proricin.
3. To purify and characterise an (asparagine-specific) 
endoprotease(s) from castor bean endosperm protein bodies which 
might post-translationally process in vitro synthesised 
proricin.
4. To compare the RNA-specific N-glycosidase activity of 
proricin before and after linker cleavage.
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2.1 METHODS OF DMA AND RNA MANIPULATION
2.1.1 GROWTH AND MAINTENANCE OF BACTERIAL CULTURES.
Details of the Escherichia coli (E.coli) strains used in 
these studies are shown in Table 2.1.1.
(i) Maintenance.
Colonies were streaked onto giucose/minimal media plates 
(lxM9 salts, ImM MgS04, ImM thiamine-HCl, O.lmM CaCl2, 0.2% w/v 
glucose, 1.57. Bacto-agar: 10xM9 salts is 60g Na2HP04, 30g 
lvH-/ r04, 10a NH4C1, 5g NaCl per litre). The plates were
incubated inverted overnight, at 37C, before being sealed with 
parafilm. They were stored at 4C for periods of up to one month 
before re-plating.
(ii) Growth on solid media.
For the selection of cells transformed witn piasmia una, 
bacteria were suspended in L-Broth (1% w/v Bacto-tryptone, 0.5% 
w/v Bacto-yeast extract, 1% w/v NaCl) and spread evenly onto L- 
Amp plates (L-Broth made 1.5% w/v Bacto-agar and 100)jg/ml 
Ampicillin). The plates were incubated inverted overnight at 
3/C. Single colonies were picked from these plates and streaked 
onto fresh L-Amp media. These colonies could be stored for up 
to two weeks at 4C.
(ill) Growth in liquid aedia.
To create an overnight culture, lOmls of L-Broth was 
inoculated with a single colony picked from a plate, and 
incubated overnight at 37C, 200rpm, in an orbital shaker. To 
select for bacterial colonies transformed with plasmids bearing 
antibiotic resistance to ampicillin, the antibiotic was added 
to the L-Broth before incubation to a final concentration of 
100^ig/ml.

2.1.2 PREPARATION OF PLASMID DNA.
(i) Small-scale preparation of plasmid DNA - "mini-preps".
The alkaline-lysis method of Maniatis at al (1989) was 
used for the rapid preparation of plasmid DNA.
(ii) Large-scale preparation of plasmid DNA.
The method used was based on the method described by 
Holmes and Quigley (1981). An overnight culture was grown from 
a colony transformed with the plasmid of interest. The 
following day, 400mls of SOB medium (2% w/v Bacto-tryptone,
0.5% yeast extract, lOmM NaCl, 2.5% KC1, lOmM MgC^: made 
lOOug/ml Ampicillin) was inoculated with 4mls of this overnight 
culture. The 400ml culture was incubated overnight as described 
above. The cells were then pelleted at 5,000rpm for lOmin at 
4C, and resuspended in 7.2mls SET (25mM Tris-HCl pH8.0, lOmM 
EDTA, 15% w/v sucrose). To this, 7.2mls lysozyme solution 
(4mg/ml lysozyme in SET: made fresh) was added and the 
suspension incubated at room temperature for 5min. Then 12mls 
of 10% w/v Triton X-100 was added and the solution boiled over 
a bunsen flame until it became gelatinous and stuck to the 
walls of the container. The container was briefly immersed in a 
boiling water bath, before plunging it into icy water.
The gelatinous cell mass formed after these treatments 
was centrifuged at 20,000rpm for 30min at 4C. The supernatant 
from this centrifugation was transfered to a fresh tube and 0.5 
volumes 7.5M ammonium acetate added. The solution was incubated 
on ice for 20min to precipitate protein, and was then 
centrifuged at 15,000rpm for lOmin at 4C. The protein pellet 
was discarded, 0.7 volumes isopropanol added, and the nucleic 
acid left to precipitate at -20C for 10 minutes. The 
precipitated nucleic acid was pelleted at 15,000rpm for lOmin 
at 4C. The pellet was drained and the nucleic acid resuspended 
in 4mls Low TE (lOmM Tris-HCl pH8.0, O.lmM EDTA).
The supercoiled plasmid DNA was then purified away from
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RNA, chromosomal and nlcked-plasmld DNA by resolution on a 
Caesium chloride gradient. 4.3g caesium chloride was dissolved 
in and 0.5ml ethidium bromide solution (5mg/ml in water) added 
to the 4ml isolated nucleic acid. The solution was sealed in a 
4.5ml Beckman 'quick-seal' ultracentrifuge tube and centrifuged 
at 55,000rpm, 20C for 6 hours in a Beckman Vti65 rotor. The 
lower, supercoiled plasmid band was removed using a syringe and 
needle, and the ethidium bromide removed by three extractions 
with isopropanol which had first been equilibrated with caesium 
chloride-saturated TE (lOmM Tris-HCl pH8.0, ImM EDTA). Four 
volumes of Low TE was then added to the aqueous phase, the 
solution made 0.3M with respect to sodium acetate, and the DNA 
precipitated by adding 2 volumes of absolute ethanol and 
incubating at -20C for 2 hours to overnight.
Finally, the DNA was pelleted at 15,000rpm for lOmin at 
4C, the pellet washed in 70% ethanol, dried in vacuo, and 
resuspended in 400pl water.
(iii) Single-stranded (ss) N13 preparations.
The single-stranded (+ strand) form of vectors and constructs 
derived from the bacteriophage M13 (Messing, 1986) was prepared 
according the method of Schreier and Cortese (1979).
(iv) Replicative fora (RF) M13 preparations.
2ml of 2xTY/magnesium (1.6% w/v Bacto-tryptone, 1% w/v 
yeast extract, 0.5% w/v NaCl, made lOmM MgC^)» was inoculated 
with an M13 plaque taken from a fresh plate - using a glass 
pipette to remove the plaque in the form of an agar plug. 0 . 0 1  
volumes of an overnight culture of E.coli TGI cells was added, 
and the culture incubated in orbital shaker for 5-6 hours at 
37C and 300rpm. The cells were then pelleted in a microfuge for 
5min and the supernatant, containing infectious ssM13 
particles, was stored overnight at 4C.
400ml of 2xTY/magnesium was inoculated with 0.01 volumes 
of an overnight culture of E.coli TGI cells and incubated at
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37C, 200rpra, until the cell culture was in mid-log phase (taken 
to be when the optical density of the culture at 600nm reached 
approximately 0.5). The suspension of infectious ssM13 
particles was then added, and the culture grown for a further 4 
hours at 37C, 300rpm. The RF form was then prepared as 
described for large-scale plasmid preparations above.
2.1.3 STORAGE OF DNA.
All preparations of purified plasmid and M13 (ss and RF) 
DNA were stored frozen in H2O or TE at -20C.
2.1.4 QUANTITATIVE ESTIMATION OF DNA.
(i) Spectrophotometric estimation.
The concentration of DNA in an aqueous solution was 
estimated by measuring the absorbance at 260nm (&260^ an<* 
converting this value to mg/ml, viz; 1 OD unit is equivalent to 
40ug/ml for double-stranded (ds) DNA or 30ug/ml for ssDNA. As 
an indication of purity, the level of protein contamination in 
a DNA solution was monitored by determination of the A26o:A280 
ratio. A solution of pure nucleic acid gives an A260:A280 ratio 
of 1.8 (Maniatis et al, 1989).
(ii) Gel analysis.
To quantitate fragments of plasmid DNA, a known aliquot 
was run on an agarose gel (as described below) alongside 500ng 
of bacteriophage lambda DNA that had been previously digested 
with Hindlll and EcoRI and heated at 65C for 5min to dissociate 
the cos sites. The bands were visualised by placing the gel on 
a UV transilluminator, and the intensity of the fragment 
compared to those of the lambda bands. The concentration of DNA 
was then determined by reference to Table 2.1.4.
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TABLE 2.1.4
SIZES AND COHCEHTRATIOHS OF LAMBDA FRAGMENTS AFTER 
EcoRl/Hlndlll DIGESTION.
Size of Fragment(bp) % of total bp dr DNA/500nR
21,226 43.7 218
5,148 run ag  ^band 
4,973
20.9 105
4,268 8.8 44
3,530 7.3 37
2,027 4.2 2 1
1,904 3.9 20
1,584 3.3 17
1,375 2 .8 14
947 2 . 0 10
831 1.7 9
564 1 . 2 6
125 0.3 2
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2.1.5 RESOLUTION OF DNA BY GEL ELECTROPHORESIS.
(i) Agarose/TBE gels (Maniatis et _al, 1989).
DNA samples were mixed with 0.1 volumes lOxLoading buffer 
(15% w/v Ficoll 400, 5mM EDTA, 0.1% Bromophenol blue) and 
loaded into the wells of a 11x14cm2 horizontal slab gel 
comprising of 0.7%-1.5% w/v agarose in lxTBE (lOxTBE is 108g 
Tris-HCl, 55g boric acid, 9.3g EDTA per litre) and containing
0.5}ig/ml ethidium bromide. The gels were run submerged in 
lxTBE, in a BRL Series H5 electrophoresis tank at 60mA for 2-4 
hours. Resolved DNA bands were visualised by placing the gel on 
a UV transilluminator.
(il) Polyacrylamide gel electrophoresis.
Both buffer-gradient (Biggin £t al, 1983) and linear 
(Maniatis et al, 1989) 6% w/v polyacrylamide gels were used for 
the resolution of DNA bands synthesised in sequencing 
reactions. The solutions necessary for preparation of a 
buffered-gradient gel are as follows:
40% acrylamide (1000ml)
380 g acrylamide 
20 g bis-acrylamide 
H2O to 10 0 0ml
Filtered through Whatman Nol. paper 
Stored in the dark at 4C.
0.5xTBE. 6% acrylamide gel mix (500ml )
75 ml 40% acrylamide 
25 mis lOxTBE 
230 g urea
Stored for 1-2 months in the dark at 4C.
(con. overleaf)
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5xTBE, 6% acrylamide gel mix (200ml)
30 ml 40% acrylamide 
100 ml lOxTBE 
92 g urea
10 mg bromophenol blue
Stored for 1-2 months in the dark at 4C.
To prepare a 40cm x 20cm x 0.35mm gel, 30ml of 0.5xTBE 
gel mix and 7ml of 5xTBE gel mix were aliquoted into separate 
beakers. 60pl and 14jj1 of a freshly prepared solution of 25% 
w/v APS in water were added to the 0.5xTBE and 5xTBE gel mixes 
respectively. Polymerisation of the acrylamide was initialised 
by adding 60jj1 and 14pl of TEMED to the respective solutions 
and mixing. Immediately, 22ml of 0.5xTBE gel mix was taken up 
into a 50ml plastic syringe. The remainder was taken up into a 
20ml syringe before slowly drawing up the 7ml of SxTBE gel mix 
into the same syringe, being careful not to mix the two layers 
that formed. When this operation had been completed, three or 
four bubbles of air were drawn through the 20ml syringe in 
order to form a gradient between the two buffers. This solution 
was then carefully dispensed in between two taped glass plates 
separated by spacers, which were held at an angle of 45° to the 
vertical. After the dispensation of the gradient the plates 
were lowered onto the bench and the 50ml syringe picked up. The 
plates were then again raised to 45° and the contents of this 
second syringe were used to complete the gel. During the 
pouring of the gradient it was important to maintain an even 
flow of fluid in order to guard against the formation of 
bubbles. Once the gel had been poured, a suitable gel comb was 
fitted and the gel left in a horizontal position to polymerise.
For linearly-buffered sequencing gels, the following 
solution, suitable for 40cm or 50cm long gels, was prepared:
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Linear gel mix (50ml)
7.5 ml 40% acrlyamide 
5 ml lOxTBE 
23 g urea 
H2O to 50 ml
To initiate polymerisation, lOOpl of 25% w/v APS and 
TEMED were added, and the solution was immediately poured 
between prepared gel plates held at an angle of 45° to maintain 
an even flow. A comb was fitted and the gel left to polymerise.
All sequencing gels were run in lxTBE, at a constant 
power of 40W for 2.5 - 5 hours. After running, the gel was 
fixed in 10% methanol, 10% acetic acid, for 15min, and dried 
onto 3MM paper on a heated vacuum gel drier. The dried gel was 
exposed to Fuji RX X-ray film in a lightproof cassette before 
developing the film as described in section 2.3.6.
For the sizing of synthetic oligonucleotides, 
phosphorylated in the presence of [ ^PjATP, 1 6% polyacrylamide 
gels were used. The 16% gel mix was made as shown below:
16% gel mix
40% acrylamide stock 80 ml
lOxTBE 20 ml
urea 92 g
H2 0 to 200 ml
Stored at 4C in the dark for 1-2 months.
To initialise polymerisation, 90pl 25% w/v APS and 90ul 
TEMED were added to 45ml of gel mix, and the gel poured between 
two taped 40x20cm^ sequencing plates.
Before loading, the sample was denatured at 80C for 5min 
in formamide dye (95% formamide, 20mM EDTA, 0.1% w/v 
bromophenol blue, 0.1% w/v xylene cyanol). The gel was run at 
40W in lxTBE until the bromophenol dye had progressed two-
51
thirds through the gel. The gel was then fixed in 10% methanol, 
10% acetic acid, covered with clingfilm and exposed to Fuji RX 
X-ray film.
2.1.6 GEL ELECTROPHORESIS OF RNA.
This was used for the resolution of radiolabelled mRNA 
species synthesised In vitro. A 15% formaldehyde, 1.5% agarose 
gel was made by first boiling 1.5g of agarose in 150ml H2O and 
20ml lOxMOPS buffer (0.2M MOPS, 50mM sodium acetate, lOmM EDTA 
- NaOH pH7.0). Once dissolved, the agarose solution was cooled 
to 60C and 30ral of filtered formaldehyde was added (40% w/v 
commercially available formaldehyde solution, filtered through 
Whatman No.l. paper before use). The gel was finally poured 
into a standard 15cm flat-bed gel plate fitted with a comb, and 
the gel allowed to set in a fume cupboard.
The samples were prepared by mixing 5pl of the RNA sample 
with 15pl of Denaturation solution (made immediately before use 
by mixing 500pl deionised formamide with 150pl filtered 
formaldehyde and lOOpl lOxMOPS buffer). This was heated at 60C 
for 5min, cooled to room temperature and 2ul RNA loading buffer 
(50% glycerol, 0.2% w/v bromophenol blue) added. Before loading 
the samples onto the gel the wells were flushed out with 
Denaturation solution.
The gel was run submerged in lxMOPS buffer, in a fume 
hood at 40mA for 2-3 hours. The gel was then dried down onto 
Whatman 3MM paper and the dried gel exposed to Fuji RX X-ray 
film.
2.1.7 GEL ISOLATION OF DNA FRAGMENTS.
Two methods of gel isolation were regularly used. For 
efficient recovery of DNA fragments, the low-melting point 
agarose gel method of Higuchi e_t al (1981) was found to be the 
most reliable and was followed exactly. However, for a more
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rapid recovery of DNA fragments where high recoveries were not 
essential, the DNA was eluted onto filter paper exactly as 
described by Dretzen eit al (1981).
2.1.8 PARTITIONING AND PRECIPITATION OF DNA.
All phenol and phenol/chloroform extractions were 
performed exactly as described by Maniatis e£ a_l (1989). 
Ethanol precipitation of nucleic acid, using 0.1 volumes 3M 
sodium acetate pH6.0 or 0.5 volumes of 7.5M ammonium acetate, 
was also as described by Maniatis £t al (1989). Isopropanol 
precipitation was used to selectively precipitate large nucleic 
acid fragments away from short-chain RNA species and free 
nucleotides. For this, the DNA solution was made 0.6M with 
respect to sodium acetate pH6.0, 0.6 volumes isopropanol was 
then added and the DNA precipitated at room temperature for 
5min. The precipitated DNA was pelleted, washed, dried and 
resuspended as described by Maniatis et al (1989).
2.1.9 RESTRICTION AND MODIFICATION OF DNA.
(i) Restriction digests.
Restriction enzymes were used according to the suppliers 
instructions. Incubations with DNA were carried out in either 
the buffers supplied with the enzyme or in the appropriate lx 
salt buffer described by Maniatis et al (1989).
(ii) Phosphatasing reactions.
The removal of 5' phosphate groups from DNA fragments was 
done according to the method of Maniatis et al (1989). The 
reaction was carried out in lxCIP buffer (made as a lOx stock, 
viz.: 0.5M Tris-HCl pH9, lOmM MgCl2, ImM ZnCl2, 10mM
spermidine) with 1 unit calf intestinal phosphatase (cip) per 
ug DNA. Incubation of the reaction was for 15min at 37C, 
followed by incubation at 56C for a further 15min. Another unit 
of cip was added and the incubation steps repeated. This method
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was used successfully to remove 5' phosphate groups from both 
'blunted' and 'sticky-ended' DNA fragments.
(ill) End-filling reactions
DNA fragments with 5' overhangs were blunt-ended 
following the method described in the BRL cloning manual (see 
Appendix for Suppliers).
(iv) Ligations.
DNA was ligated with T4 DNA ligase following the 
instructions described in the BRL cloning manual.
2.1.10 TRANSFORMATION OF E.COLI.
(i) Preparation of bacteria.
Exponentially growing E.coli were made competent for 
transformation by two washes in calcium chloride solutions. The 
cells were first pelleted at 3,000rpm for 5min at 4C, gently 
resuspended in 0.5 volumes 50mM ice-cold CaCl2 , and incubated 
on ice for 30min. The cells were then pelleted at 2,500rpm for 
5min at 4C, resuspended in 0.05 volumes 50mM CaCl2 » and left on 
ice for a minimum of 30min before transformation.
(ii) Transformation of E.coli with plassiid DNA.
Competent cells were divided into 200pl aliquots on ice, 
lOng of plasmid DNA was added, and the tubes vortexed briefly 
to help the DNA adhere to the surface of the cells. The tubes 
were incubated on ice for 45min, heat shocked at 42C for 90s, 
and allowed to recover on ice for 5min, before the addition of 
300pl L-Broth. The tubes were then incubated at 37C for 60min 
to enable the transformed cells to begin expression of the 
plasmid-borne antibiotic resistance gene. The cells were then 
pelleted in a microfuge for 30s and resuspended in 160}il fresh 
L-Broth. lOpl, 50pl and lOO^ il were then spread onto L- 
ampicillin plates and incubated, inverted, overnight at 37C.
(iii) Transformation of E.coli with ss/RF M13 DNA.
200ul of competent cells were mixed with lng M13 DNA,
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vortexed briefly, and incubated on ice for 30min. After heat- 
shocking for 45s, the cells were returned to ice for a further 
5min, before plating out in 3ml molten B-top agar (8g Bacto- 
tryptone, 5g NaCl, 6g Bacto-agar per litre) containing lOjil 
lOmM IPTG, 25 jil 40mg/ml X-Gal (in dimethylsulphonide) and 
300jil of a culture of exponentially growing E.coli, on 
glucose/minimal media plates. The plates were incubated 
inverted overnight at 37C.
2.2.11 SEQUENCING OF DNA.
(i) Preparation of DNA teaplates.
When screening putative mutants after site-directed 
mutagenesis ssM13 preparations were prepared and used directly 
as templates in sequencing reactions. To prepare caesium 
gradient-purified plasmid DNA for sequencing, the DNA strands 
were separated by incubating 2}ig of DNA, diluted to 18ul in TE, 
with 2jil 2M NaOH for 5min at room temperature. The base was 
neutralised and the DNA precipitated by the simultaneous 
addition of 8jil 5M ammonium acetate pH7.5 and lOOjil of -20C 
absolute ethanol. The tube was left on dry ice for 30min, the 
DNA pelleted for lOmin in a microfuge, washed in absolute 
ethanol, and dried in vacuo. It was resuspended in 2jil H2O and 
used immediately as a template.
To screen a number of bacterial colonies for a particular 
plasmid-borne sequence, the alkaline lysis mini-prep, method of 
Maniatis e£ al, 1989, was used with the following 
modifications. Cells from 5ml of an overnight culture were 
lysed instead of 1.5ml. Following the centrifugation step to 
pellet the chromosomal DNA, the plasmid DNA was ethanol 
precipitated from the supernatant and resuspended in TE. Boiled 
RNase A was added to a final concentration of 9 units/ml, and 
the solution incubated at 37C for 30min. The solution was made 
150mM NaCl, the aqueous phase phenol/chloroform extracted
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twice, extracted once with chloroform:IAA (24:1), and twice 
with ether. 0.2 volumes of 3M sodium acetate pH6 was added and 
the DNA precipitated with 0.6 volumes isopropanol. The DNA 
pellet was resuspended in 50jil TG. An aliquot was restricted 
and quantitated by gel analysis. 3-4pg of the mini-prep. DNA 
was then denatured as described for caesium-gradient purified 
DNA (above).
(ii) Sequencing reactions.
The synthetic oligonucleotides used as sequencing primers 
in this study, are shown in Table 2.1.11
All sequencing of DNA was performed using methods based 
on the dideoxynucleotide method of Sanger et aJL (1977). Early 
experiments followed the method of Bankier e_t jal (1986), where 
Klenow was used to extend off the sequencing primer. However, 
the more reliable and versitile Sequenase™ kit (United States 
Biochemical), which uses a modified form of T7 polymerase, was 
later used successfully to sequence M13 and plasmid DNA 
templates. The method used was exactly as described in the 
protocol provided with the Sequenase™ kit.
The products of sequencing reactions were resolved on 6% 
polyacrylamide gels (prepared and run as described in Section
2.1.5). Immediately before loading the samples on the gel, 4ul 
formamide dye (95% formamide, 20mM EDTA, 0.1% w/v bromophenol 
blue, 0.1% w/v xylene cyanol FF) was added to each
dideoxynucleotide-terminated reaction and they were incubated 
at 80C for 5min. Typically, loading 2-4pl of each reaction was 
sufficient to enable the sequence to be read after overnight 
exposure to Fuji RX X-ray film.
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TABLE 2.1.11 SEQUENCING PRIMERS
Name (bp) 
CL581 (16) 
CL585 (17) 
CL586 (18) 
CL587 (17) 
CL588 (17) 
NPT2 (20)
UNIVERSAL PRIMER 
(17)
Sequence (51 - 31)
AAA CCG GGA GGA AAT A 
A GAT CCT AGC GTA ATT A 
G CAA AGA CGT AAT GGT TC 
T GAT GTT AGG GAT GGA A 
GA TCT AAT GGA AAG TGT 
CAT CAG AGC AGC CGA TTG TC 
GTA AAA CGA CGG CCA GT
Reference No 
-102 to -87 
600 to 616 
696 to 713 
900 to 916 
1010 to 1026 
1650 to 1631 
6310 to 6294
The reference points refer to the numbering of the published 
sequences of preproricin (Lamb et alt 1985) for the CL-labelled 
primers, neomycin (Beck e_t al. 1982) for the NPT2 primer, and 
M13mpl8 (Norrander et al, 1983) for the Universal primer. The 
CL-labelled ricin primers annael to the strand complementary to 
the published sequence, the NPT2 primer annaels to the 
published strand, and the M13 Universal primer annaels to the + 
strand.
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2.1.12 SITE-DIRECTED MUTAGENESIS (SDM).
Two methods of SDM were used and both are based on the 
method of oligonucleotide-directed, site-specific mutagenesis 
described by Zoller and Smith (1982). A list of the 
oligonucleotides used in this study are given in Table 2.1.12. 
All mutagenic reactions were carried out in M13-derived 
vectors. Consequently, the region of DNA to be mutated was 
first cloned into a suitable M13 vector and ssDNA was prepared 
using the methods described in the sections above. The 
modifications to the original SDM protocol of Zoller and Smith 
which are described below, were designed to increase the 
recovery of mutant colonies.
(i) In vitro synthesis of 'honoduplex mutant* DNA.
This method, first described by Nakamaye and Eckstein 
(1986), uses strand-specific selection to eliminate the non­
mutant strand sequence in vitro, so that a homoduplex mutant 
DNA species can be transformed into E.coli. The E.coli DNA 
mismatch repair mechanism therefore does not recognise the 
mutation making the theoretical recovery of mutant progeny very 
high.
The mutant oligonucleotide is first annealed to the 
template in the usual way. Nakamaye and Eckstein (1986) found 
that the incorporation of thionucleotide dCTPalphaS into the 
mutant strand during second strand synthesis makes this strand 
resistant to digestion with Neil. The non-mutant strand can 
therefore be selectively 'nicked' by digestion with Neil. 
Limited exonuclease digestion is then used to remove the non­
mutant region of DNA before re-initiating second strand 
synthesis. This time the mutant strand is acting as DNA 
template and the net result of this is the production of 
homoduplex mutant DNA. This avoids the need for screening large 
numbers of progeny and the identification of mutants can
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TABLE 2.1.12 OLIGONUCLEOTIDES OSED AS MUTAGENIC PRIMERS.
Name (bp) Sequence (5' - 3') Source
*
MW01 (21) T ATA AGG CCA CTG GTA CCA AA ICl
j-j. _»— «_•- -•— «-A  A  fCfCrC jCwC
MW02 (29) A CTG GTA CCA AGG GGC AGT GCT GAT GTT T ICI
-i-«— «- .»__i_«- -XXX XX
MW03 (28) T TTG CTT ATA GAA GGC CGG GTA CCA AAT ICI
★  *  *
MW04 (22) TTC AAT CAC TCG AGA CGA TCG A WARWICK
*** **
MW05 (23) ATA ACA ACA GTC GAC CCA AAC AA WARWICK
* * *
0AB1049 TTG TTC AAT CAC TCG AGA CGA TCG ACG G MILANO
(28)
*** **
OAB 1179 AGG ATA ACA ACA GTC GAC CCA AAC AAT AC MILANO
(29)
0AB1049 & OAB1179 were gifts from Dr. Luca Benatti of
Farmitaiiaf Milano. (* - mismatched base with template.)
MWOl, MW02 and MW03 were gifts from Dr.M.E.Edge of ICI 
Pharmaceu t icaIs.
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usually be achieved by directly sequencing DNA prepared from 6- 
12 progenic plaques.
The reagents necessary for this method of SDM were 
available from Amersham ('Oligo-directed in vitro mutagenesis 
system, Version 2' code: RPN.1532) and the protocol supplied 
with the reagents was followed exactly.
(ii) DNA Repair-deficient strain of E.coli.
In this method, described by Kramer e_t al (1984), 
heteroduplex is first formed by annealing the mutagenic primer 
to the ssDNA template and synthesising the second strand in 
vitro. Kramer et al (1984) found that transformation of the 
heteroduplex mutant into mutL strains of E.coli. which are 
deficient in their DNA mismatch repair mechanisms, increased 
the recovery of mutant progeny. To minimise the introduction of 
opportunistic mutations, the transformants are plated out with 
exponentially growing wild-type cells, which form a lawn into 
which the M13-derived progeny transfect upon release from their 
transformed mutL host. The E.coli strains 71:18 and 71:18mutL 
were used for this work (Table 2.1.1).
The mutagenic oligonuleotide was firstly phosphorylated 
at its 5' end by adjusting its concentration to 50D units/ml in 
H2O, mixing 2.5}il with 3jil lOxKinase buffer (1M Tris-HCl pH8.0, 
lOOmM MgCl2, 70mM DTT, lOmM ATP) 24 jil H20, 2 units T4 
polynucleotide kinase, and incubating at 37C for ISmin. The 
reaction was stopped by incubation at 70C for lOmin and the 
kinased oligonucleotide stored at -20C.
The oligonucleotide was annealed to the template by 
drying down 6.2}il of the phosphorylated oligonucleotide
(lOpmoles) in a 1.5ml eppendorf, resuspending it in 3.5^ il H20, 
adding 0.5jig template (0.5mg/ml) and 0.5pl lOxTM (0.1M Tris- 
HCl, 0.1M MgCl2), and floating the eppendorf in a test-tube of 
water at 80C. The test-tube was left to cool to room 
temperature on the bench. Meanwhile, an extension mix was made
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up by mixing the following reagents together on ice:
Extension mix (6ul)
lOx TM 1 ul
5mM ATP 1 ul
0.1M DTT 1 ul
5mM dATP,dCTP,dGTP,dTTP 1 ul
h2o 2 ul
TOTAL - 6 ul
The cooled eppendorf containing the annealing reaction 
was spun briefly to collect the condensate, and then 3pl 
extension mix, 3 units of T4 DNA ligase, 0.8 units of Klenow 
were added and the extension reaction incubated at 16C 
overnight. The mix was diluted to lOOul with TG and lul, lOpl 
and 20)il used to transform competent 71:18mutL cells, as 
described in Section 2.1.10., using 300jj1 of a culture of 
exponentially growing wild-type 71:18 cells to create a lawn.
To identify mutant progeny, 1.5ml cultures were prepared 
from 100 white plaques and the cultures grown as for the 
preparation of ssM13 DNA. 50jil of each supernatant from these 
cultures, and an equivalent amount of ssM13-derived template 
(control), were loaded onto a nitrocellulose filter (Hybond C) 
using a dot-blot apparatus and the filter dried ^n vacuo at 80C 
for 2 hours. The remainder of each supernatant was stored at 
4C.
The filter was probed with radio-labelled mutant 
oligonucleotide, which was made by phosphorylating 15pmoles of 
oligonucleotide as described above, except that the lOxKinase 
buffer was depleted of ATP and 30uCi [ -^P]ATP was included in 
the reaction mix. The kinased oligonucleotide was then diluted 
to 3ml with 6xSSC (made as a 20x stock, viz.; 263g NaCl, 132.3g 
trisodium citrate, dissolved in 1.51 H2O and adjusted to pH7.0 
with concentrated NaOH), filtered through a 0.45)im filtation
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unit, the unit washed through with a further 1ml of 6xSSC, and 
the probe stored at -20C before use. The filter was first pre­
hybridised by incubating it for 60min at 67C in 10ml 6xSSC/0.2% 
w/v SDS/lOxDenhardts solution (made as a lOOx stock.viz.; 2% 
w/v BSA, 2X w/v Ficoll, 27L w/v polyvinylpyrrolidone). The 
filter was then rinsed for lmin in 50ml 6xSSC and hybridised 
with the probe at 67C for 30min. The hybridisation was 
completed by cooling to room temperature over 30min. The probe 
solution was then discarded and the filter washed 3 times in 3 
x 100ml of 6xSSC for 5min at room temperature. The filter was 
then drained of excess moisture and monitored using a Geiger 
counter. The filter was then covered in clingfilm and exposed 
to Fuji RX X-ray film at -20C for 1 hour using 2 intensifier 
screens to amplify the signal.
The mutagenic oligonucleotides used in this study were 
all over 20 nucleotides in length and therefore the 
dissociation temperature of probe from mutated template (Td) 
could not be predicted precisely using the Wallace Rules (Suggs 
et al. 1981). For this reason, after exposure to film, the 
filter was washed in 6x SSC for 5min at temperature increments 
of 5°C and the filter monitored for radioactivity after each 
wash. When the measured number of cpm had fallen to 
approximately half of the value recorded at room temperature, 
the wet filter was again exposed to X-ray film. The mutant 
progeny were taken to be those which still had probe bound at 
the temperature where the probe had been dissociated from the 
template controls. ssDNA was then prepared from the aliquots of 
these clones that had been stored at 4C. The presence of the 
mutated bases was then assessed by sequencing before preparing 
RF M13 DNA and cloning the mutated fragment back into the 
original vector.
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2.2.1 SP6/T7 IN VITRO TRANSCRIPTIONS.
DNA to be expressed in vitro was first cloned into either 
pSP64T (expression driven from the SP6 viral promoter: see 
Appendix for map) or a pGEM vector (for expression driven from 
the T7 viral promoter). Then lOug of caesium-gradient purified 
DNA was linearised with a suitable restriction enzyme for which 
the construct had a unique recognition site located downstream 
of the preproricin gene. The DNA was phenol/chloroform 
extracted twice, ethanol precipitated and resuspended to a 
final concentration of lmg/ml.
The method of transcription used was as described by 
Krieg and Melton (1986). A reaction was set up as follows: 
SP6/T7 Transcription reaction
2.2 IN VITRO EXPRESSION OF PREPRORICIN DMA.
linearised DNA (lmg/ml) 2.0 pi
H20 2.5 pi
transcription PREMIX 12.0 pi
RNasin 0.5 pi
5mM M-G(5')ppp(5')G (CAP) 1.0 ul 
T7/SP6 polymerase 2.0 ul
TOTAL - 20.0 pi
Transcription PREMIX
lOxsalts (20mM spermidine, 400mM HEPES K0H
pH7.5, 60mM magnesium acetate) 1000 pi
10 mg/ml BSA 100 pi
500mM DTT 100 pi
50mM rUTP, rATP, rCTP 100 pi
5mM rGTP 200 pi
H20 4500 pi
TOTAL - 6.0 ml
Stored in 60jj1 aliquots at -70C.
63
The transription reaction was incubated at 40C for 60min 
with ljil 8mM rGTP (in 20mM HEPES KOH pH7.6) being added after 
30min. The RNA synthesised was then stored at -70C for periods 
of up to 6 months.
To estimate the amount of RNA synthesised in a reaction, 
lOjiCi of %-UTP was first dried down in an eppendorf using a 
Speedivac. apparatus. The reaction mix was then assembled in 
this tube. After incubation of the transcription reaction, 2 x 
ljil aliquots were spotted onto Whatman DE81 paper and allowed 
to dry. The incorporated counts were estimated on one filter 
after five, two minute washes in 200ml of 0.15M Na2HP0^, 
followed by two washes in H2O and two in methanol. The dried, 
washed filter was then compared to the untreated filter in a 
scintillation counter using aqueous/non-aqueous scintillant. 
The ratio of cpm from the washed: unwashed filters (X 
incorporation) was multiplied by 14.4 (jig of NTPs added in the 
PREMIX) to give the total amount of RNA synthesised.
To visualise the transcript, 0.2^iCi ^P-UTP was included 
in the transcription reaction. After the 1 hour incubation, Sul 
was run on a formaldehyde/agarose gel as described in Section 
2. 1. 6 .
2.2.2 WHEAT GERM LYSATE TRANSLATIONS.
Transcripts synthesised in vitro were translated in wheat 
germ lysate using the method of Anderson ejt a_l (1983). A frozen 
stock of lysate was first prepared from 12g of commercially 
available wheat germ exactly as described by Anderson e_t al, 
and stored in 1ml aliquots under liquid nitrogen. A typical 
translation reaction was set up on ice by mixing the components 
listed below in the order shown;
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The translation reaction was incubated at 28C for 60min. 
In order to give an indication of the efficiency of 
translation, 1 jil of the translation mix was spotted onto 
Whatman No.l. filter paper and left to dry. The filter was then 
washed twice for 5min in 100ml ice cold 10Z TCA, boiled in 
100ml 5Z TCA for 15min, rinsed in H2O, and finally washed in 
absolute ethanol before being left to dry. The dried filter was 
counted in a scintillation counter using aqueous/non-aqueous 
scintillant and the cpm compared to a filter spotted with 1 ul
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of a control translation (no exogenous RNA) and treated in the 
same way.
Translation products were resolved by SDS-PAGE and 
visualised by fluorography (see Section 2.3.1).
2.2.3 RABBIT RETICULOCTYE LYSATE TRANSLATIONS
Rabbit reticulocyte lysate was obtained from Promega and 
used exactly as directed. Typically, 15jjCi -^S-Methionine, 20ul 
lysate and l^ il of an in vitro synthesised transcript was added 
to a translation reaction. The transcript was generally added 
directly from the transcription reaction and not from 
precipitated nucleic acid. Incubation was for 60min at 30C. The 
efficiency of translation was determined by measuring TCA- 
precipitable counts as described for wheat germ lysate 
translations. Translation products were resolved by SDS-PAGE 
and visualised by fluorography.
2.2.A XENOPPS EGG CELL-FREE TRANSLATIONS
An egg cell-free extract from Xenopus was available in 
the laboratory, prepared using a method obtained from the 
laboratory of Professor A.Colman (University of Birmingham), 
and stored under liquid nitrogen. A translation reaction was 
set up as follows:
This was split into 30pl aliquots and ljig raRNA added to 
each aliquot. Incubations were at 21C for 2 hours.
Since the system described was not dependent on exogenous 
RNA the proricin synthesised in the lysate was first 
immunoprecipitated before SDS-PAGE analysis. The translation
egg extract
125mM spermidine
350mM creatine phosphate
reticulocyte lysate S-100
^S-Methionine
l.Opl
2.5jil
lO.Ojil
lOO.OjiCi
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was diluted to 200^ il with Immunoprécipitation buffer (lOOmM 
Tris pH7.8, IX w/v Triton X-100, IX w/v deoxycholate, 0.5X w/v 
SDS, 5mM MgCl2 » lOOmM KC1, ImM methionine, ImM PMSF: pH8.2), 
4jig of rabbit anti-B chain antisera was then added plus 50jil of 
a 1:1 slurry of protein A Sepharose in immunoprécipitation 
buffer and the mix was incubated at room temperature on a 
clinostat for 2 hours. The beads were pelleted and washed three 
times in immunoprécipitation buffer. The immunoprecipitated 
protein was finally released from the beads by boiling them in 
lxProtein Sample buffer (Section 2.3) immediately prior to SDS- 
PAGE analysis.
The B chain domain of proricin synthesised in this way 
was also assessed for lectin (sugar-binding) activity by 
diluting the translation in Oocyte Homogenisation (OH) buffer 
(20mM Tris pH7.6, IX Triton X-100, 0.1M NaCl, ImM PMSF) and 
then passing it down a SeLectin™ column. The matrix of the 
column consists of lactose immobilised onto polyacrylamide 
beads. Protein bound to the immobilised lactose could be eluted 
in lOOmM galactose/OH buffer. Bound and un-bound fractions were 
immunoprecitated as above, prior to SDS-PAGE analysis.
Immunoprecipitated proricin made in this translation 
system was also incubated with endo-N-acetylglucosaminidase H 
(endoH) in order to determine the extent of N-linked 
glycosylation. The protein was first removed from the beads by 
boiling for 5min in lOOmM TrisHCl pH8/lX(w/v)SDS/lX(v/v)B- 
mercaptoethanol. The supernatant from this was diluted in 9 
volumes 0.1M sodium citrate buffer pH5.5, 5 milliunits of endoH 
was added and the reaction incubated at 37C overnight. The 
protein in this solution was then TCA precipitated (see next 
section) prior to analysis by SDS-PAGE.
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2.3.1 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS.
Soluble proteins were resolved by electrophoresing 
aliquots, under denaturing conditions, through polyacrylamide 
using the standard technique of SDS-polyacrylamlde gel 
electrophoresis (SDS-PAGE) described by Laemmli (1970). 
Proteins were first boiled in lxProtein Sample buffer (see 
below) for 2min immediately before loading into the wells of a 
gel.
2.3 ANALYTICAL PROTEIN TECHNIQUES.
2xProtein Sample Buffer (REDUCING)
0.5M Tris-HCl pH6.8 2.5 ml
SDS 0.4 g
Glycerol 4.0 ml
B-mercaptoethanol # 1.0 ml
Bromophenol blue 0-02 *
H2O to 10 ml
# ommited when making 2xN0N-REDUCING sample buffer.
2.3.2 SILVER STAINING OF SDS-POLYACRYLAMIDE GELS.
Gels were silver stained according to the method of 
Merril eit al (1981).
2.3.3 COOMASSIE BLUE STAINING OF SDS-POLYACYLAMIDE GELS.
After electrophoresis, gels were immersed in Staining
solution (0.25Z w/v Coomassie brilliant blue R, 50Z methanol, 
7X acetic acid) for 1 hour. Stained protein bands were then 
visualised by repeated washes in Destain solution (40X 
methanol, 10X acetic acid) to reduce the background.
2.3.4 WESTERN BLOTTING OF SDS-PAGE RESOLVED PROTEINS.
Proteins resolved on a gel were transferred to a 
nitrocellulose filter (Hybond-N), in transfer buffer (20mM
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Tris-HCl, 200mM Glycine, 20% methanol: pH8.3) using a Biorad 
Transblot apparatus, for 2 hours at 60V. Pre-stained protein 
markers were run on the gel to give an indication of the 
efficiency of transfer. After blotting, the gel was silver 
stained as described in Section 2.3.2. The nitrocellulose 
filter was washed for 30min in 3x 100ml Blocking buffer (PBS, 
0.1% Tween 20, 5% w/v Marvel) in order to block non-specific 
binding of the antibody to the filter, before incubating it 
overnight at 4C, in fresh Blocking buffer containing antisera 
prepared from animals immunised against ricin. Laboratory 
stocks of antisera used in this study to probe for proricin 
included anti-ricin A chain and anti-ricin B chain antibodies 
raised in rabbits. A 95% pure IgG fraction of antisera taken 
from sheep immunised against recombinant ricin A chain, a gift 
from J.Chaddock and G.Legname (Warwick), was also used.
Antibody - antigen signals were amplified using the 
Amersham biotinylated-proteinA/streptavidin-horseradish 
peroxidase system (RPN. 1231), when using antisera raised in 
rabbit. Dilutions of 3.3 in 1000 were used with both the 
biotinylated-protein A conjugate (diluted in PBS, 0.1% Tween 
20) and streptavidin-horseradish peroxidase conjugate (diluted 
in PBS/0.1% Tween 20). The signal was visualised by washing the 
filter in PBS and developing for 10-15min in Developing 
solution (30 mg 4-chloro-l-naphthol dissolved in 10ml methanol, 
and then mixed with 50ral PBS and 60 ul hydrogen peroxide). 
After development, the filter was finally rinsed in ({¿O and 
left to dry.
For filters probed with sheep IgG anti-ricin antibodies, 
the signal was amplified by probing with a second 
antibody/enzyme conjugate (anti-sheep IgG/alkaline phosphatase, 
Sigma A7789) and the filter developed using the Promega 
alkaline phosphatase developing kit (Promega AP system W3930).
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2.3.5 STORAGE OF POLYACYLAMIDE GELS.
Polyacrylamide gels, once fixed, were dried down onto 
3MM paper at 80C under vacuum, using a Biorad heated gel drier 
apparatus. Once dried, they were stored flat at room 
temperature.
2.3.6 FLUOROGRAPHY AND AUTORADIOGRAPHY OF RADIO-LABELLED
PROTEINS AFTER SDS-PAGE.
After electrophoresis, resolved protein bands were first 
fixed by washing the gel for 30min in Destain solution, before 
immersion of the gel in Amplify (Amersham) for 10-15min. The 
gel was then dried down at 60C on a vacuum gel drier and 
exposed to Fuji RX X-Ray film in a light-proof cassette, at 
-80C. Film was developed in Kodak LX24 and fixed in Kodax 
Unifix.
2.3.7 TRICHLOROACETIC ACID (TCA) PRECIPITATION OF PROTEIN
SAMPLES.
Where it was necessary to reduce protein sample volumes 
before loading onto polyacrylamide gels, the sample was made 
10% v/v TCA and the protein precipitated on ice for 30min. BSA 
was used as a carrier (to a final concentration of lOOpg/ml) 
when the concentration of protein was known to be very low. The 
protein was pelleted by centrifugation in a microfuge for 
lOmin. The pellet was washed in 100% acetone three times to 
remove residual TCA, and resuspended in lxProtein sample 
buffer. The sample was then boiled and loaded as above.
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2.4.1 INTRODUCTION.
The method of protoplast transformation described was 
based on the PEG-mediated method of protoplast transformation 
as described by Saul e£ £l (1988). All manipulations were 
performed under sterile conditions in a flow hood. All 
solutions were autoclaved or filter sterilised and all utensils 
were flamed with ethanol immediately before use.
2.4.2 GROWTH AND MAINTENANCE OF PLANTS.
(i) Sterilisation of seeds.
Seeds of Nicotiana petit Havana SRI were washed for lmin 
in 75% ethanol. They were then washed in 1% active hypochlorite 
for 2.5min. The residual hypochlorite was removed by washing 
the seeds twice in sterile distilled water, before soaking them 
in 0.5mg/ml GA3. The sterilised, prepared seeds were germinated 
on 0.5xMS medium (Flow labs) containing 5g/l sucrose, 0.8% 
agar.
(ii) Maintenance of plants.
Seedlings germinated from sterilised seeds were 
transferred to 0.5xMS medium, containing 30g/l sucrose and 0.8% 
agar. Subsequently, cuttings were taken from healthy plants and 
re-potted in the above medium. All seedlings and plants were 
grown at 26C and in 800 LUX of artificial, fluorescent light 
provided by a GROWLUX element.
2.4.3 PREPARATION OF DNA.
Caesium chloride gradient-purified plasmid DNA was 
ethanol precipitated and the pellet washed three times in 70% 
ethanol under the sterile hood. The eppendorf was sealed during 
each wash and the tube gently inverted, to sterilise the inner 
surface. The excess ethanol from the final wash was drawn off
2.4 TRANSIENT EXPRESSION IN TOBACCO LEAF PROTOPLASTS.
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and the pellet allowed to dry for 2 hours in the sterile hood. 
The dried DNA was resuspended to 3mg/ml in H2O.
2.4.4 ISOLATION OF PROTOPLASTS
(i) Enzyme digestion.
Twenty healthy leaves were taken and their midribs 
excised using a sharp scalpel, after briefly soaking the leaves 
in enzyme solution (1.2% w/v cellulase, 0.4% w/v maceroenzyme- 
R10 in K3 medium: filter sterilised, stored at -20C in dark). 
The leaves were then transferred to a petri dish containing 
25mls enzyme solution, and were cut into 0.5cm^ squares. The 
petri dish was evacuated for 3-4min in a bell jar connected to 
a vacuum line, in order to remove the air from within the leaf 
structure, before returning the petri dish to atmospheric 
pressure. The petri dish was finally sealed with parafilm and 
incubated in the dark at 25C overnight.
(ii) Separation of protoplasts from undigested leaf matter.
The petri dish was agitated by hand to release the 
protoplasts from the leaf skeletal structure, and then allowed 
to stand for a further 30min at room temperature. The digested 
solution was gently taken up using a wide-bore pipette and 
filtered through a 125micron stainless steel filter. The petri 
dish and filter were rinsed through with 0.S volumes of Sucrose 
buffer solution (0.6M sucrose, 0.5% w/v MES: pH5.6 with KOH, 
autoclaved). The filtered protoplast suspension was then 
transfered to 15ml sterile plastic tubes and 1ml W5 (154mM 
NaCl, 125mM CaCl2 » 5mM KC1, 5mM glucose: pH 6.0 with KOH, 
autoclaved) was layered on top of each aliquot. The tubes were 
centrifuged at 600rpm for lOmin at room temperature in a 
clinical centrifuge. The intact protoplasts collected at the 
sucrose/W5 interface and were transfered to fresh tubes using a 
wide-bore pipette. These protoplasts were washed twice in 10ml 
W5 (in order to dilute out any remaining digestive enzymes) by
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resuspending the cells in W5 and pelleting at 600rpm for 5min. 
The final protoplast pellet was resuspended in 2-4ml W5 and 
stored at 4C for 30min-3 hours, before transformation.
2.4.5 ESTIMATION OF VIABLE PROTOPLASTS. (Larkin, 1976)
Two 50ul aliquots of the washed protoplast suspension 
were mixed with an equal volume of diluted fluoroscein 
diacetate (FDA was stored as a 5mg/ml stock solution in 
acetone: it was diluted 4:1000 with K3 before use). The viable 
protoplasts were estimated using a haemocytometer slide mounted 
on a fluorescent microscope (viable cells fluoresce green). An 
average value from the two aliquots counted in this way was 
taken, and the protoplast concentration of the original 
suspension calculated.
2.4.6 PROTOPLAST TRANSFORMATION.
The protoplasts were pelleted as above, and resuspended 
in Mannitol/Magnesium (0.5M mannitol, 15mM MgCl2 > 0.1% w/v MES: 
pH 5.6 with KOH, autoclaved and stored at 4C) to a 
concentration of 1.6x10** viable cells/ml. They were immediately 
heat-shocked at 45C for 5min, before being left on the bench to 
cool to room temperature.
Meanwhile, the DNA was aliquoted into a sterile 15ml 
plastic tube. A typical transformation reaction contained, 30^ ig 
sheared herring sperm DNA (used as a carrier and at lmg/ml), 
9pg GUS-encoded plasmid DNA (used as a cytoplasmic control), 
and 21jig plasmid DNA of interest. To this tube was added 300jil 
of cooled, competent protoplast suspension, and the tube 
agitated gently to mix the DNA and protoplast solutions. To 
mediate the transformation, 300jil of PEG solution (40% w/v PEG 
4000, 0.4M mannitol, 0.1M Ca(N03)2: pH 8.0 with KOH, autoclaved 
and stored at 4C) was added dropwise, the tube was again 
agitated, and then allowed to stand for 30min at room
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temperature.
The PEG was diluted tenfold by the successive additions 
of 1,2, and 7ml of W5 at 3min intervals, mixing each time. The 
protoplasts were then pelleted at 500rpm for 5min, and 
resuspended in 0.5ml K3 (3.78 g/1 B5 salts, 5mM CaCl2 , 12mM 
NH4NO3 , 0.4M sucrose, 2mM xylose, 1 mg/1 6-BAP, lmg/1 NAA: 
pH5.6 with KOH, filter sterilised and stored in the dark at - 
20C). The surviving protoplasts floated on this medium. The 
tubes were incubated in the dark at 25C for 36 hours.
2.4.7 ISOLATION AND PREPARATION OF PROTOPLAST AND MEDIA
FRACTIONS.
The methods below were based on the methods described by 
Denecke e_t al (1989 & 1990). It was not necessary to carry out 
further manipulations under sterile conditions.
When the tubes were examined after 36 hours' incubation, 
three distinct phases were visible: an upper protoplast phase, 
a media phase, with any lysed, non-viable protoplasts forming 
the lowest phase which lined the bottom of the tubes. If 
perturbation of the tubes occurred during their removal from 
the incubator, the suspension was clarified by centrifugation 
at 500rpm for lOmin as above. 300^ il of the media phase was 
transferred to an eppendorf and processed, as described in (ii) 
below. All solutions and fractions from now on were kept on ice 
to minimise proteolysis.
(i) Protoplast processing.
The protoplasts were washed in 10ml W5, to dilute any 
media present, and were pelleted at 500rpm for 5min as above. 
The W5 was drawn off, the protoplasts resuspended in 400jil 
(50mM Tris-Cl pH7.5, ImM PMSF, 2mM DTT, 0.3 mg/ml BSA) and the 
suspension sonnicated for 1 0  seconds at an amplitude of 
6microns. The insoluble proteins were pelleted at 14,000rpm for 
lOmin at 4C. In early experiments, the soluble protein extract
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was used directly in the enzyme assays. However, in later 
experiments the method was modified and the following steps 
were included in the processing of the protoplast fractions.
The soluble protein extract was made 60% saturated with 
respect to ammonium sulphate, and the proteins precipitated on 
ice for 60min. The precipitated protein was pelleted in a 
microfuge for lOmin at 4C. This protein pellet was resuspended 
in Enzyme buffer (50mM Tris-HCl pH7.0, 2mM DTT) and stored at 
4C overnight, or frozen at -70C over the weekend.
(ii) Media processing.
In early experiments the media fraction was used directly 
in enzyme assays. However, it became necessary to include the 
following steps prior to enzyme analysis, in order to obtain 
reliable results.
Soluble protein, extracted from untransformed tobacco 
leaf tissue and dissolved in extraction buffer, was added to 
the media fraction to a final concentration of 100^ig/ml. The 
solution was made 60% saturation with respect to ammonium 
sulphate and the proteins precipitated on ice for 60min. The 
precipitated was pelleted for lOmin in a microfuge at 4C, and 
resuspended in 1ml Enzyme buffer. This solution was dialysed by 
three repeated concentration/dilution steps in an Amicon 
'Centricon 10' filter apparatus. This dialysed solution was 
stored at 4C overnight, or at -70C over the weekend.
2.4.8 ENZYMATIC ASSAYING OF PROTOPLAST AND MEDIA FRACTIONS.
(i) GUS assay (Jefferson, 1987).
An aliquot of each fraction was diluted to 360ul in 
Enzyme buffer, made 0.1% w/v Triton X-100, and equilibrated to 
37C. To this was added 40ul lOmM methylumbelliferryl 
glucuronide (lOmM MUG was made fresh in Enzyme buffer, 0.1% w/v 
Triton X-100) and the reaction allowed to proceed at 37C. Time 
points were taken at suitable times between 0 and 3 hours, viz;
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lOOjjl of reaction mix was added to 900jil of 0.2M NaHCOg (this 
stopped the enzyme reaction). The product, MU, released at a 
given time, was estimated by measuring the fluorescent emission 
of a time point at 455nm during excitation at 365nm, in a Jasco 
FP-550 spectrofluorometer. These values were then plotted on a 
graph of relative fluorescence vs time, to show that the 
fluorescence observed increased linearly with time. These 
readings were then converted to pmoles product released by 
reference to a standard curve of relative fluorescence vs [MU]. 
As all readings recorded were 'relative' fluorescence, a fresh 
standard curve was prepared for each assay.
(ii) nptll assay (McDonnell at al, 1987)
The following solutions were prepared;
5xReaction mix 
335mM Tris-Cl 
210mM MgClj 
2M NH4C1
Titrated to pH7.1 with maleic acid 
lxAssay mixture(made fresh)
ATP (lOmM stock) 5 pi
32P-ATP (lOmCi/ml stock) 1.5 pi 
neomycin (22mM stock) 7 pi 
NaF (1M stock) 50 pi
lx reaction buffer 4.936 ml
TOTAL 5 ml
To start the reactions, 30pl assay mixture and 30pl of 
each fraction were mixed and incubated at 37C for 30min. The 
insoluble proteins were pelleted in a microfuge for 5min at 4C. 
Duplicate aliquots of 20pl supernatant were spotted onto 
Uhatman P81 paper, which had been pre-soaked in 20mM ATP/lOOmM 
Na2P04 and dried in an oven. The filter was washed for 2min in
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500ml lOmM phosphate buffer pH7.5 at 80C, washed three times in 
500ml lOmM phosphate buffer pH7.5 at room temperature and was 
then left to dry. Finally, half of the filter was exposed to 
X-ray film at -70C for 1-7 days. From the second half of the 
filter, the duplicate spots were suspended in aqueous/non- 
aqueous scintillant and counted.
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2.5 RNA N-GLYCOSIDASE ACTIVITY OF PRORICIN
In this study, proricin was synthesised by injection of 
preproricin mRNA into Xenopus oocytes. These injections were 
performed by Prof. A.CoIman (University of Birmingham). The 
proricin was extracted from the oocytes and analysed by SDS- 
PAGE by Dr. P.Richardson (University of Warwick). The details 
of these procedures have been described elsewhere (Richardson 
et al. 1989). All analyses into the activity of proricin 
species isolated from these extracts however, were performed 
solely by this author.
The assay used to determine the RNA-dependent N- 
glycosidase activity of ricin A chain and described below is 
based on the method of Endo ejt al (1987).
2.5.1 PREPARATION OF ANILINE REAGENT.
Aniline was distilled twice and stored at -20C in the 
dark until required. 1ml of this redistilled aniline was mixed 
with 7ml H2O and 0.5ml glacial acetic acid in a universal that 
had been washed in chromic acid to inactivate any RNase 
activity. A glass pH probe was then used and the solution 
brought to pH4.5 with acetic acid. The aniline reagent was then 
made to a final volume of 11.0ml and could be stored at 4C in 
the dark for periods of up to two months.
2.5.2 INCUBATION OF RABBIT RETICULOCYTE LYSATE RIBOSOMES WITH 
RIP.
An equal volume of Promega rabbit reticulocyte lysate 
(non-nucleased batch) and preproricin sample (typically a 
translation mix of 30jil) were mixed and incubated at 37C for 
30min. The ribosomal proteins were then denatured by the 
addition of SDS to a final concentration of IX w/v, and the 
ribosomal RNA (rRNA) extracted in the aqueous phase by two 
phenol/chloroform extractions. The RNA was ethanol
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precipitated, the pellet washed once in 70% ethanol/50mM NaCl, 
once in 70% ethanol, dried in vacuo, and resuspended in lOjil 
H2O. lyl was diluted to 500ul in H2O and the absorbance 
measured at 260 and 280 nm. A protein-free rRNA sample gave an 
A260sA280 rat -^° of 1«8. The concentration of RNA was calculated 
from the A260 as follows:
[RNA] (ug/ml) ■ A^ao x extinction coefficient (40) x 500
1000
2.5.3 ANILINE TREATMENT OF MODIFIED rRNA.
2-5ug of extracted RNA was added to 20ul aniline reagent 
and the solution incubated at 60C for 2min in the dark. The 
solution was made 2.5M with respect to ammonium acetate and 2.5 
volumes -20C absolute ethanol added; the solution mixed and 
placed on dry ice for 30min in the dark. The RNA was pelleted 
for lOmin in a microfuge at 4C, washed first in 70% 
ethanol/50mM NaCl followed by 70% ethanol, and then dried in 
vacuo. The dried RNA was resuspended in 20ul RNA sample buffer 
(60% v/v formamide, 0.1%TPE: made fresh) and incubated at 65C 
for 5min. 2yl of RNA loading buffer was added and the sample 
loaded onto a 50% formamide, 1.5% agarose gel.
2.5.4 50% FORMAMIDE/1.21 AGAROSE GELS.
Commercial formamide solution was deionised by stirring 
it with BDH Amberlight Monobed Resin MB-3 until the pH had 
fallen to pH7. This was then filtered through Whatman No. 1 
paper and stored in the dark at 4C for periods up to 2 months.
The gel was made by first boiling 1.2g agarose in 50ml O.lxTPE
(made as a lx stock, viz: 36mM Tris-HCl, 30mM Na^PO^, 2mM
EDTA). Once dissolved, the agarose was cooled to 60C and 50ml
deionised formamide was added. The gel was then poured and 
allowed to set at 4C.
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2.6 ISOLATION OF PROTEIN BODY ENDOPROTEASE ACTIVITY AND ITS 
ASSAY
All work with castor bean seed tissue was performed in a 
toxin-designated area and all utensils, plant material and 
samples were detoxified by soaking for 24 hours in 0.1M NaOH 
before discarding.
2.6.1 GROWTH OF PLANTS
Plants were grown from seed in a greenhouse, under 
tungsten lighting, with a 12 hour photoperiod. Flowering took 
place 6-8 months after germination, and was induced by keeping 
the plants pot-bound and starving them of water.
2.6.2 PREPARATION OF EXTRACTS CONTAINING PRORICIN-PROCESSING
ACTIVITY FROM DEVELOPING SEEDS.
Enzyme activity was recovered from developing seeds 
following the method of Harley and Lord (1985). lOg of dehulled 
castor bean seeds harvested from the fruiting bodies of 
greenhouse-grown plants at a post-testa stage of development, 
were homogenised in lOmls lOOmM sodium phosphate buffer pH7.0 
using a mortar and pestle. The homogenate was passed through 
four layers of muslin, centrifuged at 16,000rpm, and the 
supernatant dialysed against 500 volumes of 0.5x citrate 
phosphate buffer (15.4mM sodium citrate, 19.3mM Na2HP0^s pH4.0: 
from Gomori, 1955) for 4 hours at 4C. It was stored frozen at - 
20C.
2.6.3 PREPARATION OF EXTRACTS CONTAINING PRORICIN-PROCESSING
ACTIVITY FROM THE PROTEIN BODIES OF DRY SEEDS.
The preparation of protein bodies from dry seed tissue 
(Mettler and Beevers, 1979) was performed, at room temperature, 
by homogenisation of dehulled castor seeds in 100Z glycerol 
(lml per g tissue) in an atomix, straining of the homogenate
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through four layers of muslin, and pelleting of the protein 
bodies at 8,500rpm for 15min. The protein bodies were 
resuspended in glycerol and repelleted as above.
The protein bodies were lysed by resuspending the pellet 
in ice-cold 25mM sodium phosphate buffer pH7.0. All further 
manipulations were performed at 4C. The crystalloid and 
membrane fractions were pelleted by centrifugation for 20min at 
ll,500rpm, before dialysing the supernatant for 4 hours in 3x 5 
litres of 0.5x citrate phosphate buffer pH4. Protein 
precipitated during dialysis was pelleted at 10,000rpm for 
lOmin. The soluble protein was drawn off and stored at -20C.
2.6.4 REMOVAL OF LECTINS FROM ENZYME SAMPLES USING AFFINITY
CHROMATOGRAPHY ON SEPHAROSE 6B.
Sepharose 6B (Pharmacia) that had been pre-washed in 1M 
proprionic acid was available in the laboratory. The acid 
treatment exposes sugar residues on the bead matrix to which 
ricin and RCAI will bind. 0.5ml of crude enzyme sample was 
first spun in a Beckman TL100 at 50,000rpm for 30min to pellet 
any aggregates. The supernatant was then passed down a 1ml 
column of acid-washed Sepharose, equilibrated with 0.5x citrate 
phosphate buffer, and the unbound proteins eluted. The lectins 
could be released from the column with lOOmM lactose.
2.6.5 AMMONIUM SULPHATE PRECIPITATION OF EXTRACTS FROM DRIED
SEEDS.
Soluble protein fractions from dried seeds were brought 
to 80Z saturation with ammonium sulphate on ice and the protein 
allowed to precipitate on ice for 60min. The precipitated 
protein was pelleted at 15,000rpm for lOmin and resuspended in 
0.5ml 0.5x citrate phosphate buffer pH4. The ammonium sulphate 
was dialysed overnight against 10,000 volumes of buffer.
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2.6.6 PREPARATION OF RADIOLABELLED PRORICIN FROM DEVELOPING
SEED TISSUE.
Proricln was radiolabelLed and extracted from developing 
seed tissue according to the method of Butterworth and Lord 
(1983). Developing seeds, harvested at a post-testa stage 
(stage E : see Roberts and Lord, 1981a), were dehulled, divided 
into endosperm halves and the cotelydonary tissue removed with 
a scalpel. 20 endosperm halves were placed on moistened filter 
paper, layered with 340yCi ^ S - M e t h i o n i n e  and incubated at 25C 
for 90min. The label was then chased with 400jj1 0.25M
unlabelled methionine for 60min at 25C.
The tissue was then homogenised to a fine slurry with a 
razor in 1.5ml ice-cold grinding buffer (150mM Tricine pH7.5, 
ImM EDTA, lOmM KC1, ImM MgCl2, lOOmM lactose, 12% w/w sucrose). 
The homogenised tissue was strained through four layers of 
muslin before loading onto a stepped 20% w/w / 30% w/w sucrose 
gradient (the sucrose was dissolved in ImM EDTA pH7.5) and 
centrifuging in a Beckman SU28 rotor for 2.5 hours, at 
23,000rpm. The rotor was brought down without the use of the 
brake and the microsomal fraction, visible as a milky band at 
the 20% / 30% interface, removed using a syringe needle.
The radiolabelled proricin was immunoprecipitated from 
the microsomal fraction using rabbit anti-ricin A chain 
antibodies available in the laboratory by following the method 
of Roberts and Lord (1981b). The microsomal membranes were 
dispersed by mixing in equal volume of SPA1 buffer (1% v/v 
NP40, lOmM Tris-HCl pH7.5, 150mM NaCl, 2mM EDTA, lOOmM lactose, 
40}ig/ml PMSF), and the proricin bound to antibody by incubation 
with 4pl antisera at room temperature for 60min. Protein A- 
Sepharose was added (50jul of a 1:1 slurry in SPA1) and the 
mixture rotated on a clinostat at room temperature for 30min. 
The protein A-Sepharose - antibody - proricin complex was 
pelleted in a microfuge for 30 seconds, the supernatant
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discarded, and the pelleted washed three times in SPA2 (as SPA1 
but with 0.2% NP40), twice in SPA3 (as SPA2 but with 0.5M 
NaCl), and once in lOmM Tris-HCl pH7.5. The bound proricin was 
then used as a substrate in an assay (see 2.4.6 below). The 
proricin / processed products were released from the beads by 
boiling for 5min in lxProtein sample buffer, pelleting the 
beads and loading the supernatant on a SDS-polyacrylamide gel.
2.6.7 SYNTHESIS OF KADIOLABELLED PRORICIN FROM cDNA.
Proricin cDNA was available in the laboratory cloned into 
an SP6 expression vector. The clone used for ^n vitro 
expression of proricin was pSP64Tproricin (May, 1988). This 
construct contains a 1.94 kb fragment of proricin cDNA cloned 
into the Bgl II site of pSP64T (Krieg and Melton, 1984). The 
DNA encoded for a proricin molecule which resembled the primary 
translational product of ricin, preproricin, but was lacking 
the first 11 amino acid residues. Translation was therefore 
initialised at the ATG at position -72 of the published 
sequence (Lamb et al, 1985). The DNA was transcribed and 
translated in wheat germ lysate as described in section 2.3. 
Standardly, 1-2 jil of translation products were used in an 
assay as substrate.
2.6.8 ASSAY FOR PRORICIN-PROCESSING ACTIVITY.
Proricin substrate was incubated with enzyme fractions at 
25C overnight. The products were resolved by SDS-PAGE and 
visualised by fluorography.
84
2.7 EXPRESSION OF PRORICIH IH E.coll.
2.7.1 INTRODUCTION
All expression work of proricin in E.coli was performed 
under HSE Category IV conditions.
The vector, pINIIIompA2proricin, a gift from Dr. Khalid 
Hussain (Warwick), contains proricin cDNA fused, distal to and 
in frame with, DNA encoding the 22 amino acid ompA signal 
peptide, in a pINIII vector (see Appendix for map). This was 
transformed into E.coli strain JA221 (see Table 2.1.1).
2.7.2 MAINTENANCE AND EXPRESSION OF JA221:pINIIIonpA2proricin
Colonies from this transformation were maintained on 
JA221-minimal, 1.5% agar plates containing lOOpg/ml arapicillin 
(JA221-minimal media was made by supplementing glucose/minimal 
media with 2pg/ml thiamine, 20ug/ml tryptophan, and 20pg/ml 
leucine). Overnight cultures were set up by inoculating 10ml 
JA221-minimal media with a single colony from a plate and 
incubating at 37C and 200rpm. Expression of the ompA:proricin 
chimaera was achieved by inoculating 100ml of expression media 
(JA221-minimal media made 1% w/v Caseamino acids) with 0.05 
volumes of an overnight culture, incubating for 2-3 hours 
(exponential growth) at 37C and 200rpm, and then inducing the 
expression with ImM IPTG. The cultures were grown for a further 
3 hours before preparing total cell, periplasm, and shocked 
cell fractions.
2.7.3 PREPARATION AND ANALYSIS OF FRACTIONS PREPARED FROM
EXPRESSION CULTURES OF TRANSFORMED JA221.
To prepare total cell fractions, cells from 1.5ml of 
culture were pelleted, resuspended to a concentration of 20 0D 
units/ml in ice-cold Sonication buffer (lOOmM Tris pH8.5, 5mM 
EDTA), and sonicated at Amicrons for 2-5min. The insoluble
85
material was pelleted in a raicrofuge for 5min, the supernatant 
was removed and stored at 4C.
To prepare fractions of periplasmic protein, osmotic 
shock was used. Cells from 1.5ml of culture were pelleted, 
resuspended in 500jil lOmM Tris-HCl pH7.1/5mM NaCl and incubated 
on ice for 5min. The cells were then pelleted and resuspended 
in 500jil 33mM Tris-HCl pH7.1/0.4mM EDTA/20% w/v sucrose and 
incubated at room temperature for lOmin. The cells were again 
pelleted and resuspended rapidly and violently in 500pl ice- 
cold O.lmM MgCl2 • After a lOmin incubation on ice, the shocked 
cells were pelleted for 5min and the supernatant, containing 
periplasmic proteins, was removed and stored at 4C. The shocked 
cells were then resuspended to 20 0D units/ml in Sonication 
buffer, sonicated and pelleted as for total cell fractions, and 
the supernatant stored at 4C. All fractions were analysed by 
SDS-PAGE, using 12% acrylamide, and the resolved proteins 
Western blotted using anti-ricin antisera.
2.7.4 BETA-LACTAMASE ASSAY.
In order to monitor the efficiency of recovery of 
periplasmic proteins, the total cellular/periplasmic/shocked 
cell fractions were assayed for the activity of the 
periplasmically-localised enzyme, beta-lactamase, using the 
method described by O'Callaghan et al (1972). 20jul of a freshly 
prepared solution of nitrocephin (4mg/ml in DMSO) was mixed 
with 780pl of each fraction (diluted in 0.1M phosphate buffer 
pH7.0) and the reaction followed spectrophotometrically by 
measuring the absorbance of the product at 500nra and at an 
incubation temperature of 30C, over lmin. After correcting for 
dilution factors, the relative B-lactamase activities of the 
three fractions could be compared.
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2.8 FACTOR Xa AND THROMBIN ASSAYS
Proteins translated in vitro were digested with 0.1 
volumes Factor Xa or Thrombin in one of the following buffers:
lxTEN (P.Esnouf, Oxford)“ lOmM Tris pH7.4, ImM EDTA, 
140mM NaCl (also 1.25mM CaCl2 for thrombin digestions)
lx XaBuffer (P.Esnouf, Oxford)* lOOmM Tris pH7.6, 0.05% 
Triton-X-100, lOmM CaCl2 > 0.05% deoxycholate
The Factor Xa enzyme was a gift from P.Esnouf, Radcliffe 
Hospital, Oxford. Thrombin was commercially available from 
Sigma. Reactions were carried out at 26C for 1 hour (unless 
otherwise stated).
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CHAPTER 3
CONSTRUCTION OF PRBPRORICIK/NEOMYCIH PHOSPHOTRANSFERASE 
CHIMERIC GENES IN A VECTOR SUITABLE FOR 
THEIR EXPRESSION IN PLANTS.
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3.1 IHTRODPCTION
As described in Chapter 1, ricin is initially synthesised 
as a preproprotein precursor with an N-terminal signal peptide 
that directs the protein into the lumen of the ER. However, as 
was also described, all proteins segregated into the lumen of 
the ER require some sort of positive sorting information to 
retain them within the endomembrane system and prevent 
secretion via the default pathway (Denecke ejt a_l, 1990). For 
instance, resident soluble ER-lumenal proteins are selectively 
retained from the bulk flow by possession of a carboxy-terminal 
KDEL sequence (Pelham, 1989). The presence of an 
oligosaccharide (mannose-6-phosphate) signal on lysosomal 
enzymes in animal cells which targets them to lysosomes has 
also been well documented (see Kornfield and Melhara, 1989). It 
is also now known that the information responsible for the 
correct targeting of a yeast vacuolar enzyme, CPY, to the 
vacuole is held within a contiguous stretch of four amino acid 
residues, QRPL (Vails e_t al, 1990). It has been argued that 
during plant seed development the bulk of protein transport 
through the secretory pathway is to the protein bodies and 
therefore one might expect this route to be the default 
pathway, with positive sorting being required to target 
proteins to the cell surface (a proposal considered by Bowles 
and Pappin, 1988). However, when Dorel e_t al^  (1989) expressed
an ER signal peptide :cytosolic pea albumin chimera in
transgenic tobacco they could not find accumulation of the
albumin in the protein bodies. This example appears to
contradict the proposal that the default secretory pathway in 
developing seed tissue is to the protein bodies and supports 
the hypothesis that, as with all other eukaryotic tissue 
examined to date, the secretion pathway represents the default 
pathway. It is therefore proposed here that preproricin must 
also contain a signal that targets newly-synthesised ricin to
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the protein bodies in the developing castor bean seed.
The fact that ricin is a glycoprotein has also been 
discussed. However, in contrast to the lysosomal targeting 
signal of animal proteins, the protein body targeting signal 
used by the ricin precursor is not an oligosaccharide. Non- 
glycosylated forms of ricin synthesised in the presence of 
tunicamycin, still accumulate within protein bodies (Lord, 
1985b). It is therefore reasonable to postulate that the signal 
for targeting proricin to the protein bodies is held within the 
amino acid structure of the polypeptide.
Preproricin has 35 amino acid residues at its N-terminus 
that are not present in the mature protein (referred to in 
future as the 'N-terminal presequence'). It has been considered 
for some time that not all 35aa residues function as an GR 
signal peptide (Lynne Roberts, personal communication). If this 
is the case then there must be an intermediate form of ricin 
present in the ER lumen that has an N-terminal propeptide 
(described in future as the N-propeptide to distinguish it from 
the 12 amino acid peptide that links the A and B chains in the 
precursor forms of ricin). However, efforts in the past to 
define the exact site of signal peptidase cleavage in 
preproricin by using microsequencing of in vitro synthesised 
and segregated preproricin have proven unsuccessful. This was 
because, in the in vitro assays used, preproricin was 
inefficiently imported in microsomes and the quantities 
obtained were too low for purification and analysis (Lynne 
Roberts, personal communication).
Many other vacuolar/protein body storage proteins are 
synthesised as preproproteins - that is they contain regions, 
in addition to the ER-signal peptide, that are only present in 
intermediate forms of the protein. Furthermore, it has been 
shown in some cases that these propeptides are removed after 
the protein has reached its final organellar destination.
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Therefore, it is conceivable that propeptides, which have no 
role to play in the final structure of the mature protein, may 
play a role during the transport of the protein to its 
organelle. Such functions might include;
(i) to maintain the protein in a transport-competent state. It 
has been shown that misfolded proteins are degraded or 
sequestered in the ER (Klausner ej: j*l, 1990).
(ii) to maintain the protein in an altered conformation from 
its mature form - for instance in the case of enzymes, to 
prevent them from acting on potential substrates with which it 
may be co-transported at some stage whilst en route to its 
final destination, by either sterlcally blocking the active 
site or maintaining the enzyme in an inactive configuration.
(iii) to target the protein to the correct organelle; i.e. the 
N-propeptide may contain a targeting signal which could be 
proteolytically removed from the mature protein after reaching 
its final destination.
This third role for an N-propeptide has been found in 
Saccharomyces cerevisae. The N-propeptide of yeast vacuolar 
e n z y m e s  proteinase A and CPY contain information which is 
necessary for correct targeting of the enzymes to the vacuole. 
In the case of CPY, the targeting signal has been identified as 
the tetrapeptide QRPL (Vails at a^, 1990). Although this 
sequence does not appear in the N-terminal region of 
preproricin, it is possible that the targeting machinery has 
diverged during evolution such that a different signal exists 
in plant storage protein precursors responsible for the 
targeting of these proteins to the protein bodies.
3.2 AIMS.
The aims of the work discussed in the next two chapters 
were to attempt to more clearly define the ER-signal peptide
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cleavage site and to see whether the N-terminus of preproricin 
contains a protein body targeting signal.
3.3 APPROACH.
The N-terminal region of preproricin was analysed to find 
likely sites of signal peptidase cleavage. Two constructs were 
then designed to create, in each case, a chimeric gene encoding 
a protein that would contain the N-terminal region of 
preproricin followed by the complete amino acid sequence of the 
marker enzyme, neomycin phosphotransferase (npt2). One 
construct, termed pPARTIAL, was designed to encode the first 
23aa residues of preproricin fused in front of npt2. The other 
construct, called pFULL, was designed to encode a 
preproricin/npt2 hybrid which contained all 35aa residues of 
the preproricin N-terminal region fused in front of the npt2 
enzyme. In both DNA constructs the gene was flanked on its 5' 
side by a constitutive plant promoter and on its 3' side by a 
plant transcription terminator.
The chimeric gene from the pPARTIAL construct was first 
expressed in vitro in order to determine whether or not the 
hybrid protein contained a functional ER signal peptide.
As will be discussed in the next chapter, the pPARTIAL 
and pFULL constructs were then used to transform tobacco 
protoplasts.
3.4 COMPUTER ANALYSIS OF THE N-TERMINAL REGIOW OP PEKPRORICIN.
The algorithm for predicting the site of signal peptide 
cleavage described by von Heijne (von Heijne, 1986) was used to 
identify likely sites of signal peptide cleavage in 
preproricin. The algorithm assigns a value to amino acid 
residues greater than 12 residues away from the N-terminal 
methionine residue. A residue assigned a positive value is more 
likely to be the site of cleavage than a residue with a
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negative value. Unfortunately the algorithm is complicated and 
fifteen individual probabilities must be summed before it is 
possible to assign a value for a particular residue in the 
sequence. Therefore, in order to enable many protein sequences 
to be screened accurately and quickly, a computer programme was 
designed that was based on von Heijne's algorithm (see 
Appendix).
Figure 3.4 shows a graphic representation of the Von 
Heijne algorithm when applied to the N-terminal region of 
preproricin. Five residues of the 35 had positive values. The 
algorithm identified the residues, glycine^ and threonine-*®, 
as the most likely sites of signal peptide cleavage with values 
of +4.8 and +5.4 respectively. The algorithm also confirmed the 
suspicion that, with a value of -9.33, asparagine-*^ was highly 
unlikely to be the site of signal peptide cleavage.
This data was strong indirect evidence for the presence 
of an N-propeptide region in proricin.
3.5 CLONING STRATEGIES.
[N.B. all nucleotide reference numbers for preproricin refer to 
those printed in the published sequence of Lamb e_t ¿1 (1985), 
an amended copy of which can be found in the Appendix.]
3.5.1 SOURCE AND CHARACTERISATION OF VECTORS.
The construct ppRCL617, containing the entire preproricin 
coding sequence (Lamb ¿1, 1985 & Richardson et 1989: see 
Appendix for map) was available at Warwick. This was used as 
the source of the preproricin DNA. ppPCL617 has a unique Xhol 
restriction site immediately upstream to the 5' end of the 
preproricin gene. This preproricin cDNA also has three BamHI 
sites at positions -41, 852 and 1551. The site at -41 lies 
within codon Gly^ . The computer analysis described in the 
section above identified this glycine residue as being a likely
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FIGURE 3.» VOW HEIJNB PLOT OF N-TERMINAL REGION OF PREPRORICIN
Graphic representation of the von Heijne algorithm when applied 
to the N-terminal region of preproricin. This algorithm is used 
to predict the likely sites of signal peptidase cleavage in the 
N-terminal regions of proteins that are co-translationally 
translocated into the lumen of the ER. Sites of cleavage are 
predicted to lie on the carboxyl side of residues that have a 
high (positive) value. Von Heijne reported that this algorithm 
has 80% predictive accuracy (von Heijne, 1986). The algorithmic 
values for preproricin (shown opposite) were obtained by 
entering the first 37 amino acid residues into a computer 
programme designed by this author (see Appendix). Residues 
g l y c i n e ^  and threonine^® have high values and can be 
considered as likely signal peptidase cleavage sites. This plot 
also shows that asparagine^ (the residue immediately before 
the first residue of the mature A chain) is highly unlikely to 
be the site of signal peptidase cleavage. This supports the 
hypothesis that the intracellularly transported form of ricin 
(proricin) contains an N-terminal propeptide.
site of signal peptide cleavage. It was therefore decided to 
utilise this BamHI site in order to create a construct encoding 
a fusion protein between an N-terminal fragment of preproricin 
and the marker enzyme npt2, using standard molecular biology 
procedures (described in Section 3.5.3). This fusion protein 
would then be used to check that the first 22 N-terminal 
residues of preproricin were sufficient to co-translationally 
transport a foreign protein across the ER membrane and 
subsequently, to determine whether the ER-segregated protein is 
secreted (by default) in tobacco protoplasts.
In order to determine the effects of fusing the complete 
N-terminal region of preproricin (i.e. the first 35aa residues) 
to the N-terminus of npt2 on its intracellular transport, it 
was necessary to mutate the preproricin DNA to introduce a 
unique restriction site at the junction of the N-terminal 
region and the mature A chain region. The cloning procedures 
followed to achieve this are described below in Section 3.5.4.
The plant system expression vector, pCaMVNEO (Fromm e_t 
al. 1986), was a gift from Dr. Aldo Ceriotti, Milan. It 
contains the 35S-cauliflower mosaic virus promoter (35S-CaMV), 
the coding region of the the neomycin phosphotransferase gene 
(npt2) from transposon Tn5 and the nopaline synthase 
transcription terminator sequence (nos). This vector was used 
as the expression vector for the plant transformation 
experiments described in the next chapter and as a source of 
the npt2 gene. However, in order to use this npt2 gene for the 
construction of ricin:npt2 chimeric genes it was necessary to 
mutate the translation initiating codon ATG, to prevent 
initiation of translation at this site in the fusion proteins.
The first step in this process was to determine the exact 
DNA sequence around the N-terminus of the npt2 gene. Based on 
the sequence data for npt2 published by Beck ¿t a_l (1982), a 
sequencing oligonucleotide (npt2 primer) was made that was
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complementary to the published strand and annealed 
approximately 100 bases downstream of the npt2 initiation 
codon. Its sequence and exact annealing positions are shown in 
Table 2.1.12. A large scale plasmid preparation of pCaMVNEO was 
made and an aliquot was plasmid sequenced using the npt2 
primer. Restriction mapping was also performed on the vector. 
The vector, restriction map, and DNA sequence around the 5' 
terminus of the npt2 gene are shown in figure 3.5.1.
Study of the restriction map revealed that there were no 
Xhol restriction sites. It was therefore decided to introduce 
simultaneously a unique Xhol site at the 5' end of the npt2 
gene whilst changing the npt2 initiation (ATG) codon. Close 
inspection of the sequence showed that a 3 base mismatch 
mutation was required to introduce the Xhol recognition 
sequence, CTCGAG, such that it also altered the initiating ATG 
(methionine) to GTG (valine);
i.e. (DNA sequence in pCaMVNEO)...TTTCGC ATG...>npt2 gene
*  *  *
(same region after mutagenesis)...TCTCGA GTG...>npt2 gene
The next section describes the cloning procedures 
followed to achieve this.
3.5.2 CONSTRUCTIOH OF pCaMVNEQAj.
(for cloning strategy, see figure 3.5.2.1)
A 1.6Kb Hindlll - Bglll fragment from pCaMVNEO was cloned 
into the HindIII - BamHI sites of M13mpl9 (Messing, 1986). 
Single-stranded M13 preparations from white plaques selected on 
IPTG/X-gal plates were sequenced using the npt2 primer to 
select M13 clones containing a single copy of the npt2 
fragment. These were named M13mpl9npt2 and were used as a 
template for site-directed mutagenesis.
An oligonucleotide, MW04 (see Table 2.1.12), was designed 
and synthesised on an Applied Biosystems 380B DNA synthesiser
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FIGURE 3.5.1 RESTRICTION MAP AND PARTIAL DWA SEQUENCE OF 
pCaMVNEO
A/ Restriction map of the plant expression vector pCaMVNEO 
(Fromm e_t ¿1, 1986), assembled by deduction from the paper of 
Fromm £t^  al^  and by restriction mapping carried out by this 
author. In this vector, the gene for neomycin 
phosphotransferase (npt2) from the transposon Tn5 (see Beck e_t 
al, 1982) is situated between the constitutive plant promoter 
from the cauliflower mosaic virus (35S-CaMV) and the nopaline 
synthase transcription terminator region (nos poly A). This 
vector contains the B-lactamase gene (APR), used to confer 
ampicillin resistance to bacterial colonies during cloning. Of 
relevance is the absence of any Xhol restriction sites in this 
vector.
B/ DNA sequence of the vector pCaMVNEO in the region around 
the 5' terminus of the npt2 gene, sequenced using the npt2 
primer as described in the text. The npt2 sequence, the npt2 
primer and its site of annealing on the npt2 gene are shown in 
red.
B
TTCCAACCACGT CTT CAAAGCM GT GGATT GAT GT GATAT CT CCACT GAC
GTAAGGGAT GACGCACAAT CCCACTAT CCTT CGCAAGACCCTT CCTCTATMl ...1
ATAAGGAAGTTCATTTCATTTGGAGAGGA CGACCTGCÂGëTCGACGGATC
Pvw 1550
CGTCGATCGTTTCGCATG ATT GAA CAA GAT GGA TTG CAC GCA
1600
GGT TCT CCG GCC GCT TGG GTG GAG AGG CTA (TGA CTG GGC
TAT GAC TGG GCA CAA CAG ACA ATC GGC TG C TCT GAT GCCi i i i  i i i  t i t  i i i  t i i  m i  i
C TGT TAG CCG ACG AGA CTA C c
3  L
NPT2 SEQUENCE IN RED
(Nucleotide nos. refer to Beck et al, 1982)
CaMV 3 5 S  IN BLUE
LINKER IN pCaMVNEO IN BLACK
Bracketed sequence from  Beck et al (19 8 2 )
FIGURE 3.5.2.1 CLONING STRATEGY FOR pCaMVNEOAX
Step 1: Ligation of 1.6Kb Hindlll - Bglll fragment from 
pCaMVNEO into Hindlll & BamHI -restricted M13mpl9, to produce 
the construct M13mpl9npt2. Single-stranded DNA was prepared and 
used as a template for site-directed mutagenesis.
Step 2: Site-directed mutagenesis of M13mpl9npt2 to mutate 
simultaneously the initiating codon ATG to GTG and introduce a 
Xhol restriction site at the 5' end of the npt2 gene. Putative 
mutants were screened and the clone D7 was found to contain the 
correct mutation.
Step 3: Ligation of 1.0Kb BamHI fragment (containing the 
mutated sequence) into the 3.4Kb BamHI vector fragment from 
wild type pCaMVNEO to produce the construct, pCaMVNEOAX.
KEY.
Restriction sites:
Apr
□
B BamHI
Bg Bglll
H3 Hindlll
R1 EcoRI
X Xhol
resistance
35S CaMV promoter
neomycin phosphotransferase (npt2) gene 
mutated npt2 gene (initiation codon ATG - GTG) 
nopaline synthase transcription termination sequence
Sizes of plasmids shown in brackets (in Kb).
apparatus, that would enable mutagenesis of the initiating ATG 
codon of npt2 and create a Xhol restriction site. This 
oligonucleotide was annealed to the template and 
oligonucleotide-directed, site-specific mutagenesis based on 
the method of Nakamaye and Eckstein (1986), was used to attempt 
to generate the desired mutants. This method is a modification 
of the oligonucleotide-directed, site-specific mutagenesis 
protocol described by Zoller and Smith (1982). Nakamaye and 
Eckstein (1986) described how the incorporation of 
thionucleotides into the mutant strand enabled the Iji vitro 
restriction and exonuclease digestion of the non-mutant strand. 
This sufficiently increases the recovery of mutants to make 
feasible the successful screening of a small number of putative 
mutant progeny. However, when this method was used to try to 
generate an npt2 Xhol mutant, sequencing analysis of DNA from 
12 putative mutants revealed that all twelve were wild-type 
sequences.
It was then checked that the MW04 oligonucleotide had 
annealed correctly to the 5' end of the npt2 gene. The 
SequenaseTÎ* kit was used to sequence from the 3' end of MW04 
after the latter had been first annealed to the template. No 
sequences were visible in any tracks where 0.5pmols (lx the 
suggested amount of sequencing primer), 5pmols (lOx) and 
50pmols were annealed to the template. When 500pmols of MW04 
was annealed to the template (lOOOx), a sequence was visible 
and corresponded to a region of Ml3mpl9 that had no significant 
sequence homology to the primer used. It was therefore 
concluded that the oligonucleotide had a defective sequence and 
a new oligonucleotide was synthesised. This second 
oligonucleotide, named OAB1049 (see Table 2.1.12), was 6 
nucleotides longer than MW04 in order to improve its 
specificity for annealing to the template. This oligonucleotide 
was used as a sequencing primer and it gave a readable sequence
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at the suggested primer concentration that corresponded to the 
expected region of the template. This confirmed that 0AB1049 
annealed uniquely to the 5' region of the npt2 gene.
Mutagenesis was then repeated using the method described 
above and with 0AB1049 as the mutagenic oligonucleotide. 
However, all 33 putative mutants which were subsequently 
sequenced were found to contain wild-type sequences in the 
region of the desired mutation.
An alternative method of site-directed mutagenesis was 
then used in an attempt to generate mutant progeny (Kramer, 
Kramer and Fritz, 1984). This procedure (described in detail in 
Section 2.1.12) has a single in vitro 'second-strand synthesis' 
step before transformation into a mutL strain of E.coli (a 
strain deficient in DNA repair mechanisms, used to increase the 
mutation frequency). It was hoped that by reducing the number 
of in vitro mutagenic manipulations an increased recovery of 
mutants would be possible. After following this protocol, DNA 
from 96 putative mutant plaques was hybridised onto 
nitrocellulose and probed with -^P-labelled OAB1049. Figure
3.5.2.2 shows the results of this probing after washing the 
filters at room temperature (Fig.3.5.2.2A) and then at 65C 
(Fig.3.5.2.2.B). From this, 15 positives were identified giving 
a mutagenic frequency of 15.6%. Single-stranded DNA was 
prepared from seven of these, A3,B1,B8,B10,C3,C9,D7. The npt2 
primer was used to sequence each clone in the region of the 
mutation. Clone A3 had a wild-type sequence; B1 was a deletion 
mutant; but the sequenced clones B8-D7 all contained a Xhol 
restriction site in the desired position (Figure 3.5.2.3).
RF DNA was then prepared from clone D7. A 1Kb BamHI 
fragment, containing the mutated npt2 gene, was ligated to a 
3.4Kb BamHI gel-isolated vector fragment from pCaMVNEO. 
Competent cells were transformed with this ligation mix and 
plasmid DNA prepared from colonies selected on ampicillin. The
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FIGURE 3.5.2.2 HYBRIPISATIOH SCREENING OF PUTATIVE XHOI MUTANTS
USING THE 32P-LABBLLED MUTAGENIC OLIGONUCLEOTIDE, QAB1049.
Autoradiographs of a nitrocellulose filter onto which was fixed 
50ul aliquots of supernatant, containing ssM13 DNA, from 96 
putative mutant progeny. The filter was probed with 15pmoles of 
the ^P-labelled 0AB1049 mutagenic oligonucleotide and 
subsequently washed in 6xSSC at the temperatures shown. Two 
lOOng aliquots of the ssMl3mpl9Xnpt2 DNA (the template for the 
mutagenesis) were used as controls (C) to show the temperature 
above which the probe would no longer remain bound to the wild- 
type (non-mutated) sequence. Note the selective binding of the 
probe to certain clones at the higher temperature, but not to 
the control DNA.
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FIGURE 3.5.2.3 DWA SEQUENCE ANALYSIS OF PUTATIVE XHOI MUTANT
CLONES B8, BIO. C3. C9 AMD D7.
Single-stranded M13 DNA was prepared from these clones after 
they had been identified as putative mutants by hybridisation 
screening (Figure 3.5.22). 2ug of each ssDNA was then sequenced 
using the npt2 primer and the Sequenase™ kit. All clones shown 
contained the 3 base mismatch mutation (asterisked) which 
confirmed them as Xhol mutants. The introduced restriction site 
is arrowed and labelled 'X'. Note the compression present in 
all the tracks. The significance of this compression with 
respect to the failure of the Amersham iri vitro mutagenesis kit 
to generate Xhol mutants is discussed in the text.
R)
0  35S-CaMV
C^npt2
E£1 nos poly A
-► npt2 primer and direction of sequencing.
orientation of the fragment was determined by restriction 
digest analysis (Figure 3.5.2.4). One clone, named pCaMVNEOAX, 
contained the correctly mutated npt2 gene in the desired 
orientation with respect to the 35S-CaMV promoter. The 
orientation of the fragment in this clone was finally checked 
by plasmid sequencing, using the npt2 primer.
3.5.3 CONSTRUCTION OF pPARTIAL.
(for cloning strategy, see Figure 3.5.3.1)
A 71bp Xhol - BamHI fragment from the vector ppRCL617, 
which contains 'the full-length coding sequence of preproricin, 
was end-filled and gel-isolated. This DNA fragment encodes the 
first 23 N-terminal amino acid residues of preproricin. It was 
cloned into the Xhol restriction site of the mutated vector, 
pCaMVNEOAX. This was accomplished by first cutting the vector 
with Xhol before end-filling the 3'-recessed 'sticky-ends'. The 
vector was then phosphatased and the 71bp ricin fragment 
ligated. Mini-preparations of plasmid DNA from transformed 
E.coli were sequenced to identify a pCaMVNEOAX clone that 
contained a single, correctly-orientated 71bp fragment. Once 
identified, a large scale DNA plasmid preparation was made and 
the construct named pPARTIAL. It was finally sequenced once 
more using the npt2 primer.
3.5.4 CONSTRUCTION OF pFULL.
(for cloning strategy, see Figure 3.5.4.1)
As there were no convenient restriction sites in the 
preproricin cDNA in the region encoding the junction between 
the N-terminal region and the first amino acid residue of the 
mature A chain, it was decided to use site-directed mutagenesis 
to introduce a Sail restriction site at position +1 in the DNA.
A 702 bp Xhol - Bglll fragment from ppRCL617 was cloned 
into the Xhol/BamHI sites of the Ml3mpl8-derived vector,
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FIGURE 3.5.2.» RESTRICTION DIGEST ANALYSIS OF pCaMVNEOAx 
SHOWING THE CORRECT ORIENTATION OF THE 1KB BAMHI FRAGMENT 
(CONTAINING THE MUTATED NPT2 GENE).
lug of pCaMVNEOAX DNA was digested with 10 units each of Xhol 
and Bglll for 1 hour at 37C. DNA bands were then resolved by 
electrophoresis through a l%agarose (lxTBE buffer) gel
containing 0.5ug/ml EtBr. Bands were visualised on a UV- 
transilluminator.
1. lug 'wild-type' pCaMVNEO digested with Xhol and Bglll. As 
there is no Xhol restriction site the plasmid is linearised.
2. lug of a pCaMVNEOAX clone in which the lkb BamHI fragment 
was inserted in the wrong orientation. Digestion with Xhol and 
Bglll therefore releases a small fragment of approximately 
250bp (predicted size).
3. lug of pCaMVNEOAx digested with Xhol and Bglll. The 
predicted release of a 1.25kb fragment is seen (see plasmid map 
of pCaMVNEO X below).
M. Lambda DNA digested with EcoRI and Hindlll. Sizes (in bp) 
are shown.
0  35S CaMV (0.43kb) 
C^npt2 (l.Okb)
nos poly A (0.25kb)
FIGURE 3.5.3.1 CLOWING STRATEGY FOR pPARTIAL COWSTRUCT
Step 1: The 71bp Xhol - BamHI fragment from ppRCL617 
(containing the first 23 codons of preproricin) was end-filled, 
gel isolated and ligated into pCaMVNEOAX, after it had first 
been linearised with Xhol and end-filled. The ligated DNA was 
transformed into E.coli TGI cells and DNA from ampicillin- 
resistant colonies was sequenced to identify a clone which 
contained the 71bp preproricin fragment inserted (in the 
correct orientation) in front of the npt2 gene such that the 
reading frame was conserved (i.e. in-frame). This construct was 
termed 'pPARTIAL'.
KEY.
Restriction sites: B BamHI
Bg Bglll
H3 HindiII
R1 EcoRI
X Xhol
Apr B-lactamase gene (confers resistance to Ampicillin)
35S CaMV promoter
neomycin phosphotransferase (npt2) gene 
mutated npt2 gene (initiating codon ATG - GTG) 
nopaline synthase transcription termination sequence 
S region encoding preproricin N-terminal presequence
A ricin A chain coding sequence
L linker region coding sequence of preproricin
B ricin B chain coding sequence
Sizes of plasmids shown in brackets (in Kb).
Nucleotide reference numbers refer to the published cDNA 
sequence of preproricin (Lamb et al, 1985).
FIGURE 3.5.4.1 CLONING STRATEGY FOR pFULL CONSTRUCT
Step 1: The 702bp Xhol - Bglll fragment from ppRCL617 
(containing the preproricin 5' end encoding the entire N- 
terminal presequence) was cloned into the multiple-cloning site 
of M13mpl8X, after first restricting the M13 vector with Xhol 
and BamHI. Single-stranded DNA was prepared and used as a 
template for site-directed mutagenesis.Step 2: Site-directed mutagenesis was used to introduce a Sail 
restriction site immediately 3' to the last codon of the 
preproricin 35aa residue N-terminal region. The DNA from 
putative mutants was sequenced and the clone F10 identified as 
containing the correct mutation. RF DNA was prepared from this 
clone.Step 3: The 124bp Sail fragment from clone F10 (containing the 
complete preproricin N-terminal region coding sequence) was 
then cloned into the Xhol restriction site of pCaMVNEOAX. A 
clone containing the preproricin N-terminal region coding 
sequence, fused in frame with and in the correct orientation 
with respect to the npt2 coding sequence was identified by 
restriction digest analysis and plasmid sequencing. This clone 
was termed 'pFULL' .
KEY.
Restriction sites: B
Bg
H3
R1
S
X
BamHI
Bglll 
Hindlll 
EcoRI
SiTl
XKoI
Apr B-lactamase gene (confers resistance to ampicillin)
[2 35S CaMV promoter
neomycin phosphotransferase (npt2) gene 
mutated npt2 gene (initiating ATG - GTG) 
nopaline synthase transcription termination sequence 
S region encoding preproricin N-terminal presequence
A ricin A chain coding sequence
L linker region coding sequence of preproricin
B ricin B chain coding sequence
Sizes of plasmids shown in brackets (in Kb).
Nucleotide reference numbers refer to the published cDNA 
sequence of preproricin (Lamb et al, 1985).
Ml3mpl8X (Turner, 1991). This vector contains a unique Xhol 
restriction site in the M13 polylinker. Single-stranded DNA 
preparations were sequenced using the M13 universal primer 
(Table 2.1.12) and a clone containing the correctly-inserted 
preproricin fragment was used as a template for mutagenesis.
A mutagenic oligonucleotide, MW05 (Table 2.1.12), was 
designed to introduce a five base mismatch mutation. This 
oligonucleotide was made on the same machine as oligonucleotide 
MW04, which had been shown to be defective (above). Therefore, 
MW05 was first used as a primer in a sequencing reaction and 
this confirmed that it annealed to the template in the correct 
place. MW05 was then used in conjunction with the method for 
site-specific mutagenesis described by Nakamaye and Eckstein 
(1986) to try to create the desired mutation. However, all 
putative mutants screened by sequencing were found to be wild- 
type. When this method was repeated it again proved 
unsuccessful at generating mutants. The ability of the 
mutagenic oligonucleotide to prime sequencing of the template 
illustrated that it was annealing in the correct place and the 
3' end of the oligonucleotide was attached to the template. 
However, in light of the problems encountered with the 
mutagenic oligonucleotide, MW04 (discussed in Section 3.5.2 
above), synthesised at the same time as MW05, it was thought 
likely that MW05 was also defective, possibly at its 5' end 
which would affect the ligation reaction during the second- 
strand synthesis stage of mutagenesis and affect the frequency 
of mutants. Therefore, it was decided to re-synthesise a 
mutagenic oligonucleotide.
This second oligonucleotide, OAB1179 (Table 2.1.12), was 
used in conjunction with the method of mutagenesis described by 
Kramer, Kramer and Fritz (1984), which had proven successful in 
the creation of pCaMVNEOAX (above). DNA from 96 putative 
mutants was probed with ^P-labelled OAB1179 and the results
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are shown in Figure 3.5.4.2. From this, 10 positive clones were 
identified which gave a mutation frequency of 10.4%. Single- 
stranded DNA was prepared from six of these positive clones 
(B4, Cl, C5, E9, E12, F10) and sequenced using the universal 
primer. Clone B4 contained a wild-type sequence. Clones C1-E12 
had poor sequence in the area of the desired mutation and it 
was not possible to determine if all 4 bases had been correctly 
mutated. However, clone F10 possessed the correct sequence 
(Figure 3.5.4.3).
RF DNA was then prepared from clone F10 and a 124bp Sail 
fragment, containing the entire coding region for the 
preproricin N-terminal region, was cloned into the Xhol site of 
pCaMVNEOAX. Mini plasmid DNA preparations were sequenced using 
the npt2 primer to identify a pCaMVNEOAX clone with the 
correctly-inserted and orientated ricin fragment. A large scale 
plasmid preparation was made from this and the construct was 
termed pFULL.
3.6 COMPUTER ANALYSIS OF pPAETIAL and pFULL CONSTRUCTS.
The predicted N-terminal amino acid sequences and von 
Heijne plots of the ricin:npt2 chimeras encoded by the pPARTIAL 
and pFULL constructs are shown in Figure 3.6. It is relevant to 
note that, in the construction of both chimeras, two 'extra' 
codons were created at the junction between the ricin and npt2 
coding sequence. They encode the 'foreign' residues arginine 
(positions 24 and 36 for the pPARTIAL and pFULL gene products 
respectively) and valine (positions 25 and 37).
The von Heijne algorithm gave a strong, predicted signal 
peptide cleavage site after Gly^ for the pPARTIAL chimeric 
gene product. This means that the environment around this site 
in the protein is favourable for signal peptidase action. When 
the predicted N-terminal sequence of the pFULL gene product was
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FIGURE 3.5.4.2 HYBRIDISATION SCREENING OF PUTATIVE SAL I MUTANTS
USING THE 32P-LABBLLED MUTAGENIC OLIGONUCLEOTIDE. 0AB1179.
Autoradiographs of a nitrocellulose filter onto which was fixed 
50ul aliquots of supernatant, containing ssM13 DNA, from 96 
putative mutant progeny. The filter was probed with 15pmoles of 
the ^^P-labelled OAB1179 mutagenic oligonucleotide and 
subsequently washed in 6xSSC at the temperatures shown. Two 
lOOng aliquots of the ssM13mpl8signal DNA (the template for the 
mutagenesis) were used as controls (C) to show the temperature 
above which the probe would no longer remain bound to the wild- 
type (non-mutated) sequence. Note the selective binding of the 
probe to certain clones at the higher temperature, but not to 
the control DNA.
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FIGURE 3.5.4.3 DHA SEQUENCE ANALYSIS OF PUTATIVE SALT MUTAHT 
CLONES B4 & F10.
Single-stranded M13DNA was prepared from these clones after 
they had been identified as putative mutants by hybridisation 
screening (Figure 3.5.43). 2ug of this DNA was sequenced using 
the M13 universal primer and the Sequenase™ kit. An 
autoradiograph of the sequencing gel is shown giving the 
relevant regions in clones B4 and F10. The clone B4 appeared as 
a non-mutant (i.e. wild-type sequence) in this region, but 
clone F10 contained the desired 5-base mismatch mutation 
(asterisked), which introduced a Sail restriction site at the 
position shown (arrowed and labelled 'S'). Below the 
photographs is the 5' DNA coding sequence of preproricin, 
amended from Lamb £t ^1 (1985)(see Appendix for the complete 
DNA coding sequence). The region shown in the photographs above 
is highlighted.
S N-terminal region coding sequence of preproricin
A ricin A chain coding sequence
“► M13 universal primer and direction of sequencing
t
-105 -100
CTCGAGG ATG AAA. CCG GGA AGA AAT ACT ATT GTA ATA TGG (Met Lys Pro Gly Gly Asn Thr lie V a l  H e  Trp
• • * ^ATH TAT CCA CTC CCA ACA TCC CTT TGT TTC GGA TCC ACC TO GCC TGC TCT TTC ACA TTA GAC 
-tet Tyr Ala Val Ala Thr Trp Leu Cys Phe Cly Ser Thr Ser Cly Trp Ser Phe Thr Leu Glu
___ _______ __________________________ -X
GAT AAC AAC ATA TTC CCC AAA CAA TAC CCA ATT ATA AAC TTT ACC ACA GOG OCT GCC ACT CTG CAA ACC TAC ACA AAC flT ATC ACA GCT 
AaP Aan Aan lie Phe Pro Lya Gin Tyr Pro lie lie Iftsn Phe ThrlThr Ala Cly Ala Thr Val Gin Ser Tyr Thr Aan FT* lie Arg Ala
(^ T CCC CCT OCT TTA ACA ACT GGA GCT GAT CTG ACA CAT GAT ATA CCA GTG TIG CCA AAC AGA CTT GCT TTC CCT ATA AAC CAA OQC TTT
Val Arg Cly Arg Leu Thr Thr Gly Ala Aap Val Arg Hla Asp lie Pro Val Leu Pro Asn Arg Val Gly Leu Pro lie Am Cln Are Phe10 ' 40 Glu *o
FIGURE 3.6 DNA SEQUENCE AND VON HEIJNE ANALYSIS OF PREDICTED 
H-TERMINAL REGIONS OF FUSION PROTEINS ENOCODBP BY THE 
CONSTRUCTS pPARTIAL AHD pFULL.
A/ DNA sequences and deduced amino acid sequences of the N- 
terminal regions encoded by the chimeric genes in pPARTIAL and 
pFULL. The 'extra' codons created as a result of cloning 
manipulations are highlighted by dashed lines. The mutated 
initiating codon of the npt2 gene (ATG to GTG) is asterisked.
B/ Graphic representation of the von Heijne algorithm when 
applied to the predicted N-terminal sequences shown in A. The 
residues are shown along the x-axis. The first 23 residues are 
invariant (shown by dashes). In both cases the residue 
glycine^ remains a good candidate for the site of signal 
peptidase cleavage. In the predicted N-terminal sequence for 
the pFULL chimeric gene product, threonine^® also has a high 
value.
A
P A R T I A L
ATGM et AAAL y s CCGP r o GGAG l y GGAG l y AATA sn ACTThr ATTl i e
TTTP h e GGAG l y TCTS e r CGAA rg ★GTGV a l -►npt2
FU LL
ATGMet AAAL y s CCGP r o GGAG l y GGAG l y AATA sn ACTThr ATTl i e
TTTP h e GGAG l y TCCS e r ACCThr TCAS e r GGGG l y TGGTrp TCTS e r
30GTA ATA TGG ATG V a l  11« Trp M et
30GTA ATA TGG ATG V a l  I I »  Trp M e t90TTC ACA TTA GAG P h e  Thr Leu G l u
TAT GCA GTG GCA Tyr A l a  V a l  A l a
TAT GCA GTG GCA Tyr A l a  V a l  A l a
GAT AAC AAC AGT Asp A sn  Asn J e r
60ACA TGG CTT TGT Thr Trp Leu C y s
60ACA TGG CTT TGT Thr Trp L e u  C y s
CGA GTG -►npt2A r g  V a l
B
algoritm value
___  = PARTIAL
-----  = FULL
analysed, it showed a similar profile to that of the 
preproricin N-terminus (compare with Figure 3.2).
3.7 IN VITRO EXPRESSION OF THE CHIMERIC GENE FROM THE pPARTIAL
CONSTRUCT.
The ability of the partial preproricin N-terminal 
sequence cloned into the pPARTIAL construct to act as a 
functional ER signal peptide was then assessed using an in 
vitro expression system. The 1Kb BamHI chimeric gene fragment 
from the pPARTIAL construct was first cloned into the Bglll 
site of the SP6 expression vector, pSP64T (Krieg and 
Melton,1984) and the new construct named pSP64Tpartial. The 1Kb 
BamHI fragment from pCaMVNEO, containing the wild-type npt2 
gene was also cloned into pSP64T (named pSP64Tnpt2) to be used 
as a control.
Transcripts from pSP64Tnpt2 and from pSP64Tpartial were 
translated in rabbit reticulocyte lysates - in the presence or 
absence of dog pancreatic microsomes. The results are shown in 
Figure 3.7. In both cases, when translated in the absence of 
microsomes a single labelled protein product was observed 
(lanes 1 and 3). The protein expressed from pSP64Tpartial was 
estimated to be 30kD in size, which was about 2kD larger than 
the npt2 gene translated from pSP64Tnpt2 mRNA. This 'wild-type' 
npt2 gene product was similar in size when translated in the 
presence of dog microsomes (lane 2). However, when 
pSP64Tpartial mRNA was translated in the presence of dog 
microsomes (lane 4), a second band (of similar size to npt2) 
was observed in addition to the full-length fusion protein 
(compare lanes 1,3 and 4). It is proposed that this lower band 
represented protein which had been co-translationally 
translocated across the microsomal membrane and been processed 
by signal peptidase. As there are no tripartite (Asn-X-Ser/Thr) 
sequences in the fusion protein, no asparagine-linked
NPT2 PARTIAL 
kD 1 2  3 4
69-
46-
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FIGURE 3.7 IN VITRO EXPRESSION OF THE CHIMERIC GENE FROM 
pPARTIAL.
The npt2 gene from pCaMVNEO and the chimeric partial ricin 
presequence/npt2 gene from pPARTIAL were cloned into the in 
vitro expression vector, pPSP64T, and transcribed and 
translated in rabbit reticulocyte lysate using the methods 
described in Chapter 2. The translated products were resolved 
by reducing SDS-PAGE and the bands visualised by fluorography. 
Lanes 1 and 3 show the single protein products from the in 
vitro expression of npt2 and pPARTIAL genes respectively. In 
the translations shown in lanes 2 and 4, lul of dog pancreatic 
microsomes had been added at the start of each incubation.
glycosylation would be expected to occur. The segregated fusion 
protein, after cleavage of the N-terminal signal, was therefore 
smaller in size than the non-segregated fusion protein. 
Furthermore, the site of signal peptidase cleavage in the 
fusion protein must be at/close to the site of cleavage 
predicted by the von Heijne algorithm - namely to the carboxyl 
side of Gly22 - as the segregated protein was of similar size 
to wild-type npt2. It was therefore concluded that the 22 
residues at the N-terminus of preproricin was able to function 
as a signal peptide and mediated the transport of the pPARTIAL- 
encoded fusion protein across the ER membrane.
3.8 DISCUSSION.
The algorithm of von Heijne was applied to the N-terminal 
residues of preproricin and a computer programme was designed 
to help do this. The algorithm identified the residues 
glycine22 and t h r e o n i n e - * ®  in the N-terminal region of 
preproricin as being the most likely sites for signal peptide 
cleavage. On the other hand, the last residue of the 35aa 
residue N-terminal presequence, asparagine-*^, was given a 
negative value which according to von Heijne (1985) renders it 
a very poor candidate for signal peptide cleavage. This is, 
therefore, strong indirect evidence to support the idea that 
once translocated into the lumen of the ER, proricin has an N- 
terminal propeptide of 5-13 residues.
Two constructs suitable for expression in plant systems 
were then successfully constructed. These contained chimeric 
genes between preproricin cDNA and the gene for the marker 
enzyme npt2. In the process of their construction, two site- 
directed mutagenesis steps were necessary and were carried out 
successfully. However, the method of mutagenesis described by 
Nakamaye and Eckstein (1986) failed to generate any mutant 
progeny. In the construction of the mutated vector pCaMVNEOAX,
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the failure of this method to introduce a 3-base mismatch 
mutation was attributed to the region of DNA near to the site 
of mutation which showed compressions when sequenced (see 
Figure 3.5.2.3). This is characteristic of secondary structure 
formation in the DNA and this may have hindered one or more of 
the in vitro manipulations involved in this mutagenesis 
protocol. Based on this observation, another mutagenesis 
protocol (Kramer, Kramer and Fritz, 1984) was followed which 
involved fewer in vitro manipulations. This protocol used a 
strain of E.coli which is deficient in its DNA repair 
mechanisms and so increases the viability of heteroduplex 
plasmid DNA. This second method proved successful in generating 
both of the desired mutants with a mutation frequency of 10- 
15%. Because this is lower than the mutation frequencies 
claimed possible with the method for mutagenesis of Nakamaye 
and Eckstein (1986), an additional hybridisation screening step 
was necessary to identify putative mutants before DNA 
sequencing was used to confirm the presence of the desired 
mutation.
Of the two constructs designed, one, termed pPARTIAL, 
encoded a protein chimera with 23aa residues from the N- 
terminus of preproricin fused onto npt2. This protein therefore 
contained the N-terminal presequence of preproricin up to and 
including g l y c i n e ^ ,  one of the two residues identified by the 
von Heijne algorithm as being a likely site of signal peptide 
cleavage. The second construct named pFULL, encoded a protein 
with the complete preproricin N-terminal presequence (35 
residues) fused to npt2. The von Heijne algorithm was applied 
to the predicted N-terminal regions of both gene products and 
both were found to have residues near their N-termini which 
were good candidates for being the sites of signal peptide 
cleavage.
Since both constructs pPARTIAL and pFULL were designed
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for expression in plant protoplasts in order to study plant 
protein targeting, it was necessary to check that the fusion 
protein encoded by pPARTIAL contained a functional ER signal 
peptide. The ability of the first 23 amino acid residues of 
preproricin to mediate the transport of a nascent ricin/npt2 
polypeptide chain across the ER-membrane was therefore assessed 
by cloning the chimeric gene from the pPARTIAL construct into 
the in vitro expression vector pSP64T, and then expressing the 
gene fn vitro in the presence or absence of dog pancreatic 
microsomes. The results revealed that in the presence of 
microsomes about 50% of the fusion protein was processed to a 
size similar to wild-type npt2 (Figure 3.7, lanes 1 & 4). As 
expected, there was no such processing observed when wild-type 
npt2 was translated in the presence of microsomes (Figure 3.7, 
lane 2). This suggests that the preproricin-derived portion of 
the fusion protein mediated this processing response. Since the 
processing of the chimaera resulted in a protein product which 
was of similar size to wild-type npt2, it was concluded that 
cleavage of the signal peptide by the ER signal peptidase 
occurred at or very near to the carboxyl side of the residue 
g l y c i n e ^ .  This had been identified by von Heijne's algorithm 
as being a good candidate for the site of signal peptide
99cleavage in preproricin. However, whether glycine'4,4’ is the 
actual site of signal peptide cleavage in preproricin cannot be 
unequivocally determined from this data.
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4.1 IHTRODPCTION.
The construction of the plasmids pPARTIAL and pFULL have 
been described in the last chapter. This chapter will deal with 
the expression of these ricin/npt2 chimeric genes in tobacco 
leaf protoplasts. The chapter will begin with a short section 
which explains the reasons for the selection of npt2 as a 
suitable marker enzyme and the transient expression in 
protoplasts as an appropriate system for expression of the 
ricin/npt2 chimeras. The results will then be presented, along 
with the conclusions that have been drawn from them.
It should be noted that all of the work presented in this 
chapter was performed at the Istituto Biosintesi Vegetali, 
Milan, under the supervision of Dr. Aldo Cerlotti.
4.2 CHOICE OF MARKER ENZYME AMD EXPRESSION SYSTEM.
The use of recombinant DNA techniques for studying 
protein targeting in eukaryotic cells is well documented and 
was reviewed by Garoff (1985). B-glucuronidase (GUS), neomycin 
phosphotransferase (npt2), chloramphenicolacetyltransferase 
(CAT), and phosphinothricin acetyltransferase (PAT) have all 
been used successfully as reporter genes in plants. Sensitive 
assays have been described for each reporter gene system 
(Jefferson e_t a_l, 1987 - GUS: McDonnell e_t al, 1987 - npt2: 
Gormen e_t aj^ , 1982 - CAT: De Block e_t a_l, 1987 - PAT). They 
have been used for both studies in transgenic plants and rapid 
analysis using transient expression in protoplasts.
The regeneration of transgenic plants after 
transformation with a foreign gene is a useful system for 
studying the tissue-specific expression of foreign plant 
promoters. It is also necessary if accumulation of relatively 
large quantities of the foreign protein is desirable. Boutry £t 
al (1987) have also used transgenic plants to study 
intracellular targeting of a reporter gene (npt2) to the
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mitochondria after tagging with a mitochondrial presequence.
However, the high sensitivity of the marker enzyme assays 
and the relatively rapid analysis capable with transient 
expression studies have made this alternative an attractive 
system for the rapid screening of many different constructs, in 
preference to the time consuming process of regenerating 
transgenic plants. For example, Werr and Lorz (1986) described 
a transient expression system for analysing plant promoters in 
Graminaceae protoplasts using npt2 as the marker gene. Topfer 
et al (1988) compared the relative activities of GUS, CAT and 
npt2 in transient expression studies using tobacco leaf 
protoplasts. Their results showed that the order of relative 
sensitivity for the three reporter genes under these conditions 
was CAT < npt2 < GUS.
Denecke e_t al^  (1990) used transient expression in tobacco 
leaf protoplasts to study the plant secretion pathway. They 
compared the relative rates of secretion of GUS, npt2 and PAT 
by fusing an ER signal peptide sequence to each gene and then 
transforming protoplasts. After a 36 hour incubation they 
analysed the cell and media fractions for enzyme activity. In 
each case the marker enzyme was targeted to the lumen of the ER 
and was then secreted into the media. However, the relative 
rates of secretion of GUS, npt2 and PAT into the media differed 
considerably. They found that the order was GUS < npt2 < PAT. 
GUS is a tetrameric protein and its assembly in the ER was 
thought to retard its rate of secretion. GUS also has the 
disadvantage of containing two potential N-glycosylation sites 
which, when glycosylated, result in a complete loss of enzyme 
activity. These considerations meant that GUS was not a good 
candidate for making ricin/marker enzyme fusions to be targeted 
to the endomembrane system. However, the observations of Topfer 
et al (1988: above) illustrates its high sensitivity and make 
it an excellent cytosolic marker.
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On the other hand, npt2 has a significantly high 
sensitivity in transient expression systems (Topfer et al, 
1988: above), an acceptable rate of secretion from the ER lumen 
(Denecke e_t ^1, 1990: above) and it is able to tolerate 
relatively long N-terminal extensions without appreciable loss 
of enzyme activity (Denecke, personal comm.). This made it the 
most attractive candidate for this work and, therefore, the 
constructs pPARTIAL and pFULL were designed and made as 
described in Chapter 3.
The site of action of the neomycin phosphotransferase 
enzyme encoded by the npt2 gene from transposon Tn5 (Beck e_t 
al, 1982) on its substrate, neomycin, is shown in figure 4.2. 
The vector pCaMVNEO, used as a building block for the 
ricin/npt2 chimeras, encodes a copy of this gene. Details of 
its enzyme kinetics can be found in a review by Davies and 
Smith (1978).
4.3 ISOLATIOH AMD TRANSFORMATION OF PROTOPLASTS.
4.3.1 ISOLATIOH OF PROTOPLASTS
The protocol described in Section 2.7 was used for the 
asceptic isolation of SRI protoplasts from the leaves of 
N.tabaccum petit Havana var. Early attempts to isolate intact 
protoplasts proved unsuccessful. This failure was attributed to 
the high light intensity under which the plants were grown. It 
was thought to be sufficient to cause a significant 
accumulation of starch grains in the chloroplasts which 
ruptured the protoplasts during centrifugation steps. The light 
intensity was therefore adjusted to 700 Lux, the illumination 
being provided by a single GROWLUX tungsten element, and this 
enabled an average yield of 5 x 10^ viable protoplasts from 20 
healthy leaves (See Figure 4.3.1).
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FIGURE 4.2 SITE OF ACTION OF NPT2 ON NEOKYCIN.
The npt2 gene product from Tn5 (see Beck e_t al^ , 1982) is 
classified as a 3'-O-phosphotransferase (3'APH). It catalyses 
the transfer of the gamma phosphate group from ATP to the 
arrowed hydroxyl group on carbon ring II of neomycin. This 
forms the basis of a sensitive assay for npt2 activity 
(McDonnell e£ al., 1987).
FIGURE 4.3 IMMUNOFLUORESCENCE OF VIABLE PROTOPLASTS
The photographs opposite show how viable protoplasts can be 
estimated by fluorescein diacetate (FDA) staining. 50jil of a 
4:1000 dilution of FDA (5mg/ml stock in acetone) in K3 media 
was mixed with 50jil of the isolated protoplast suspension (in 
W5) using a wide bore pipette. Photograph A shows the 
protoplasts under transmitted light: photograph B is the view 
seen under fluorescent light. The dye passes freely across the 
plasma membrane but only in living protoplasts are the 
molecules cleaved by the action of esterases (Larkin, 1976). 
Cleavage results in the releease of fluorescein which is no 
longer able to pass back across the membrane. The fluorescein 
therefore accumulates within intact cells and can be excited by 
ultraviolet light. By carrying out this operation on a 
haemocytometer slide, the numbers of viable protoplasts can be 
estimated.
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4.3.2 PEG/CALCIUM NITRATE-MEDIATED PROTOPLAST TRANSFORMATION.
Intact, isolated protoplasts were transformed with the 
npt2-encoded vector of interest. During PEG treatment the 
protoplasts were seen to form small clumps. This was thought to 
be a result of the effects of PEG on the cell membranes. As the 
PEG solution was first diluted and then finally removed from 
the protoplast suspension, the protoplasts became re-dispersed 
into single cells.
Approximately 90% protoplast survival was observed after 
this PEG treatment. This was estimated visually as being the 
proportion of protoplasts that floated in the K3 expression 
medium into which the protoplasts were placed after 
transformation. In this medium, which is 0.4M with respect to 
sucrose, only intact protoplasts will float (Saul et a_l, 1988).
Transformed protoplasts were stable in this medium when 
incubated in the dark, at 26C and for 36 hours.
4.4 TRANSFORMATION OF PROTOPLASTS WITH pCaMVNEO. pPARTIAL AND
¿FULU
Viable protoplasts were transformed with 21ug of sterile, 
covalently-closed, circular npt2-encoded plasmid DNA. After 36 
hours' incubation, the protoplasts and media were analysed 
separately for npt2 activity. Figure 4.4 shows the result of 
the npt2 activities in protoplast and media fractions. No 
endogenous npt2 activity was seen in protoplast or media 
fractions from untransformed protoplasts. This showed that 
there was no measurable background npt2 activity in tobacco 
protoplasts when treated in this way.
On the other hand, when protoplasts were transformed with 
pCaMVNEO, pPARTIAL or pFULL, high levels of npt2 activity were 
observed in the cell fractions. From this it was concluded that 
a soluble, functional npt2 enzyme was being expressed from each 
of the constructs.
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FIGURE 4.4 HPT2 ACTIVITIES IN CELL AMD MEDIA FRACTIONS OF
PROTOPLASTS, 36 HOURS AFTER TRANSFORMATION WITH pCaMVNEO, 
pPARTIAL and pFULL.
The dot blot assay of McDonnell £t a^l (1987) was 
used to determine the npt2 activities in cell (protoplast) and 
media fractions (see Methods). Under the assay conditions, npt2 
activity present in a fraction catalyses the transfer of ^2p_ 
labelled gamma phosphate groups from ATP to neomycin. At the 
end of the assay, the soluble protein was spotted onto Whatman 
P-81 paper and the un-incorporated ^P-ATP waahed away. The 
filter was then dried and any bound, radiolabelled neomycin was 
identified by autoradiography. Fractions containing npt2 
activity appear as black spots.
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5 pFULL
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No npt2 activity was seen in any of the media fractions. 
This result was as expected for protoplasts transformed with 
pCaMVNEO. In these cells, npt2 was being expressed in the 
cytosol and any activity present in the media could only have 
arisen as a result of lysis and cytosolic release. However, 
this result was not as expected for the fusion proteins 
expressed from both the pPARTIAL and pFULL constructs. One 
interpretation of these results is that once expressed, the 
fusion proteins remain in the cytosol. However, the results 
from the iji vitro expression of the pPARTIAL construct (shown 
in Figure 3.7) indicate that this fusion protein contains a 
functional signal peptide. In addition, other workers have 
shown that the full 35amino acid residue N-terminal presequence 
of preproricin (as is present in the pFULL construct) can also 
mediate the translocation of fusion proteins across the ER 
membrane (Richardson et al, 1988). Therefore it is reasonable 
to assume that in protoplasts transformed with pPARTIAL or 
pFULL, the expressed fusion protein is co-translationally 
translocated across the ER-membrane.
Based on the assumption that the fusion proteins are 
segregated in the ER lumen, there must be another reason for 
the absence of npt2 activity in the medium. One possible 
interpretation is that the segregated products are misfolded in 
the environment of the ER lumen and are therefore retained in 
this compartment by, for example, association with the binding 
protein, BiP. An alternative, though unlikely, interpretation 
of the results is that npt2, which is normally expressed in the 
cytosol, contains some form of redundant targeting or retention 
signal which interacts with a receptor in the secretory pathway 
and so retards it from bulk flow secretion. Finally, the 
preproricin-derived residues on the segregated fusion proteins 
expressed from pPARTIAL and pFULL may contain a targeting or 
retention signal which interacts with some factor along the
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secretory pathway and prevents secretion of the proteins into 
the medium.
Denecke e_t al^  (1990) have shown that when npt2 is 
targeted to ER lumen in tobacco protoplasts by fusion to a 
signal peptide, it was efficiently secreted into the medium. 
From this data it can be concluded that 'wild-type' npt2 folds 
in the ER in such a way that there is no permanent association 
with BiP and that also the protein contains no 
retention/targeting signals, since it is secreted by bulk flow 
into the medium. From the data presented in the previous 
chapter were the pPARTIAL construct was expressed in vitro 
(see Figure 3.7), it was concluded that the ER-segregated form 
of the fusion protein was similar in size to wild-type npt2. If 
cleavage of the signal peptide occurs at the same site during 
expression of the pPARTIAL construct in protoplasts, then the 
segregated form must closely resemble wild-type npt2. This 
would suggest that it folds correctly in the ER lumen and is 
not retained or targeted away from the bulk flow secretion 
pathway. Therefore, it was expected that npt2 activity would be 
found in the medium from protoplasts transformed with pPARTIAL. 
The only remaining alternatives as to why this was not observed 
were considered to be, either the preproricin signal peptide 
does not function correctly in this plant expression system and 
therefore the fusion proteins remain localised in the cytosol, 
or that secreted npt2 is inactivated in the media. However, the 
existing data was insufficient to enable discrimination between 
these alternatives
In light of this apparently anomalous result with 
expression of the gene from pPARTIAL, it was impossible to make 
any further conclusions from the data obtained with the pFULL 
construct; such as the possibility of preproricin-borne signal- 
mediated retention of npt2 activity in the cells of pFULL- 
transformed protoplasts. A control, known to produce a secreted
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protein in this system, was clearly desirable. Furthermore, it 
was deemed necessary to modify the protocol and approach both 
to test the hypothesis of npt2 inhibition in the media 
fractions (mentioned above) and to monitor the amount of cell 
damage. These are described in the section below.
4.5 PROTOCOL MODIFICATIONS AMD FURTHER TRANSIENT EXPRESSION 
STUDIES.
4.5.1 AMENDED APPROACH.
In an effort to get a better understanding of the 
destination of the ricin/npt2 chimeras expressed in this 
transient expression system, the following modifications to the 
original method were applied.
(a) The plasmid, pDE307 (a gift from Jurgen Denecke: for 
map see Denecke et al, 1990), was obtained. It encodes a fusion 
protein between a functional ER signal peptide from the 
pathogenesis-related protein lb (Cornelissen ^t al, 1986) and 
npt2. Denecke and co-workers showed that when this plasmid was 
transformed into tobacco leaf protoplasts, approximately 50% of 
the expressed npt2 activity was found in the media 36 hours 
after transformation. They concluded that the signal peptide 
had directed the npt2 into the lumen of the ER from where it 
was secreted by default into the medium. This plasmid was 
therefore used to provide a control for default secretion of 
npt2 from the ER.
(b) All protoplasts were co-transformed with pDP33GUS and 
the npt2-encoded plasmid of interest. The plasmid pDP33GUS (a 
gift from Aldo Ceriotti) contains the GUS gene located between 
a 35S CaMV promoter and a nopaline synthase transcription 
terminator sequence. Protoplasts transformed with this plasmid 
should therefore express GUS in the cytosol. This was used as a 
sensitive cytosolic marker. By analysing aliquots of the cell 
and media fractions for GUS activity (as well as npt2
activity), it was hoped that the amount of contamination of the 
media with cytosol could be determined and this in turn would 
assist interpretation of any npt2 activity found in the media 
fractions. This will be explained in more detail with actual 
data obtained, in Section 4.5.2 below.
(c) Following the transformation and incubation of 
protoplasts, the soluble proteins in the cell and media 
fractions were precipitated with ammonium sulphate (see Methods 
2.4.7). The protein was then resuspended in enzyme reaction 
buffer and the salt was dialysed away prior to assaying each 
fraction for GUS and npt2 activity. This step was an attempt to 
remove any enzyme-inhibiting factors from the cell/media 
fractions (see Denecke e£ al_, 1989: also, personal 
communication, Jurgen Denecke). It was hoped that this would 
reduce the likelihood of there being inhibition of npt2 
activity in the media fractions (as was a possibility 
considered in the last experiment described above).
(d) Soluble protein from the leaves of a pCaMVNEO- 
transformed transgenic tobacco plant was used as a source of 
npt2. Controls could therefore be set up using appropriate 
amounts of this protein, diluted in cell and media buffers. 
These controls were processed in an identical fashion to the 
fractions from transformed protoplasts and were then assayed 
for npt2 activity. By doing this it was possible to check the 
relative recoveries of npt2 activity between cell and media 
fractions after they had been processed. In the third 
experiment described below, 6 milliunits of commercially- 
obtained GUS (Sigma) was also added to these controls before 
precipitation and dialysis, in order to check the relative 
recovery of GUS activity in the same way.
Using these modifications, three further transformation 
experiments were performed. The three experiments will be 
referred to in chronological order as Experiments 1, 2, and 3.
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In each experiment, the following transformations were done:
1. 21 jig pCaMVNEO
2. 21jig pDE307
3. 21jig pPARTIAL
4. 21jig pFULL
5. no DNA
In Experiment 1, protoplasts were heat-shocked at 45C for 
5min immediately prior to co-transformation with 7jig pDP33GUS 
and the relevant npt2-encoded plasmid indicated above.
Experiment 2 was as above, but without the heat-shock
step.
In Experiment 3 the protoplasts were not heat-shocked 
and only 1.3jag pDP33GUS was co-transformed with each of the 
npt2-encoded plasmids.
4.5.2 RESULTS FROM GUS ASSAYS.
After 36 hours' incubation, cell and media fractions were 
prepared from transformed protoplasts and aliquots assayed for 
GUS/npt2 activity. The results of the GUS assays are shown in 
Figures 4.5.2.1 and 4.5.2.2. Figure 4.5.2.1 shows how the raw 
data from these GUS assays was converted to give the final 
values for GUS activity, expressed in the preferred units of 
nmoles product released/min (Jefferson, 1987) and displayed 
graphically in Figure 4.5.2.2.
For each sample four time points were taken. The samples 
from the control protoplasts which had been PEG-treated in the 
absence of pDP33GUS (labelled 'no DNA') had very low levels of 
relative fluorescence and these values did not increase with 
time. From this it was concluded that extracts from 'no DNA' 
PEG-treated protoplasts contained negligible levels of GUS 
activity and there was also a negligible level of non-specific 
MUG hydrolysis under the assay conditions used.
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FIGURE 4.5.21 CALCULATION OF GUS ACTIVITY IN CELL AND MEDIA
FRACTIONS.
The graphs opposite show a plot of relative fluorescence versus 
time for the GUS assays performed in Experiment 3. The 
following calculations were performed to convert these relative 
fluorescence values to the prefered units for GUS activity; 
nmoles product/min/fraction (Jefferson, 1987). As an example, 
the calculation for the 'pCaMVNEO'-transformed protoplast 
(cell) sample is shown in bold type.
1. Calibrate the spectrofluorometer with a series dilution 
of 10-2to 10_6mM MU:
[MU](mM) 10"2 10~3 10~4 10-5 1CT6
rel. fluor. 24.0 3.15 0.315 0.032 0
therefore rel. fluor. [MU] between 0.032 and 3.15
2. Read each time point of sample (diluting with 0.2M 
NaHCOj if necessary to get rel. fluor. betwwen 0.032 & 3.15):
time (min) 0 30 71 110
pCaMVNEO(rel. fluor.) 0.025 1.635 0.380* 0.665*
(* * lOx dilution)
3. Plot graph of rel. fluor. versus time to show linear 
relationship (taking into account dilutions made above):
see open squares on graphs opposite.
4. Read off fluorescence at 60min:
3 3.24units [4]
5. As 1ml of 10-3MU (rel. fluor. *3.15) contains lnmole, 
calculate nmoles MU released per hour for sample:
[4] x 1/3.15 3 1.03nmoles MU/hour [5]
6. Only 1/4 of the total reaction was stopped at each time 
point (lOOul from 400ul):
[5] x 4 3 4.11nmoles MU/hour/assay [6]
7. Correct for activity per minute:
[6] x 1/60 3 0.07nmoles MU/ain/assay [7]
8. Correct for total activity in cell/media:
I71 x 416(volume of total soluble protein froa cell fraction)
65(volume of above used In GUS assay)
3 0.44nmoles MU produced/mln/cell fraction
(4
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FIGURE 4.5.22 GUS ACTIVITIES IN CELL AHD MEDIA FRACTIONS OF
PROTOPLASTS, 36 HOURS AFTER TRANSFORMATION WITH pDP33GUS.
3 x 10^ viable protoplasts were transformed with 
the plasmids indicated below and the genes expressed for 36 
hours by incubation of the protoplasts at 26C in K3 medium in 
the dark. Protoplast (cell) and media fractions were then 
prepared as described in Methods (2.4.7) and assayed for GUS 
activity according to Jefferson (1987). This assay follows the 
GUS-catalysed release of methylumbelliferone (MU) from 4- 
methyl-umbelliferyl glucuronide (MUG) spectrofluorometrically. 
The amount of MU present at different time points was 
determined by diluting aliquots of the reaction in 9 volumes 
0.2M NaHCOj, measurement of the relative fluorescence of this 
solution (at 455nm when excited at 365nm) and reference to a 
standard curve of relative fluorescence versus [MU] (not
shown). These values were corrected for assay volume versus 
total cell/media volume and the GUS activities were then 
expressed as nmoles MU released/min/total fraction. An example 
of such a calculation is shown in Figure 4.5.21
Graph A: Protoplasts were heat-shocked for 5min at 45C 
immediately before transformation with 7.0yig pDP33GUS.
Graph B: No heat shock: transformation with 7.0pg pDP33GUS. 
Graph C: No heat shock: transformation with 1.3pg pDP33GUS.
In each case (A,B,C) protoplasts were co-transformed with 
21.0yg of the npt2-encoded plasmid indicated along the X- 
axis. "No DNA” indicates that protoplasts were PEG-treated in 
the absence of any npt2/GUS-encoded plasmid DNA. "npt2” 
(GRAPH C only) indicates control tubes that contained O.lmg 
soluble protein from leaves of transgenic tobacco and 6mU of 
commercially-obtained GUS.
Values above each bar cluster represent % cell lysis;
i.e. _______GUS activity in media______ x 100
Total GUS activity in cell + media
Graph D: Comparison of the total GUS activities (cell+media) 
from the three experiments (expressed as nmoles MU 
released/min/ug pDP33GUS)
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However, with all cell extracts from pDP33GUS-transformed 
protoplasts a detectable level of fluorescence was observed. By 
plotting the relative fluorescence of these time points versus 
time (see graphs in Figure 4.5.2.1) it was also possible to 
confirm that the observed fluorescence in extracts from 
pDP33GUS-transformed protoplasts increased linearly with time 
during the assay. From these results it was concluded that the 
conversion of MUG to MU, in samples from pDP33GUS-transformed 
protoplasts, was GUS-catalysed.
Jefferson (1987) has reported that the PEG treatment of 
protoplasts can sometimes result in the production of phenolic 
compounds which give a high background fluorescence in the GUS 
assay. This problem was not encountered in these experiments, 
however, and, as stated in the paragraph above, by following a 
time course it was possible to distinguish between background 
fluorescence and GUS-catalysed hydrolysis of the substrate, 
MUG.
Figure 4.5.2.2 shows the processed results for the GUS 
assays from all three experiments expressed in graphical form. 
Although the values for GUS activity shown in these graphs may 
appear low, they are deceptive as the units used mask the high 
sensitivity of the assay. For example, the background GUS 
activity in the 'no DNA' controls was calculated to be less 
than 1 x 10“^nmoles MU/min/tube, whereas even the lowest value 
for GUS activity recorded in pDP33-transformed protoplasts (see 
Figure 4.5.2.2, graph B) was 4000 times greater than this value 
(0.4nmoles MU/min/tube). It was therefore concluded that, in 
every case, transformation of the protoplast samples had been 
successful and each was expressing significant levels of 
functional GUS enzyme.
These results shown in Figure 4.5.2.2 also revealed that 
within each experiment the GUS activity varied between samples, 
despite the fact that each sample had been transformed with an
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equal amount of pDP33GUS. Furthermore, these variations were 
not random, as is shown in Graph D, where the total GUS 
activities (cell+media) were standardised to take into account 
the fact that each protoplast sample in Experiment 3 was 
transformed with 1.3jig of pDP33GUS (as opposed to 7jig in 
Experiments 1 & 2). This graph shows that in each experiment 
the order of GUS activity was as follows:
GUS activity pDE307 < pCaMVNEO/pPARTIAL < pFULL.
As the only variable factor between transformations was the 
npt2 plasmid with which pDP33GUS was co-transformed, it must be 
concluded that the npt2 plasmid has some effect on the 
efficiency of transformation or level of expression of the 
pDP33GUS plasmid. Further discussion of this observation must 
be left until after the results of the npt2 assays have been 
presented below.
As was discussed in Section 4.5.1, the reason for co­
transformation of the protoplasts with pDP33GUS in addition to 
the npt2 plasmid of interest was to use the former as a 
cytosolic marker in the hope of calculating the level of 
contamination of the media fractions with cytosol. It was hoped 
that this, in turn, would make the results from the npt2 assay 
more meaningful. In graphs A-C of Figure 4.5.2.2 the level of 
cytosolic contamination, expressed as percentage cell lysis, is 
shown above the bars. The justification for using this value as 
a valid indication of cell lysis, was that all GUS activity 
observed in the media fractions could only have originated from 
within protoplasts transformed with pDP33GUS and expressing the 
enzyme.
Using this data to compare the results obtained in 
Experiments 1 and 2, reveals that although the heat-shock 
treatment, performed prior to transformation in Experiment 1 
only, increased the total average level of expression of GUS in 
protoplast samples from the first experiment (3.1 versus
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1.4nmol.es MU/min/tube respectively), this treatment also 
increased the average amount of cell lysis (13.5% versus 6.8% 
respectively). The increased transformation observed in heat- 
shocked versus non-heat-shocked protoplasts has been reported 
before (Saul e£ al^ 1988). However, in this instance it is 
desirable to minimise cell lysis in order to maximise the 
relevance of the results from the npt2 assays. Therefore, it 
was decided to also omit the heat-shock step in Experiment 3.
As a final check to show that there was a comparable 
recovery of GUS activity from cell and media fractions after 
processing the samples, two controls (see lanes labelled 'npt2' 
in Figure 4.5.2.1 and Graph C of Figure 4.5.2.2) were set up 
which consisted of lOOjig of soluble leaf protein in the 
relevant extraction buffer and 'spiked' with 6mU of 
commercially-available GUS (Sigma). These controls were 
processed at the same time and in an identical way to all other 
cell and media fractions. Graph C in Figure 4.5.2.2 shows that 
a very similar activity was recovered. When- these values were 
compared to a time course, also set up using 6mU of GUS 
activity but which had not been processed (0.24nmol 
MU/min/tube: not shown on graph), it was calculated that 83% of 
the original GUS activity had been recovered after cell 
fraction processing and 75% after media processing. As only one 
set of controls were done, however, these values were not 
thought to be sufficiently statistically valid to allow 
empirical adjustment of the values for the cell and media 
fractions of pDP33GUS-transformed samples (i.e. to take into 
account that only 83%(cell) or 75%(media) of the original GUS 
activity in fractions was detected after processing. On a more 
positive note, what these results do show is that the huge 
differences observed between cell and media fractions were not 
simply artefacts of the extraction and processing steps but
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were due to real differences in GUS activity between the cell 
and media fractions.
4.5.3 RESULTS FROM NPT2 ASSAYS
The fractions from the three experiments were then 
assayed for npt2 activity using the same dot blot method of 
McDonnell e£ a^L (1987) as was used in the initial 
transformation experiment (Section 4.4). The results of 
Experiments 1 and 2 are shown in Figure 4.5.3.1.
The controls used to compare recovery of npt2 activity 
between cell and media processing (see C5-C8), where soluble 
protein from leaves of pCaMVNEO-transformed transgenic tobacco 
was extracted and processed in a similar way to either cell or 
media protoplast fractions, revealed that npt2 enzyme activity 
could now be recovered from both fractions. This meant that by 
following the amendments to the protocol as described in 
Section 4.5.1 above, it should now be possible to detect any 
npt2 activity in the media fractions of protoplasts transformed 
with npt2 constructs.
In the cell fractions of protoplasts PEG-treated in the 
absence of any plasmid DNA ('no DNA': see lanes A5 & B2) spots 
of diffuse radioactivity, surrounded by a darker 'halo', were 
observed. By comparison to the results from the previous 
transient expression experiment (Figure 4.4), where npt2- 
specific activity in cell fractions appeared as dark spots 
centred around the point of sample application to the filter 
(^P-neomycin phosphate only diffuses slowly before becoming 
bound), it was concluded that the diffuse spots seen in these 
controls was probably due to non-neomycin-bound ^P-phosphate 
(by remaining unassociated from neomycin the radiolabel can 
diffuse further from the point of application before becoming 
bound to the filter). For some inexplicable reason this unbound 
phosphate was not not washed off the filter completely during
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FIGURE A.5.31 NPT2 ACTIVITY IN CELL AND MEDIA FRACTIONS OF
PROTOPLASTS 36 HOURS AFTER TRANSFORMATION: EXPERIMENTS 1 & 2.
The same assaying procedure was used as described in 
Figure 4.4. Protoplasts were heat-shocked for 5 min. at 45 C 
immediately before transformation in Experiment 1. No heat-shock 
step was performed in Experiment 2.
EXPERIMENT 1 npt2-encoded plasmid EXPERIMENT 2
(LANE:) (21ug) (LANE:)
Al pCaMVNEO - cell fraction A6
A2 pDE307 - f t  f t A7
A3 pPARTIAL - f t  f t A8
A4 pFULL - f t  f t B1
A5 no DNA - f t  f t B2
B3 pCaMVNEO - media B8
B4 pDE307 - f t Cl
B5 pPARTIAL - f t C2
B6 pFULL - f t C3
B7 no DNA - f t C4
C5 npt2 control - cell fraction C7
C6 »• tl1 - media C8
O.lmg of soluble protein from the leaves of pCaMVNEO-transformed 
transgenic tobacco was used as a source of enzyme activity for 
the npt2 controls (C5-C8).
All protoplast samples were co-transformed with 7.0ug pDP33GUS.
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the rinsing steps and so was detected on the autoradiograph. In 
addition to this non-specific background radioactivity, the 'no 
DNA' cell fraction (Lane B2) showed a low level of npt2-Like 
activity which suggested that there might be a low level of 
endogenous activity in non-transformed protoplasts.
In cell fractions of protoplasts transformed with the 
npt2-encoded plasmids, pCaMVNEO, pDE307 and pFULL on the other 
hand, dark spots of npt2-specific activity were observed 
(Experiment 1, A1-A4: Experiment 2, A6-B1). From this it was 
concluded that all protoplasts transformed with these plasmids 
were expressing a functional npt2 enzyme. However, in the cell 
fractions of protoplasts transformed with pPARTIAL, only a very 
low level of activity above background was visible (Lanes A3 
and A8). This result was in direct contradiction with the 
result from the previous transient expression experiment where 
a high level of npt2 activity had been observed in the cell 
fraction of protoplasts transformed with the same preparation 
of pPARTIAL DNA (compare Lanes A3 & A8 with Lane 4 in Figure 
4.4).
No npt2-specific activity was observed in media fractions 
of the 'no DNA' controls. In the media fractions of protoplasts 
transformed with pCaMVNEO (lanes B3 & B8), no significant 
activity was seen. However, in the protoplasts transformed with 
pDE307, npt2 activity was observed in the medium (Lanes B4 & 
Cl). As the there were negligible levels of npt2 in the cell 
fractions of pPARTIAL-transformed protoplast it was of no 
surprise that no npt2 activity was detected in the media 
fractions either. Some npt2 activity was observed in the media 
fraction of pFULL-transformed protoplasts from Experiment 1 
(Lane B6) but not in the corresponding fraction from Experiment 
2 (Lane C2).
Taken in isolation, these results suggested that in the 
protoplasts transformed with pDE307 and, to a lesser extent
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those transformed with pFULL, the expressed npt2 derivative was 
being secreted into the media. However, there is another 
possible reason for the detection of npt2 activity in the 
media. In these cases the media may have been contaminated with 
cytosol containing npt2 activity. To check whether this was 
likely, it was possible to refer to the results of the relevant 
GUS assay described above. In Experiment 1 it was estimated 
from the GUS assay that there had been 22% protoplast lysis, 
which might explain why a significant proportion of the npt2 
activity was found in the media. However, the pCaMVNEO- 
transformed protoplasts were estimated to have suffered 14 % 
lysis in the same experiment and yet there was no significant 
npt2 activity seen in the media fraction (Lane B3). These 
results were unclear and therefore it was decided in Experiment 
3 to omit the heat-shock treatment prior to transformation and 
to exercise great care when separating the cell and media 
fractions in order to minimise the contamination
The results from the third experiment are shown in Figure 
4.5.3.2. The npt2 controls (Lane 6) showed that the relative 
recovery of npt2 activity after cell and media processing was 
similar. The fractions from protoplasts treated with PEG in the 
absence of plasmid DNA showed no significant endogenous npt2 
activity (Lane 5: no DNA). Conversely, npt2 activity was 
observed in the cell fractions from protoplasts transformed 
with npt2-encoded plasmids (Lanes 1-4). Although there was a 
large amount of npt2 activity in cell fractions of protoplasts 
transformed with pCaMVNEO, no activity was observed in the 
media fraction above background. However, in protoplasts 
transformed with pDE307, 12.5% of the activity was observed in 
the media (as estimated by densitometry). As in Experiments 1 
and 2, there was only a low level of npt2 activity in the cell 
fraction of protoplasts transformed with pPARTIAL. No npt2 
activity was observed in the media fraction from these
139

FIGURE 4.5.32 HPT2 ACTIVITIES IE CELL AND MEDIA FRACTIONS OF 
PROTOLASTS, 36 HOURS AFTER TRANSFORMATION: EXPERIMENT 3.
The same assaying procedure was used as described in 
Figure 4.4. Protoplasts were NOT heat-shocked before 
transformation.
LANE: npt2-encoded plasmid
1 pCaMVNEO
2 pDE307
3 pPARTIAL
4 pFULL
5 no DNA
6 npt2 control
( 21 jig )
O.lmg of soluble protein from the leaves of pCaMVNEO-transformed 
transgenic tobacco was used as a source of enzyme activity for 
the npt2 controls (C5-C8).
All protoplast samples were also co-transformed with 1.3jig 
PDP33GUS.
protoplasts. From the autoradiograph in Figure 4.5.32 it was 
also estimated by densitometry that 7% of the npt2 activity in 
protoplasts transformed with pFULL was in the media fraction.
The results of the GUS assays on cell and media fractions 
in Experiment 3 showed that in protoplasts transformed with 
pDE307 or pFULL, 4.4% and 1.1% cell lysis occurred 
respectively. This meant that the cytosolic contamination of 
media could not account for the levels of npt2 activity found 
in these two fractions. It was therefore concluded that the 
npt2 activity in the media fractions of protoplasts transformed 
with pDE307 and pFULL was present as a result of secretion of 
the enzyme from the cell.
As mentioned above, the amount of GUS activity expressed 
in the protoplasts transformed in all three experiments was 
apparently linked to the npt2-encoded plasmid with which 
pDP33GUS was co-transformed. The possibility that contaminating 
factors present in the DNA preparations of the npt2 plasmids 
affected the expression of the pDP33GUS plasmid was thought 
unlikely as pDE307-transformed protoplasts that consistently 
showed the lowest GUS activities, expressed the highest levels 
of npt2 activity. If contamination was the determining factor 
with regards to the level of expression, then one would expect 
low GUS activities to be mirrored by low npt2 levels and vice 
versa. Furthermore, all plasmids were purified on caesium 
chloride gradients and checked spectrophotometrically for 
protein contamination. Another possible explanation for this 
discrepency would be competition between the GUS-encoding gene 
and npt2-encoding gene for the same cellular RNA and protein 
expression machinery. Tobacco leaf mesophyll cells are 
primarily photosynthetic organs. This means that, unlike other 
heterologous expression systems, they do not have high turnover 
rates of protein synthesis. It is conceivable therefore that in 
protoplasts co-expressing two genes with a highly efficient
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constitutive 35S-CaMV promoter, there would be competition for 
the same cell transcription and translation machinery. If this 
were the case then one would expect to see an inversely 
proportional relationship between the levels of GUS and npt2 in 
each protoplast sample. This was observed for the pDE307- 
transformed protoplasts which consistently had the lowest GUS 
activities but the highest npt2 activities of any samples 
tested. Conversely, the pFULL-transformed protoplasts had high 
GUS activities but low npt2 activities. However, the extracts 
from pPARTIAL-transformed protoplasts did not fit this pattern 
as they had low GUS and npt2 levels. Therefore, there appeared 
to be no single satisfactory explanation for the patterns in 
GUS activities observed.
4.6 DISCUSSION.
Stable protoplasts were produced using the methods 
described. The PEG-mediated method for protoplast 
transformation described by Saul et ill (1989) enabled the 
transformation of protoplasts with npt2 and GUS-encoded 
plasmids. Protoplasts transformed with these plasmids and 
incubated for 36 hours, expressed detectable levels of the 
plasmid-encoded enzymes above background. Although heat-shock 
treatment of the protoplasts prior to transformation increased 
the efficiency of transformation and lead to a higher level of 
cytosolic expression, it also lead to a higher degree of cell 
lysis which was undesirable.
Both constructs, pPARTIAL and pFULL, encoded functional 
npt2 enzymes. The enzyme can therefore tolerate the preproricin 
extensions fused to its N-terminus without loss of activity 
upon removal of these extensions (in part or wholly). 
However, in the space of time between the initial experiment 
and the next set of three experiments, the transformation 
efficiency of the preparation of the pPARTIAL construct dropped
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dramatically. The reason for this anomaly is unknown as both 
the original preparations of pPARTIAL and pFULL constructs were 
stored together at -20C.
Partial purification of the media fractions, by ammonium 
sulphate precipitation, was necessary in order to detect npt2 
activity present in these fractions. It seems therefore that 
there are factors in the crude media which inhibit npt2 
activity. This observation is in agreement with the results 
from other groups who have used npt2 for studying the secretory 
pathway in transient expression systems (Denecke, personal 
communication).
Co-transformation of pDP33GUS with the different npt2- 
encoded plasmids resulted in a similar expression pattern of 
the cytosolic marker, GUS, in each of the three experiments. 
However, there was no obvious correlation between the level of 
expression of the GUS gene and the level of expression of the 
npt2 gene; i.e. high GUS levels were not consistently balanced 
by low npt2 levels (and vice versa). Therefore this variation 
in the level of expression of the GUS gene when co-transformed 
with different plasmids did not seem to be due to a competition 
for the cellular translation machinery within the same cells. 
It was also not thought to be solely as a result of inhibitory 
factors being present within the npt2-encoded plasmid 
preparations. No single reason for this observation was obvious 
to this author.
The results of the GUS and npt2 enzyme assays from 
Experiment 3 would suggest that the npt2 expressed in 
protoplasts transformed with pDE307 and pFULL was being 
exported to the media at a similar rate. The appearance of npt2 
activity in the media did not co-incide with a significant 
contamination of the media with the co-expressed cytosolic 
marker, GUS. It is therefore, reasonable to suggest that this 
export was occurring from intact protoplasts. As both genes are
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known to encode proteins with functional ER-signal peptides, it 
is likely that this enzyme activity is being exported from the 
ER lumen by the default pathway. This data would suggest 
therefore that the 35 residue N-prepropeptide of preproricin 
does not contain a contiguous stretch of amino acids 
representing a targeting or retention signal.
Unfortunately, the limited time of study in Milan did not 
allow time for more experiments.
Recently, a number of investigations into 
vacuolar/protein body targeting in plants have been reported. 
As has been described earlier, Chrispeels and co-workers have 
decided to use a yeast expression system to study the vacuolar 
targeting of the bean lectin, PHA. They showed that when PHA 
was expressed in transgenic yeast it was correctly targeted to 
the vacuole (Tague and Chrispeels, 1987). This suggested that 
the mechanisms and signals involved in vacuolar/protein body 
targeting were similar between yeast and higher plants. They 
then constructed hybrids between N-terminal regions of PHA and 
the yeast secretory enzyme, invertase. When expressed in yeast 
they found that the hybrid was targeted to the vacuole (Tague 
et al. 1990). They concluded that the N-terminal region of PHA 
contained a vacuolar targeting signal which re-directed the 
invertase in the hybrid protein to the vacuole. They 
identified a region in the N-terminal region of PHA, LQR, 
which resembles the yeast vacuolar targeting signal, QRPL, and 
they suggested that this may represent a plant vacuolar 
targeting signal (Chrispeels and Tague, 1990). In order to test 
this hypothesis they expressed the PHA/invertase hybrid in 
transgenic tobacco, but found that it was secreted (Chrispeels, 
1991). Therefore, it seems that the components of the vacuolar 
targeting mechanism in yeast and higher plants are not 
compatible. Studying plant vacuolar proteins in yeast systems 
may reveal more about the yeast vacuolar targeting machinery
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than the signals in the plant protein which are involved in the 
targeting of the protein to the plant vacuole.
On the other hand Raikhel and co-workers have expressed 
barley lectin precursor in transgenic tobacco and have shown 
that it was correctly targeted to the vacuoles (Wilkins £t al, 
1990). The lectin precursor contains a negatively-charged, 14 
amino acid residue C-terminal propeptide which is co- 
translationally N-glycosylated. After comparison to the 
targeting of animal proteins to the lysosome, which involves a 
mannose-6-phosphate signal/receptor pathway, they hypothesised 
that this propeptide-borne glycan may be involved in the 
targeting of barley lectin to the vacuole. They used site- 
directed mutagenesis to remove the N-glycosylation signal in 
the propeptide and expressed this mutant in transgenic tobacco. 
However, this was glycosylation-minus mutant was also targeted 
to the vacuole (Wilkins jat al, 1990). On the other hand, when 
this propeptide was removed completely the propeptide-minus 
mutant was secreted from the tobacco cells (Bednarek £t al, 
1990). It therefore seems that the C-terminal propeptide of 
barley lectin is involved in the targeting of the protein to 
the vacuole, but the glycan moiety does not form part of this 
signal.
More recently, Nakamura and co-workers have shown that 
the N-terminal propeptide of the sporamin precursor, the 
vacuolar-localised storage protein from the tuberous roots of 
the sweet potato, is involved in vacuolar targeting. When they 
expressed the cDNA for the sporamin precursor (Hattori et al. 
1985) in transgenic tobacco, they found that it was correctly 
targeted to the vacuole (Matsuoka et al, 1990). However, when 
they used site-directed mutagenesis to remove a highly-charged 
16 amino acid residue N-terminal region, identified by ¿n vitro 
studies as being a propeptide (Hattori ¿t al, 1987), and 
expressed it in suspension-cultured tobacco, they found that
145
this propeptide-minus mutant was secreted (Matsuoka and 
Nakamura, 1991). One observation made by Matsuoka et al (1990) 
which suggests that there are limits to the use of transgenic 
tobacco expression for the study of targeting and processing of 
foreign plant proteins, was the proteolytic processing of the 
wild-type sporamin precursor in the vacuoles of transgenic 
tobacco to a nearly-mature size which was longer than the 
sporamin isolated from sweet potato by three residues.
Thus the groups of Raikhel and Nakamura have shown an 
involvement of propeptides in vacuolar targeting. However, they 
have yet to show that these regions of vacuolar protein 
precursors contain all the information necessary for such 
targeting. Work is now under way using recombinant DNA 
techniques and studies in transgenic tobacco to determine 
whether the propeptides of these proteins can act autonomously 
and mediate the transport of normally non-vacuolar proteins to 
the vacuole.
A detailed computer analysis of plant storage protein 
sequences has recently identified regions of homology which may 
be involved in vacuolar/protein body targeting (Sebastiani et 
al. 1991). These regions of homology lie within the mature 
protein sequence and it suggested that different regions may 
interact forming part of a 3-D signal patch, only when the 
protein has folded into its tertiary or quaternary structure. 
It remains to be proved whether or not these regions represent 
the elusive signal.
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5.1 INTRODUCTION
It has long been known that ricin enzymatically 
inhibits protein synthesis (reviewed by Olsnes and Pihl, 1982). 
The inhibitory effect is attributable to the A subunit, or 
effectomer, whose structure and mode of action seems to 
resemble other proteins that have been collectively termed 
ribosome inactivating proteins (RIPs). Cell-free translation 
studies have been used in the past to study the kinetics of RIP 
action. For example, Olsnes e_t £l (1976) compared the 
polyphenylalanine-synthesising activity of untreated and ricin- 
treated rabbit reticulocyte ribosomes in a cell-free lysate. 
They performed competition studies with elongation factor 
preparations and calculated the affinity constant (Km) and rate 
of reaction for the A chain action on the ribosomes. However, 
although ricin strongly inhibited the translating ability of 
the reticulocyte ribosomes, the significance of their 
conclusions as to the true kinetics of ricin inhibition is 
questionable since they used crude elongation factor 
preparations and artificially high (non-physiological) 
magnesium salt concentrations in their assays.
Using the same cell-free translation system, Olsnes 
et al (1976) also showed that non-reduced 'whole' ricin had 
relatively no inhibitory effect on the translating-ability of 
ribosomes. They concluded that the close association of the B 
chain when disulphide bonded with the A chain either blocked 
the active site or maintained the A chain in an altered 
(inactive) conformation. However, there have been no studies on 
the precursor forms of ricin.
More recently, the precise molecular mechanism of A 
chain action on eukaryotic ribosomes has been elucidated. Endo 
and Tsurugi (1987) showed that the A chain is an RNA-specific 
N-glycosidase. Furthermore, Endo et al (1987) showed that other 
RIPs share the same mode of action; that is, they depurinate a
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specific adenine residue in eukaryotic 26S or 28S ribosomal 
RNA (rRNA). This particular adenine (A^24 in rat 28S rRNA) 
lies in a highly-conserved loop in the 26S or 28S rRNA 
component of the 60S ribosomal subunit, which may explain why 
ricin and other RIPs are active against all eukaryotic 
ribosomes. The ricin-catalysed depurination at this site makes 
the phosphodiester bond susceptible to mild base hydrolysis and 
in this way Gndo e£ al (1987) used acetic aniline to design a 
sensitive assay for following the depurination of eukaryotic 
ribosomes. Osborn and Hartley (1990) have since used this assay 
to show that both translation initiation and elongation steps 
are inhibited by the action of A chain on ribosomes.
The data of Olsnes et al (1976) discussed above 
would suggest that proricin should have no inhibitory effect on 
eukaryotic ribosomes as there is a close association between A 
and B chains. However, as was discussed above, the assay system 
used by Olsnes and co-workers is not necessarily the best way 
to study the inhibitory effects of RIPs. The aniline assay now 
provides a sensitive alternative since it allows ricin 
catalysed inactivation of ribosomes to be done under 
physiological conditions (e.g. in an in vitro translation) 
before analysing the modification of the rRNA via aniline 
hydrolysis post-catalysis.
5.2 AIMS AND APPROACH.
The aim was to determine if recombinant proricin 
possessed any ribosome inactivating ability. The most direct 
way to study this would be to translate a proricin clone in 
vitro in a rabbit reticulocyte lysate and subsequently to 
examine the extracted rRNA for proricin-catalysed depurination. 
This approach has been used by May et al (1989) who showed that 
recombinant ricin A chain synthesised in rabbit reticulocyte 
lysate is biologically active on the 28S rRNA. This suggests
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that in this vitro expression system the A chain can fold 
into an active conformation. However, initial attempts to 
translate transcripts of proricin in reticulocyte lysates 
appeared to fail (M.May; unpublished data). Very little protein 
was synthesised and the ribosomes appeared modified, suggesting 
that proricin possessed RNA-specific N-glycosidase activity. 
However, on long exposures of the protein gels it was found 
that there were many labelled protein bands below the full- 
length proricin band. These could have arisen from premature 
termination events during translation of the proricin 
transcripts or from post-translational proteolysis of the full- 
length proricin polypeptide. In either case, it was thought 
that some of these bands may possess ribosome inactivating 
properties. For this reason it was not possible to 
inequivocally attribute the ribosome-inactivating activity 
observed to the full-length proricin polypeptide. Therefore, 
another system for the expression of recombinant proricin was 
necessary.
The expression of genes by injection of transcripts 
into Xenopus oocytes provides a system for recombinant 
proteins, synthesised with signal peptides, to be segregated in 
the lumen of the GR. In the context of this study, should 
proricin contain any ribosome-inactivating activity, the 
sequestering of the protein in the ER lumen would segregate it 
from the ribosome population and so enable further translation 
of proricin transcripts. A further advantage of ER-segregation 
is that the proricin will be co-translationally N-glycosylated 
and disulphide bonded. Richardson e_t al (1988) have 
demonstrated that ricin B chain synthesised and segregated in 
this system is stable and possesses lectin activity. Therefore, 
it will be possible to determine whether the recombinant 
proricin made in this system possesses any lectin activity.
In this work the oocyte injections were performed by
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Professor A.Colman (Birmingham): the protein fractionation and 
SDS-PAGE analysis was performed by Dr. P.Richardson (Warwick). 
The results from this study have been published (Richardson ^t 
al, 1989).
5,3 RESULTS
5.3.1 SOURCE OF RECOMBINANT PRORICIN.
The complete preproricin clone, ppRCL617 (see 
Appendix B), was available at Warwick in the jji vitro 
expression vector, pGEMl. Preproricin transcripts expressed 
from this construct were injected into oocytes (30-50ng mRNA 
per oocyte) and newly synthesised proteins were labelled by 
incubation of the oocytes in a medium containing ^S-methionine 
(as described by Richardson et al, 1988). A crude homogenate 
from these oocytes was then used as the source of recombinant 
proricin.
5.3.2 ANILINE ASSAY.
Protein from the oocytes was extracted in lx oocyte 
homogenisation buffer. It was therefore necessary to confirm 
that depurination of ribosomes was not inhibited in this 
buffer. The acetic aniline reagent was first prepared as 
described in Chapter 2 and this was then used to treat 
extracted rabbit reticulocyte rRNA after pre-incubation of the 
ribosomes in lx homogenisation buffer in the absence or 
presence of purified recombinant ricin A chain. The results are 
shown in Figure 5.3.2. An extra band was detected in the RNA 
sample where ribosomes had been preincubated in the presence of 
A chain. This represents the diagnostic 390 nucleotide fragment 
cleaved from the modified 28S RNA by aniline. It was concluded 
that the RNA-specific N-glycosidase activity of A chain was not 
inhibited in the oocyte homogenisation buffer and therefore
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FIGURE 5.3.2 RICIN-CATALYSED DEPURINATION OF RABBIT RIBOSOMES
III OOCYTE HOMOGENISATION BUFFER.
Denaturing gel electrophoresis of 4jig of aniline- 
treated rRNA, extracted from 30pl of rabbit reticulocyte lysate 
(Promega) that had been pre-incubated, at 37C for 30min, in lx 
oocyte homogenisation buffer in the absence (Lane 1) or 
presence (Lane 2) of 10"®M purified recombinant ricin A chain. 
Note the extra band (arrowed) in the track containing A chain- 
treated rRNA. This represents the 390 nucleotide fragment, 
released by aniline hydrolysis from the 28S rRNA component, 
which is diagnostic of ricin-catalysed depurination. RNA bands 
were stained in ethidium bromide solution and visualised on a 
UV-transilluminator.
this assay could be used to study the activity of recombinant 
proricin made in oocytes.
5.3.3 RESULTS FROM THE FIRST EXPERIMENT.
Results from immunoprécipitation and SDS-PAGE 
analysis of the crude oocyte homogenate revealed that
expression of preproricin in oocytes produced a disulphide 
bonded, N-glycosylated proricin product of the expected size 
(see Figure 5.3.3 A). However, a small population of 
immunoreactive bands of lower molecular weight were observed 
under reducing conditions (Lane 3). This suggested that a 
proportion of the proricin synthesised was either prematurely 
terminated (leading to the release of partial-length proricin 
species into the ER-lumen) or, that a proportion of the full- 
length proricin polypeptide was somehow endoproteolytically 
cleaved in the oocyte. It was likely that some of these lower 
molecular weight species would have RNA N-glycosidase activity 
and therefore it was decided to pass the crude homogenate down 
a G-75 Sephadex column under reducing conditions in an attempt 
to separate the full-length proricin from these other species 
before assaying the oocyte homogenate samples for depurination 
activity.
Figure 5.3.3 B shows the result when 36 x 1ml 
fractions eluted from a G75 Sephadex column were examined for 
depurination activity. Two peaks of depurination activity were 
seen, in fractions 13-16 and fractions 34-37. When aliquots of 
each fraction were immunoprecipitated and examined by SDS-FAGE 
(not shown) proricin was detected in fractions 13-16 which 
would suggest that recombinant proricin made in oocytes has RNA 
N-glycosidase activity. However, faint low molecular weight 
bands were also seen in these tracks which may have represented 
biologically-active A chain or partial-proricin species. The 
presence of these low molecular weight species in the proricin
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FIGURE 5.3,3 RNA N-GLYCOSIDASE ACTIVITY OF CRUDE HOMOGENATE
FROM OOCYTES INJECTED VITH PREPRORICIN mRNA.
A. SDS-PAGE analysis of protein immunoprecipitated from 
oocytes injected with preproricin mRNA (SDS-PAGE performed by 
Dr. P.Richardson).
B. 1ml of crude homogenate (from 25 oocytes) was loaded 
onto a 1 x 30cm G-75 Sephadex column equilabrated with lx 
homogenisation buffer containing 50mM DTT. 36 x 1ml fractions 
were collected and 30)il aliquots of every third fraction was 
incubated, at 37C for 30min, with an equal volume of rabbit 
reticulocyte lysate. RNA was then extracted and 4jig of this was 
analysed for ricin-catalysed depurination using the aniline 
assay. Note the diagnostic 390 nucleotide band present in 
fractions 13-16 and 34-37, indicating ricin modification. 
Control track (C) contains 4jig of aniline treated RNA extracted 
from reticulocyte lysate after pre-incubation in lx oocyte 
homogenate containing 10"®M biocheraically-pure ricin A chain.
1 2 3 4 5 6
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Synthesis of recombinant proricin. The in vitro transcript 
encoding preproridn was translated in a wheat germ cell-free 
system or microinjected into Xetiopus oocytes in the presence of 
(,sS]methionine. Proricm was recovered from oocyte 
homogenates by immunoprecipitation using anti-ridn B  chain 
antibodies, analysed by SDS-polyacrylamide gel decrophoresis 
and visualized by fluorography. Lanes: (1) molecular mass 
markers (values indicated on the left, in kDa), (2) wheat germ 
product, (3) oocyte product after treatment with endoH, (4) 
oocyte product prepared under normal (reducing) conditions, 
(S) unreduced oocyte product, (6) control oocytes.
7 10 13 16 19 22 25 28 31 34 37
fractions was thought to be due to the fact that crude 
homogenate was loaded onto the column. This may have lead to 
the formation of aggregates between these proteins and other 
oocyte proteins which eluted from the column, in or close to, 
the void volume with the 66kD full-length proricin. A 
proportion of the low molecular weight species must have been 
retarded by the Sephadex beads and separated from the proricin 
however, to explain the second peak of activity in the 
fractions 34-37.
5.3.4 RESULTS FROM THE SECOND EXPERIMENT
The protocol was therefore modified in an effort to 
purify the proricin component before reduction and size 
fractionation on the Sephadex G-75 column. Proricin was first 
affinity-purified from crude homogenate by passage down a 
SeLectin™ column (immobilised lactose matrix). This procedure 
allowed testing of any lectin activity of the precursor. 
Proricin was retained on the column by its association with the 
immobilised lactose indicating that this lectin precursor 
contained a biochemically-active B chain moiety. After washing 
the column through to remove all unbound oocyte proteins, the 
proricin could be eluted in buffer contairiing lOOmM galactose. 
Using SDS-PAGE analysis, it was found that this method allowed 
single-step purification of proricin from the crude homogenate 
and indicated that the ricin precursor is an active lectin 
(Figure 5.3.4.1).
After reduction of this affinity-purified proricin 
fraction, it was passed down a G-75 Sephadex column and 
fractions analysed as in the previous experiment. The results 
are shown in Figure 5.3.4.2. They show that a peak of 
depurination activity was observed in fractions 31-34, 
presumably corresponding to the biologically-active low 
molecular weight species observed in the previous experiment.
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FIGURE 5.3.4.1 AFFINITY PURIFICATION OF RECOMBINANT PRORICIN
A crude homogenate from preproricin RNA-injected 
oocytes was diluted in oocyte homogenisation buffer and passed 
three times down a 1.0ml SeLectin™ column (lanes 2-4). The 
column was then washed three times with oocyte homogenisation 
buffer (lanes 5-7) before eluting the bound proricin with lOOmM 
galactose (lanes 8-10). The bound proricin is eluted in the 
first fraction (lane 8). (Performed by Dr. P.Richardson, 
Warwick.)
(a) 1 2 3 4 5 6 7 8 9 10
FIGURE 5.3.A.2 RNA N-GLYCOSIDASE ACTIVITY OF AFFININTY-
PURIFIED RECOMBINANT PRORICIN.
A. SDS-PAGE analysis of G-75 fractions after 
immunoprécipitation. 0.9volumes of each fraction eluted from 
the column was immunoprecipitated with anti-ricin B chain 
antibodies to identify fractions containing recombinant 
proricin. Note an immunoreactive band of the expected size in 
fractions 13-19. (SDS-PAGE performed by Dr. P.Richardson).
B. O.lvolumes of each fraction was incubated with an 
equal volume of rabbit reticulocyte lysate for 30min at 37C. 
RNA was then extracted and 4jig was analysed for ricin-catalysed 
depurination using the aniline assay. Note the diagnostic bands 
present in fractions 31-34, but not in the fractions identified 
as containing the recombinant proricin (above). Control lane 
(C) was prepared as in figure 5.3.3.
F ractio n  number
37  40  43rtt »
These polypeptides must have had an active lectin-binding 
component to be retained on the SeLectin™ column, but this was 
possibly released from the A chain component by reduction of 
the disulphide bond prior to gel filtration.
On the other hand, in fractions 13-19 containing the 
full-length proricin, no depurination of the reticulocyte 
ribosomes was observed. From this it was concluded that full- 
length recombinant proricin did not possess RNA-specific N- 
glycosidase activity.
5.4 DISCUSSION
Soluble, disulphide bonded, N-glycosylated and GR 
lumen-segregated proricin was synthesised in Xenopus oocytes. 
Crude homogenate from oocytes injected with preproricin 
transcripts were shown to have RNA-specific N-glycosidase 
activity, but this activity was later attributed to the likely 
contamination of the proricin fractions with lower molecular 
weight species. These lower molecular weight proteins were 
immunoreactive, suggesting that they were related to the full- 
length proricin species. They may represent prematurely- 
terminated and segregated forms of proricin which had 
depurinating activity. The low molecular weight species were 
most clearly visible when resolved by SDS-PAGE under reducing 
conditions. This suggested that these species may have arisen 
by endoproteolytic cleavage of proricin in the oocytes which 
lead to the formation of disulphide bonded heterodimers. These 
low molecular weight proteins could be separated from the full- 
length recombinant proricin species by gel filtration under 
reducing conditions, but only after first purifying the 
proricin by affinity chromatography on an immobilised lactose 
column.
This purification step also indicated that the 
oocyte-synthesised proricin had a biologically-active B chain
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moiety. It can be inferred that the A chain moiety folded 
correctly also since the immunoreactive, lower molecular 
species described above, were shown to have RNA N-glycosidase 
activity. However, the results from this study showed that the 
full-length recombinant proricin synthesised in oocytes does 
not depurinate 28S rRNA from rabbit ribosomes and therefore 
does not possess any RNA N-glycosidase activity.
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CHAPTER 6
IN VITRO PROCESSING OF RECOMBINANT PRORICIN 
USING A SOLUBLE MATRIX FRACTION FROM DRY 
CASTOR BEAN SEEDS.
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2.1 INTRODUCTION
As with many other plant seed storage proteins, 
ricin is initially synthesised as a preproprotein and is co- 
translationally translocated into the ER lumen where it becomes 
glycosylated and loses its N-terminal signal peptide. It is 
then transported in this intermediate form, via the Golgi 
(where it receives modifications to its oligosaccharide side 
chains), to the protein bodies (Lord, 1985ab). It is only upon 
reaching this final sub-cellular organelle that the single 
chain proricin intermediate is processed into its mature, 
heterodimeric form. As was discussed earlier, processing is 
believed to involve the removal of an N-propeptide as well as 
the removal of the 12 amino acid residue linker. The carboxy- 
terminal residue of both the putative N-propeptide and the 
linker is an asparagine.
The protein body-localised proricin processing 
activity has been demonstrated ^n vitro by Harley and Lord 
(1985). They first used a total soluble protein extract from 
developing castor seeds to process ^S-labelled 
immunoprecipitated proricin, isolated from the endosperm of 
developing seeds, into A chain and B chain-sized fragments. 
They found that complete conversion of proricin to ricin 
subunits required an overnight incubation, and that the pH 
optimum for the reaction was pH4.6 (consistent with the pH 
inside plant vacuoles/protein bodies). They also prepared a 
protein body-enriched fraction from dry castor bean seeds which 
processed the immunoprecipitated proricin in a similar way. 
Extracts from both the developing seed and the dry seed also 
processed the precursor of the closely related castor bean 
lectin, RCA.
They concluded that this proricin processing 
activity was localised in the protein bodies, processing was 
slow, had a pH optimum of 4.6, and did not have a unique
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substrate specificity.
In vitro processing of an HS-globulin precursor 
from pumpkin, using a vacuolar matrix fraction from developing 
pumpkin cotyledons, has also been demonstrated (Nishimura and 
Nishimura, 1987). Nishimura and Nishimura (1987) suggest that 
the enzyme(s) involved in the cleavage of the pumpkin 
proglobulin polypeptide is an asparagine-specific thiol 
protease with an acidic pH optimum of 4. They also reported 
that a protein body matrix fraction from dry castor bean seeds 
processed the proglobulin from pumpkin into mature-sized 
globulin fragments.
Comparison of the predicted protein sequences for 
seed storage protein cDNAs suggests that asparagine plays a 
prominent role in precursor processing sites. This has led to 
the hypothesis that the enzyme(s) involved in the maturation of 
most (but not all) storage protein precursors is an asparagine- 
specific endoprotease (Lord and Robinson, 1986).
At the time when this work was initiated nothing was 
known about the asparagine-specific proteases. It was therefore 
deemed desirable to purify and fully characterise a storage 
protein precursor processing enzyme. As dry castor bean seeds 
have been shown previously to contain proricin processing 
activity, they provide a source of enzyme. Also, proricin 
clones are available in in vitro expression vectors, providing 
a means of synthesising a substrate for an enzyme assay. It was 
therefore decided to design an in vitro assay to enable 
purification of the proricin processing enzyme(s).
6,2 RESULTS,
6.2.1 SOURCE OF PRORICIN SUBSTRATE.
The construct, pSP64Tproricin (M.May, PhD thesis, 
Warwick), was used as the source of proricin cDNA (see Figure 
6.2.1). This construct contains the proricin clone
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FIGURE 6.2.1 SOURCE OF PRORICIN SUBSTRATE AND PREDICTED 
SITES OF ASPARAGINE-LINKED PROCESSING.
The construct, pSP64Tproricin (M.May, PhD thesis, 
Warwick), contains the incomplete cDNA clone pRCL617delta4, 
cloned into the expression vector pSP64T at the Bglll site. The 
proricin clone in this construct is therefore flanked by by 5' 
and 3' untranslated regions of B-globin DNA (hashed boxes). The 
construct pSP64Tproricin was first linearised by digestion with 
EcoRI, before in vitro transcription and translation. 
Translation is initiated in the proricin clone at position -72 
(Lamb £t al, 1985: Appendix A). Translation of this clone in a 
wheat germ lysate produces the non-glycosylated 62.9kD proricin 
form shown in A. Asparagine-linked proteolytic processing of 
this polypeptide at one or both of the sites arrowed, is 
predicted to yield the various sized fragments shown in B, C 
and D. The production of a mature A chain (shown in E) would 
require additional enzyme activities to remove the linker 
region at the C-terminus of A chain-linker fragments.
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pRCL617delta4, inserted into the ^n vitro expression vector, 
pSP64T (Krieg and Melton, 1984). Expression of the gene is 
driven from the SP6 promoter, and translation is initiated from 
the ATG codon at position -72 (see Appendix A). The protein 
product encoded by this gene therefore lacks the first 11 N- 
terminal residues of the preproricin presequence.
6.2.2 TRANSCRIPTION OF THE PRORICIN GENE.
Proricin transcripts were synthesised rn vitro from 
pSP64Tproricin, after first linearising the construct by 
digestion with EcoRI. Transcripts were quantitated by the 
addition of ^H-UTP to the transcription reaction mix, and then 
by comparing the radioactivity incorporated into RNA to the 
total radioactivity present at the end of the incubation. 
Typically, 4-6jig of proricin mRNA was synthesised from a 20jil 
transcription reaction (containing 2jig of linearised 
pSP64Tproricin and 2units of SP6 RNA polymerase).
Proricin transcripts were also visualised by 
synthesis in the presence of ^^P-UTP and subsequent resolution 
of the labelled mRNA by denaturing agarose gel electrophoresis 
(Figure 6.2.2). The proricin mRNA appeared as a single band, 
which indicated that the proricin transcript synthesised in 
vitro from pSP64Tproricin existed as a single species.
6.2.3 OPTIMISATION OF WHEAT GERM LYSATE.
A wheat germ lysate and reaction Premix was prepared 
as described by Anderson et al (1983). As part of the protocol, 
low molecular weight inhibitors are removed from the lysate by 
gel filtration. The low molecular weight inhibitors appear as a 
bright yellow band which is retarded on the column relative to 
the active lysate fraction. The latter elutes as a pale brown 
band in the void volume and was collected in 1ml fractions.
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FIGURE 6.2.2 DENATURING AGAROSE GEL ELECTROPHORESIS OF 
PRORICIN TRANSCRIPTS.
5pl from a 20pl transcription reaction (containing 
2ug linearised pSP64Tproricin and 0.25yCi ^^P-UTP), denatured 
and resolved on a 50% formaldehyde/1.5% agarose (lxMOPS) gel 
(Pr). A 650 ribonucleotide transcript, synthesised from a yeast 
preproalpha-factor clone pGEM2alpha36 (a gift from J.Rothblat, 
EMBL, Heidleberg, Germany: see Rothblat £t ¿1, 1987), was run 
as a control (oO.The gel was run at 40mA for 3 hours before 
drying under vacuum and visualising bands by autoradiography.
Aliquots of these fractions were then assayed for 
their ability to translate transcripts ¿n vitro. Figure 6.2.3A 
shows the incorporation of ^ S - m e t h i o n i n e  into TCA-precipitable 
protein, when the aliquots were used to translate lug of pea 
polyA+ mRNA. The highest incorporation of radioactivity into 
protein was observed in translations containing fractions 20 
and 25. It was concluded therefore, that fractions 20-25 were 
the most active. These were stored under liquid nitrogen and 
used in all subsequent wheat germ translation reactions.
In order to optimise the synthesis of proricin in 
wheat germ lysate, ^n vitro translation reactions were set up 
using various amounts of the proricin transcription reaction 
mix from 6.2.2 above. Figure 6.2.3B shows the TCA-precipitable 
counts recovered from these reactions. It was found that l.O^ il 
of proricin transcription mix gave the highest level of protein 
synthesis. In the translation reactions containing less than 
l.Opl, the amount of transcript is likely to be the limiting 
factor. However, a drop in protein synthesis was observed in 
reactions containing 1.5^ il and 2.0pl, suggesting an inhibition 
of translation (probably due to other factors present in the 
proricin transcription reaction mix). Although the amount of 
proricin mRNA synthesised in ^n vitro transcription reactions 
will vary slightly, altering the slope of the curve from 0- 
l.Ojil and the maximum level of protein synthesis (Figure 
6.2.3B), all other factors in the transcription reaction mix 
(e.g. enzyme, RNasein, Premix) remain constant and therefore 
would be expected to inhibit a translation reaction to the same 
degree. It was concluded therefore to use l.Oyil of proricin 
transcription mix in all future translation reactions.
Translation of l.Opl of proricin transcript in wheat 
germ lysate under these optimised conditions gave 200,000- 
250,000cpm/^il of TCA-precipitable protein.
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FIGURE 6.2.3 OPTIMISATION OF WHEAT GERM LYSATE FOR IN VITRO 
TRANSLATION OF PRORICIN.
GRAPH A: Identification of active wheat germ lysate fractions
eluted from a Sephadex G-75 column.
TCA-precipitable counts from l/6th of ^n vitro 
translation reactions where lug of polyA+ RNA from pea (gift 
from P.Kirwin, Warwick) was translated, in the presence of 
15uCi 35s_methionine> using aliquots of wheat germ lysate 
fractions eluted from a 30cm G-75 Sephadex column. The most 
active fractions (20-25: arrowed) were then used for all 
subsequent wheat germ lysate translations.
GRAPH B: Optimisation of proricin transcript in wheat germ
lysate.
TCA-precipitable counts from l/6th of wheat germ 
translation reactions in which variable amounts of a 
transcription reaction, containing newly synthesised proricin 
transcripts, were added. The optimal amount, ljil, typically 
contained 200-300ng proricin mRNA (estimated by comparison of 
incorporated cpm versus total cpm from a transcription reaction 
containing ^^P-UTP).
5
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6.2.4 PROTEIN BOOT MATRIX FRACTIONATION.
The isolation of protein bodies from dry castor bean 
seeds using the non-aqueous method of Yatsu and Jacks (1968) 
has been used previously to localise the proricin maturation 
enzyme activity (Harley and Lord, 1985: Nishimura and 
Nishimura, 1987). Protein bodies were therefore extracted from 
dry castor beans in this way (as described in Section 2.6.3) 
and aliquots of the soluble matrix fraction from the isolated 
protein bodies were analysed using SDS-PAGE.
The three major polypeptides identified in the 
soluble protein body matrix fraction were between 32-37kD in 
size and correspond to the reduced ricin and RCA A and B 
subunits. The bands represent (in ascending order of Mc), 
ricin/RCA A chains, ricin B chain and RCA B chain. All other 
proteins which were stained using this gel system appeared 
lower in molecular weight than the lectin subunits. It was 
estimated that the lectins RCA and ricin accounted for over 80% 
of the protein visualised in the soluble matrix fraction.
The low molecular weight proteins were further 
resolved using the modified SDS-PAGE method of Shagger and von 
Jagor (1987), in which tricine replaces, the glycine in the 
upper reservoir buffer (for details see Irwin, 1989). Figure
6.2.4 shows the protein profile of the protein body soluble 
matrix fraction resolved using this gel system. This gel 
reaffirms the estimate that the lectins account for over 80% of 
the protein in the matrix fraction. The other major ingredients 
in this fraction, the 2S albumins, were not visualised as they 
cannot be silver stained (Irwin, 1989).
The extract was initially stored overnight at 4C. 
Upon storage or dialysis the lectins were slowly precipitated 
out of solution.
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FIGURE 6.2.4 SDS-PAGE ANALYSIS OF SOLUBLE MATRIX FRACTION
FROM PROTEIN BODIES ISOLATED FROM DRY CASTOR BEAN SEEDS.
1, 5 and 15pg of total soluble protein from the
matrix fraction of protein bodies, isolated from dry castor 
bean seeds, was analysed by SDS-PAGE (16% acrylamide/ tricine 
buffer: lanes 1, 2 and 3 respectively). Bands were visualised 
by silver stain. The most prominent bands (arrowed) correspond 
to the reduced A and B chains of the castor bean lectins. Low 
molecular weight markers used were; myoglobin fragments I+II 
(14.4kD); myoglobin fragment I (8.16kD); myoglobin fragment II 
(6.21kD); myoglobin fragment III (2.51kD). Source was
S.D.Irwin, Warwick.
6.2.5 IN VITRO ASSAY FOR PROCESSING ACTIVITY.
Aliquots of the protein body soluble matrix fraction 
described above were then assayed for their ability to cleave 
the ¿n vitro synthesised proricin substrate. Aliquots were 
assayed in citrate phosphate buffer at the pH optimum for the 
processing activity described by Harley and Lord (1985). The 
incubation temperature (26C) and length of incubation 
(overnight) required to maximise processing were also as 
described previously. Proricin and any cleaved products were 
then analysed by SDS-PAGE analysis as shown in Figure 6.2.5.
When proricin, synthesised ^n vitro in wheat germ 
lysate, was incubated overnight in citrate phosphate buffer 
alone, a band of the expected size (63kD) was observed (Figure 
6.2.5: lane 1). Labelled polypeptide bands, which appeared 
below the full-length proricin product in lane 1 in the form of 
a smear, were also visible in freshly-translated proricin 
samples (not shown), and were therefore produced during the in 
vitro synthesis reaction, as opposed to being caused by 
proteolysis during overnight incubation in the citrate 
phosphate buffer. As the fidelity of the proricin transcript 
had been confirmed previously (Figure 6.2.2)» it was concluded 
that these lower molecular weight bands were the result of 
incomplete elongation and premature termination events 
occurring in the wheat germ lysate during translation of the 
proricin message.
In samples where proricin was incubated with the 
soluble protein body matrix fraction, either before (lane 2) or 
after (lane 4) dialysis (to remove the residual glycerol 
present after the non-aqueous fractionation of the protein 
bodies), or after 80Z ammonium sulphate precipitation (lane 6), 
the full-length proricin band was partially digested and bands 
of 29-31kD were observed. Distortion of the bands was observed, 
together with precipitation of radioactivity in the wells and
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FIGURE 6.2.5 IH VITRO ASSAY FOR PRORICIH PROCESSING ENZYMES
Autoradiograph of in vitro synthesised, 
radiolabelled proricin after overnight incubation with soluble 
matrix fractions from castor bean protein bodies, and 
resolution of polypeptides by SDS-PAGE. Aliquots of matrix 
fractions were assayed before (lane 2) or after (lane 4) 
dialysis in 3x 1000 volumes citrate phosphate buffer; after 80% 
ammonium sulphate precipitation, resuspension in citrate 
phosphate buffer and subsequent dialysis (lane 6); and after 10 
fold or 20 fold dilution to reduce the distortion of the lanes 
by the 30kD lectins (lanes 8 and 10 respectively). Lanes 3, 5, 
7, 9 and 11 represent the fractions assayed in 2, 4, 6, 8, and 
10 (respectively), except that the former were assayed for 
activity after storage at -80C. As a control, proricin (P) was 
incubated overnight in citrate phosphate buffer pH4.6 (lane 1) 
In some lanes significant amounts of radiolabel were 
precipitated in the wells (W) or at the interface (I) betweeen 
stacking and resolving gel mixes. Approximate protein
concentrations of the protein body matrix fractions used in the 
assay were; 150jig/ml (lanes 2,3,6,7); 120yg/ml (lanes 4,5); 
60pg/ml (lanes 8,9) and 6jig/ml (lanes 10,11). Protein was 
estimated by Bradford protein assay or estimation of protein on 
stained gels.
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stacking/resolving gel interface, caused by the high amounts of 
endogenous lectin present in the soluble matrix fraction. When 
assays containing 10 fold and 20 fold dilutions of the soluble 
matrix fraction were analysed (lanes 8 and 10), only in the 
former were any faint bands observed.
Aliquots of these fractions remained active after 
storage at -80C (lanes 3, 5, 7, 9, 11).
6.2.6 REMOVAL OF LECTINS BY AFFINITY CHROMATOGRAPHY.
As illustrated in Figures 6.2.4 and 6.2.5, the major 
protein components of the protein body soluble matrix fraction 
are the lectins which distorted the lanes in the in vitro 
processing assay. Overloading of the reduced lectin bands meant 
that complete digestion of the proricin and accurate size 
estimation of the digested fragments was not possible. It was 
therefore desirable to remove the lectins from the soluble 
matrix fraction.
The lectins were removed by affinity chromatography 
on propionic acid-treated Sepharose 6B. The lectins are 
selectively retained on the column by interaction with the 
sugar residues exposed on the gel matrix.. Figure 6.2.6 shows 
the column profile and SDS-PAGE analysis of the unbound (E3) 
and lectin (E4) fractions eluted from a Sepharose 6B column, 
onto which was loaded a dialysed fraction of soluble protein 
body proteins (E2), prepared from a crude protein body matrix 
extract (El). Although most of the lectin components were bound 
to the column, SDS-PAGE analysis revealed that the unbound 
fraction still contained a significant proportion of ricin 
(Figure 6.2.6: E3). The apparent discrepancy between the
estimated amount of protein loaded in lane E3 and the amount of 
protein visualised after silver staining is likely to be due to 
the fact that the major components of this fraction were the 2S 
albumins which are not stained by silver.
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FIGURE 6.2.6 REMOVAL OF LECTINS FROM PROTEIN BODY SOLUBLE
MATRIX FRACTION BY AFFINITY CHROMATOGRAPHY ON SEPHAROSE-6B
A/ ^280 Pr°file °f fractions eluted from Sepharose-6B 
affinity column, loaded with a protein body matrix fraction 
(E2). Lectins bound to the column were eluted in citrate 
phosphate buffer containing lOOmM lactose (arrowed).
B/ SDS-PAGE analysis of crude protein body matrix 
fraction before (El) or after (E2) dialysis to remove glycerol; 
and of (pooled) fractions eluted from the Sepharose 6-B column 
in citrate phosphate buffer (E3) or in the same buffer made 
lOOmM lactose (E4). Approximately lOOng of protein was loaded 
in lanes El, E2 and E4 (as determined by the Bradford protein 
assay), ljig protein was loaded in lane E3. Resolved polypeptide 
bands were visualised by silver stain.
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6.2.7 EFFECTS OF AMINO ACID ANALOGUE INCORPORATION/DTT ON
THE PROCESSING OF PRORICIN IN VITRO.
The fractions E1-E4 described in the section above 
were assayed for proricin processing activity by incubation 
with in vitro synthesised proricin (Figure 6.2.7: lanes 1-5). 
The fractions were also assayed using proricin substrates 
containing either the amino acid analogues azetidine or 
canavanine (azetidine - proline analogue; canavanine - arginine 
analogue: lanes 6-10 and 11-15 respectively), or proricin 
synthesised in ImM DTT (lanes 16-20). The processing of the 
analogue-substituted/DTT substrates was compared to the 
processing of the 'wild-type' proricin substrate. It was 
thought that proricin synthesised in a wheat germ, lacking the 
intrachain disulphide bonds normally present when proricin is 
synthesised and sequestered in the ER lumen of the developing 
castor bean endosperm, may not fold into a conformation which 
would allow access of the processing enzyme to the linker 
region. The enzyme would therefore be unable to cleave the 
polypeptide backbone to release the A and B chain fragments. It 
was therefore thought worthwhile to synthesise proricin 
containing the amino acid analogues canavanine and azetidine, 
to see whether the polypeptides produced had an altered 
conformation which would allow access of the enzyme to the 
linker. Similarly it was hoped that the DTT present would 
prevent the formation of any 'non-productive' (i.e. not present 
in native proricin from castor bean) disulphide bonds in the 
proricin substrate, which may alter its conformation and 
prevent access of the enzyme to the linker.
As with the previous assay (Figure 6.2.5) partial 
processing was observed in protein body matrix fractions before 
and after dialysis (El and E2). No processing however, was 
observed with fraction E3. In lanes containing the lectin peak 
(E4), the reduced lectin subunits somehow affected the
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Proricin transcripts, translated in a wheat germ 
lysate using a normal 5mM amino acid mix as described in 
Methods (lanes 1-5), a 5mM amino acid mix in which azetidine 
replaced proline (lanes 6-10), a 5mM amino acid mix in which 
canavanine replaced arginine (lanes 11-15), or which contained 
a normal reaction made ImM DTT (lanes 16-20), were incubated in 
citrate phosphate buffer (lanes 1, 6, 11 and 16); or with
crude protein body matrix fractions El (lanes 2, 7, 12 and 17), 
dialysed fractions E2 (lanes 3, 8, 13 and 18), unbound column 
fractions E3 (lanes 4, 9, 14 and 19) and lactose-eluted 
fractions E4 (lanes 5, 10, 15, 20). Polypeptides and digested 
fragments were resolved by SDS-PAGE and visualised by 
fluorography. Estimated protein concentrations were; 90jig/ml 
(El); 60pg/ml (E2); lOyig/ml (E3, E4). Protein concentrations 
estimated by Bradford protein assay.
FIGURE 6.2.7 EFFECT OF AMINO ACID ANALOGUE-INCORPORATION
INTO PRORICIN ON THE PROCESSING OF THE PRORICIN PRECURSOR.
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resolution of radioactive protein and no conclusions could be 
drawn. However, it was not expected to find any processing 
activity in this peak.
Incorporation of the amino acid analogues into the 
substrate or translation in ImM DTT had no visible effects on 
its processing. In both cases, the fractions El and E2 caused 
partial cleavage; E3 was inactive and in lanes containing E4, 
labelled polypeptides were resolved poorly. Furthermore, the 
level of expression of proricin containing azetidine was very 
low. It was concluded from this that the folding of the 
proricin substrate synthesised In vitro in the wheat germ 
lysate could not be altered by incorporation of amino acid 
analogues to improve its processing by the protein body matrix 
fractions.
All attempts to concentrate E3 fractions failed to 
show any processing activity (not shown) and also resulted in a 
concentration of the endogenous ricin which had not bound to 
the Sepharose 6B column (see Figure 6.2.6: lane E3).
6.2.8 EFFECTS OF EDTA AND PMSF ON ENZYME ACTIVITY.
PMSF is a known inhibitor of serine proteases. EDTA 
chelates magnesium and calcium ions and therefore specifically 
inhibits enzymes which require either of these cations for 
activity. The proricin processing activity described by Harley 
and Lord (1985) was not affected by either of these chemicals. 
It was decided to test the activity of the soluble matrix 
fraction on the iji vitro synthesised proricin substrate in the 
presence of these protease inhibitors (Figure 6.2.8).
In this assay a low concentration of E2 was used. 
This gave a low degree of processing but enabled good 
resolution of the digested fragments. In the assay EDTA had no 
visible effect on the processing of the proricin substrate. 
However, in the reaction containing 5mM PMSF no fragments were
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FIGURE 6.2.8 EFFECT OF EDTA AND PMSF OH PRORICIN PROCESSING 
ACTIVITY ISOLATED FROM DRY SEEDS.
Aliquots of a protein body matrix fraction from dry 
castor bean seeds were assayed for proricin processing activity 
(as in Figure 6.2.7), after a 20min pre-incubation at 30C in 
either citrate phosphate buffer pH4.6 (lane 5) or buffer 
containing lOpM EDTA (lane 1), IOOjiM EDTA (lane 2), ImM EDTA, 
and 5mM PMSF (lane 4). Non-specific proteolysis of proricin was 
tested by incubation of proricin in citrate phosphate buffer in 
the absence of castor bean extract (lane 6). Labelled proricin 
was resolved by SDS-PAGE and visualised by fluorography. 
Protein concentration of the matrix fraction (60jig/ml) 
estimated by Bradford protein assay.
was
visible. It was concluded that the processing activity observed 
in these experiments was inhibited by 5mM PMSF, in 
contradiction to the results of Harley and Lord (1985).
6.2.9 IN VITRO PROCESSING OF PULSE-CHASED AND 
IMMUNOPRECIPITATED PRORICIN ISOLATED FROM DEVELOPING SEEDS.
In light of the apparently anomalous result above, 
it was thought possible that the processing activity described 
in this chapter, was not the same as the activity described by 
Harley and Lord (1985) who had used pulse-labelled 
immunoprecipitated proricin from developing seeds as a 
substrate. Therefore, it was decided to confirm that the 
soluble matrix fractions used for the experiments described in 
this chapter did contain an enzyme activity capable of 
processing proricin isolated from developing seeds.
Endosperm slices from developing castor bean seeds 
were pulse-chased with ^^S-methionine and labelled proricin 
immunoprecipitated from a microsomal fraction, as described in 
Methods. This was used as a substrate for assaying the proricin 
processing activity in protein body soluble matrix fractions 
before (E2) or after (E3) passage down a Sepharose 6B column. A 
crude homogenate from developing seeds was also assayed for 
processing activity.
Figure 6.2.9A shows the result from this experiment. 
The major labelled proteins visible in the microsomal fraction 
were the precursors to the 7S lectins, 11S globulins and 2S 
albumins (lane 5). A band of 68kD was immunoprecipitated from 
the microsomal fraction corresponding to glycosylated proricin 
(lane 1). A fainter band of approximately 34kD was also visible 
in the immunoprecipitated fraction. This was present before 
overnight incubation and therefore did not represent a 
processed form of the 68kD band, but instead corresponds to the 
2S albumin precursor immunoprecipitated by the anti-ricin
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FIGURE 6.2.9 IH VITRO PROCESSING OF PULSE-CHASED, 35S- 
LABELLED PRORICIN FROM DEVELOPING SEEDS.
A/ Radiolabelled proricin, immunopcecipitated from the 
microsomal fraction of 33S-methionine pulse-chased castor bean 
endosperm (60min pulse with 300pCi 3^S-methionine followed by 
90min chase with 0.25M methionine) was incubated overnight at 
26C with citrate phosphate buffer (lane 1), an extract from 
developing castor bean seeds (lane 2), and protein body matrix 
fractions E2 (lane 3) and E3 (lane 4) from dry castor bean 
seeds. Lane S shows the unbound (i.e. protein not 
immunoprecipitated) protein from the endosperm microsomal 
fraction, with the prominent bands present corresponding to the 
precursors of the 7S-lectins (7S-P), the HS-globulins (11S-P) 
and the 2S-albumins (2S-P) (Lord, 1985a). Proricin was 
immunoprecipitated using rabbit anti-ricin antisera. Labelled 
polypeptides were resolved by SDS-PAGE and visualised by 
fluorography.
B/ The same experiment performed by Harley and Lord 
(1985) (lane 1, control; lane 2, incubated with extract from 
developing seeds; lane 3, incubated with extract from protein 
bodies of dry seed; lane 4, incubated with extract from dry 
seeds after removal of the lectins). Proricin and the processed 
fragments were immunoprecipitate with anti-RCA antisera, which 
also cross-react with ricin. Reproduced by permission of
J.M.Lord.
antisera (compare lanes 1 and 5). Harley and Lord (1985) also 
reported 2S-albumin precursor contamination in some 
immunoprecipitated fractions during their study.
Overnight incubation with the fresh and dry seed 
tissues completely processed aliquots of the immunoprecipitated 
proricin (lanes 2-4). In the incubation with the fresh seed 
tissue, two bands of 32kD and 34kD were seen (lane 2). The 32kD 
band was distorted in the track containing the dry seed 
preparation E2, due to the high concentration of endogenous 
lectins. This 'smile' was corrected in the track containing the 
protein body matrix fraction E3, in which the lectins had been 
removed. In the tracks 2-4 there is a faint band present of 
37kD which may represent RCA B chain, processed from 
contaminating RCA precursor co-immunoprecipitated with 
proricin.
These results correspond to those of Harley and Lord 
(Figure 6.2.9B). Unfortunately, the antibodies used seemed to 
cross-react with the 2S-albumin and RCA precursors and did not 
seem to successfully immunoprecipitate all the labelled 
proricin. However, the processing of the proricin precursor in 
all tracks containing seed extracts, to bands of 32kD and 34kD, 
indicate that the fractions E2 and E3 contained proricin 
processing activity.
6.3 DISCUSSIOH.
^^S-labelled proricin was successfully synthesised 
in vitro using a wheat germ lysate. Once optimised, the lysate 
synthesised 200,000-250,OOOcpm/jil of TCA-precipitable 
radiolabelled protein. A 63kD polypeptide was resolved by SDS- 
PAGE analysis of the translation reaction, corresponding to the 
expected size of 62.9kD for non-glycosylated proricin (Figures 
6.2.5, lane 1; 6.2.1, A). A smear of bands appeared below the 
full-length proricin polypeptide caused by incomplete
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elongation/premature termination events during the in vitro 
translation in wheat germ lysate. These bands could not be 
removed and made difficult the analysis of assay results. 
Immunoprécipitation did not clarify this profile (data not 
shown) presumably because all of the bands were translated from 
the proricin transcript and so were detected by the anti-ricin 
antibodies.
A protein body preparation from dry seeds was made 
using the non-aqueous method of Yatsu and Jacks (1967). The 
soluble matrix fraction from the isolated protein bodies 
appeared to consist of approximately SOX lectins upon SDS-PAGE 
analysis (Figure 6.2.4). When aliquots of this fraction were 
assayed for proricin processing activity a disappearance of the 
63kD radiolabelled proricin substrate with concomittant 
appearance of bands at 30kD was observed. It was proposed that 
this represented specific proricin-processing activity in the 
soluble protein body extract. Processing was approximately 90X 
in the assays where protein body matrix fractions containing 
150jig/ral protein were used (Figure 6.2.5; lane 2). The activity 
appeared stable after dialysis to remove residual levels of 
glycerol, frozen storage at -80C and after ammonium sulphate 
precipitation (Figure 6.2.5; lanes 2-7). However, the high 
levels of endogenous lectins present in these samples distorted 
the radiolabelled protein bands, making accurate size 
determination impossible. The overloaded lectins also caused 
significant precipitation of radiolabel in the wells and at the 
gel interface. It could be argued that the disappearance of the 
63kD proricin band observed in the lanes containing the 
protein body matrix fractions was due to precipitation of the 
proricin substrate in the well and at the gel interface. 
However, when a control incubation was 'spiked' with protein 
body matrix fraction immediately before SDS-PAGE the proricin 
band was visualised at 63kD, despite the presence of the
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radiolabel higher up the gel (not shown). It was therefore 
concluded that the radiolabel observed in the wells and gel 
interface was un-incorporated ^^S-methionine and did not 
represent labelled proricin.
When the protein body matrix fraction was diluted to 
reduce the adverse effects of the endogenous lectins discussed 
above, partial processing was observed at a protein 
concentration of approximately 60pg/ml (e.g. Figure 6.2.8, lane 
2). At this lower protein concentration 3 bands were resolved 
after overnight incubation with the proricin substrate. There 
was a doublet of approximately 31kD and a lower polypeptide 
band of 29kD. By comparison to the predicted sizes of fragments 
produced by asparagine-linked proteolysis of proricin (shown in 
Figure 6.2.1) it was suggested that the lower band represents B 
chain (predicted size is 28,950kD) and the size of the doublet 
resembles the predicted size for an A chain-linker polypeptide 
(31,250kD). There was no visible evidence on any fluorographs 
of a 60kD polypeptide; the predicted size for an A chain- 
linker-B chain fragment produced by proteolytic cleavage at the 
asparagine residue at the C-terminus of the N-terminal 
presequence.
The protein concentrations of the protein body 
matrix extracts were 10-50 fold more dilute than those used by 
Harley and Lord (1985). Precipitation of the radiolabel in the 
wells of the gel and gross distortion of the lanes occurred at 
high concentrations and so limited the amounts used in the 
assay. Attempts to remove these endogenous lectins by affinity 
chromatography on Sepharose 6B were only partially successful, 
and ricin subunits were still visualised upon SDS-PAGE analysis 
of unbound protein fractions eluted from the column. 
Furthermore, when these fractions were assayed for proricin- 
processing activity, they failed to cleave the substrate, 
before or after protein concentration.
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The partial processing activity observed in dilute 
samples of the protein body matrix fraction was not inhibited 
by the chelating agent EDTA, but was inhibited by 5mM PMSF. 
This contradicts both the results of Harley and Lord (1985) and 
Nishimura and Nishimura (1987), who each reported that the 
processing enzyme activity they had demonstrated in vitro was 
not inhibited by PMSF. The conditions used were not identical 
as those used by either Harley and Lord (1985) or Nishimura and 
Nishimura (1987), who both assayed for the processing activity 
by using a de novo-labelled native substrate, instead of the in 
vitro-synthesised substrate described above. One explanation 
would be therefore, that the protease activity discussed in 
this chapter is different to the ricin-processing activity 
reported by Harley and Lord (1985). In other words the 
digestion of the wheat germ lysate-synthesised proricin 
substrate was catalysed by a serine protease (sensitive to PMSF 
inhibition) present in the protein body matrix fraction, and 
not by the processing enzyme identified by Harley and Lord. 
This could be due to the fact that the ^n vitro synthesised 
substrate was not folded in such a way as to allow access of 
the processing enzyme to the linker region. The attempts to 
fold the substrate into a different conformation (by 
incorporating amino acid analogues into the polypeptide) failed 
to increase the processing observed.
However, the possibility of experimental error 
cannot be ruled out as this experiment was only repeated once 
(not shown) and the result clearly appears anomalous.
In retrospect, dry castor bean seeds were not an 
ideal source for the purification of an asparagine-specific 
endoprotease. Although it had distinct advantages; namely, a 
constant supply of material, the ability to isolate protein 
bodies from dry seed tissue and the potential for the selective 
removal of the co-compartmentalised lectins, one might expect
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that the maturation protease activity in dessicated seeds is 
significantly lower than in the developing seed, where it is 
required for processing of the lectin precursors. It may be 
therefore, that the endoprotease activity recovered from dry 
seeds demonstrated by Harley and Lord (1985) and shown above 
only represents a residual level of functional enzyme. 
Furthermore, homogenisation of large quantities of castor bean 
seed tissue releases high levels of ricin. Manipulation of 
these extracts is consequently restricted in order to minimise 
the risk of exposure to toxin, making this a problematical 
source of a storage protein processing enzyme.
The substrate used was also far from optimal. SDS- 
PAGE analysis of the proricin synthesised in wheat germ lysate 
revealed a smear of polypeptide bands below the 63kD full- 
length product. As these were all synthesised from the same 
proricin transcript they were all recognised by anti-ricin 
antisera. This made identification of the 30kD processed 
fragments by immunoprécipitation with either anti-A chain or 
anti-B chain antibodies impossible.
In any future work it may be more prudent to use 
another seed tissue as a source of processing enzyme, since the 
hypothesis proposed at the beginning of this chapter is that 
many different plant storage proteins are processed by a common 
asparagine-specific endoprotease. Also, recombinant proricin 
synthesised in Xenopus oocytes would be a preferable substrate 
since the results presented in the previous chapter have shown 
that proricin synthesised in this way is glycosylated, 
disulphide bonded and biologically active suggesting that its 
conformation closely resembles native ricin.
Most recently, Nishimura and Nishimura (1991) have 
reported the purification of the proglobulin-processing enzyme 
from pumpkin. No details of the purification strategy have been
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7.1 IHTRODOCTION.
As discussed in the previous chapters, it was 
initially desirable to cleave proricin in vitro to yield 
biologically-active A and B chains. After the unsuccessful 
efforts to purify the endogenous endoprotease(s) responsible 
for proricin maturation in the plant, an alternative approach 
was designed. It was decided to use molecular biological 
techniques in order to introduce into the proricin linker 
region, a recognition sequence for a purified and commercially- 
available enzyme. It was hoped that such a molecule would also 
provide a ready source of active subunits and would therefore 
circumvent problems of producing biologically-active 
recombinant ricin B chain. However, the low specificity of many 
commonly available endoproteases made them unsuitable. For 
example, trypsin cleaves Lys/Arg-X peptide bonds, chymotrypsin 
cleaves on the carboxyl side of aromatic and other bulky 
nonpolar residues, and proteinase V8 from Staphylococcus aureus 
cleaves Glu-X bonds. Digestion of proricin with any of these 
enzymes would yield a host of fragments.
On the other hand, Factor Xa and thrombin are 
trypsin-like proteases which, under appropriate conditions 
possess a unique substrate specificity. Both enzymes are blood 
clotting factors involved in the complicated hemostatic cascade 
reactions (reviewed by Mann, 1987). They normally exist in the 
blood as inactive zymogens, Factor X and prothrombin, but upon 
vascular damage a network of cellular and protease reactions 
are initiated to localise the hemorrhage. These involve the 
activation of Factor X (to Factor Xa) and prothrombin (to 
alpha-thrombin: termed 'thrombin' hereafter). Both enzymes have 
been purified from various sources. Factor X can be activated 
in vitro using Russell's viper venom (Fujikawa, Legaz and 
Davie, 1972) and prothrombin is the physiological substrate of 
Factor Xa (see Mann, 1987).
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Their unique substrate specificity is derived from 
the fact that, although they cleave peptide bonds on the 
carboxyl side of arginine residues with a similar reaction 
mechanism as trypsin, the molecular environment around their 
active sites restricts the access of most amino acid sequences. 
This means that they have preferred amino acid 'recognition' 
sequences: L-V-P-R-N-S is the preferred sequence for thrombin 
(Chang, 1985), and I-E-G-R has been shown to be the Factor Xa 
recognition sequence at both of its cleavage sites in 
prothrombin (see Nagai and Thogerson, 1984), with cleavage 
occurring after the arginine (R) residue in both cases.
The incorporation of thrombin and Factor Xa 
recognition sequences into hybrid proteins has been reported 
(Nagai and Thogerson, 1984: Smith and Johnson, 1988). Nagai and 
Thogerson expressed in E.coli a hybrid between the amino 
terminal region of lambda ell protein and human beta-globin, 
which were linked by a Factor Xa recognition sequence. The 
lambda-derived region enabled high expression of the hybrid and 
the beta-globin was subsequently released by digestion with 
Factor Xa. Smith and Johnson reported a method for single-step 
purification of recombinant eukaryotic proteins by expressing 
them in E.coli as fusions with glutathione-S-transferase. Once 
expressed, the hybrid protein is affinity purified by specific 
binding of the glutathione-S-transferase domain to a column 
containing a glutathione-bound matrix. By designing the 
chimeric gene to encode a fusion protein with a Factor Xa or 
thrombin recognition sequence at the junction between the two 
protein domains, the eukaryotic protein of interest can be 
separated from the glutathione-S-transferase domain by protease 
digestion following affinity purification.
It was therefore decided to design proricin 
constructs encoding proteins with either a Factor Xa or 
thrombin recognition sequence within the natural proricin
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linker region. These constructs would then be expressed and the 
linker regions cleaved to produce heterodimeric recombinant 
proteins, hopefully with the desired biological activities.
Soluble recombinant A chain has been made in E.coli 
(O'Hare et al, 1988) but efforts to produce a soluble B chain 
in E.coli have not proved successful. However, B chain is known 
to be stabilised in solution by the presence of the A chain 
(whole ricin is stable in aqueous solution). It was therefore 
hoped that recombinant proricin produced in E.coli would be 
stable. In order to promote the formation of disulphide bonds 
in the recombinant protein, a factor important for the 
stability of B chain and essential for covalent linkage of the 
A chain and B chain following proteolytic cleavage, it was 
decided to target proricin to the periplasmic space, which has 
an oxidising environment better suited to disulphide bond 
formation than the cytoplasm. Secretion of recombinant proteins 
into the periplasmic space has been reported (reviewed by 
Schein, 1989) and reduces the risk of producing insoluble 
aggregates or inclusion bodies (Mitraki and King, 1989). It 
also has the advantage that the recombinant protein can be 
selectively fractionated away from cytosolic E.coli proteins, 
which is an aid in the subsequent design of a protein 
purification strategy.
The aims of the work described in this chapter 
therefore were to design and create mutant proricin clones 
encoding linkers with Factor Xa and thrombin recognition 
sequences, and to assess the use of an E.coli periplasmic 
expression system for the synthesis of soluble, disulphide- 
bonded recombinant (mutant) proricin.
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7.2 CLONING AMD MUTAGENESIS.
7.2.1 SOURCE OF VECTOR, PINIIIoapA2proricin.
The construct pIIIompA2proricin was a gift from
K.Hussain (Warwick). It contains the partial proricin clone 
pRCL617oxl6 (see Appendix A) inserted into the high expression 
E.coli secretion vector, pINIIIompA2 (Ghrayeb e_t aJL, 1984: 
Appendix C for map), such that it was in-frame with the ompA 
signal peptide coding sequence. The chimeric gene in
pINIIIompA2proricin therefore encodes a fusion protein with a 
21 amino acid residue N-terminal ompA-derived signal peptide 
fused to the 5th residue of the A chain. Expression of the gene 
is under the control of the lipoprotein/lactose promoter and 
once expression is induced (by IPTG) the signal peptide should 
direct the fusion protein to the periplasmic space.
7.2.2 CONSTRUCTION OF CLONES CONTAINING FACTOR Xa AND 
THROMBIN ENCODING LINKERS.
(see Figure 7.2.2.1 for cloning strategy)
(a) Construction of autogenic template.
A 552bp Bglll fragment, containing the proricin 
linker coding region, was excised from pINIIIompA2proricin and 
cloned into the unique Bglll restriction site of pIC20H (see 
Appendix C for map). A clone containing a single copy of the 
552bp proricin fragment was identified by colour selection on 
Xgal/IPTG/L-Amp plates and by restriction digest analysis of 
mini-prep. DNA.
A 600bp Hindlll/EcoRI fragment from this clone was 
then cloned into the polylinker of M13mpl9. Single-stranded M13 
DNA was prepared from white plaques and sequenced (using the 
universal primer) to identify a clone in which the DNA strand 
of the 552bp proricin DNA fragment present in the ssM13 was 
complementary to the published sequence of Lamb et al 
(1985:Appendix A). This was the preferred orientation for the
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FIGURE 7.2.2.1 CLONING STRATEGY FOR THE CREATION OF PRORICIN 
LINKERS CONTAINING EITHER A FACTOR Xa OR THROMBIN CLEAVAGE 
SITE.
KEY
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ricin fragment in the M13mpl9 vector because the ricin 
sequencing primers (which would be needed at a latter stage to 
identify mutant clones) were the same sense as the published 
sequence (see Table 2.1.11 for list of primers). Once 
identified, this clone was used as a template for mutagenesis. 
In all subsequent mutagenic manipulations, care was taken to 
minimise the creation of codons which rarely appear in E.coli 
genes (Edge et al, 1983).
(b) Mutagenesis to create a thrombin recognition 
sequence in the proricin linker region.
A 21 base mutagenic oligonucleotide, MW01, was 
designed which would introduce a one-base mismatch mutation in 
the linker coding region, G^O to C8^0 (Table 2.1.12). The 
method of site-directed mutagenesis described by Nakamaye and 
Eckstein (1986) was followed and four mutants were identified 
by sequencing ssM13 preparations from 12 putative mutants, 
using the ricin sequencing primer CL586 (Table 2.1.11). ssDNA 
from one of these was then used as template in a second round 
of mutagenesis with the mutant oligonucleotide MW02 (Table 
2.1.12). This second oligonucleotide was designed to introduce 
a 7 base mismatch mutation, A830TTTTAA836 to G830GGGCAG836. The 
method of Nakamaye and Eckstein (1986) was again used to 
perform the mutagenesis and of six putative mutant progeny 
sequenced, two were found to contain the correct mutations. The 
mutant DNA sequence is shown alongside the wild-type sequence 
in Figure 7.2.2.2. The complete 552bp ricin-derived region from 
one of these mutants was sequenced using the ricin primers to 
ensure that no opportunistic mutations had occurred.
This mutated linker will now be referred to as the 
'thrombin linker', and all proricin clones containing this 
linker will be suffixed "Th".
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PIGURE 7.2.2.2 DNA SEQUENCE ANALYSIS OP WILD-TYPE PRORICIN AND 
THROMBIN MUTANT.
DNA sequence of pINIIIompA2proricin (wild-type) and 
pINIIIompA2proricinTh (thrombin mutant) in the linker coding 
region, showing the 7 base mismatch mutation in the mutant 
(asterisked). The deduced amino acid sequence of the wild-type 
linker region is shown on the right and the thrombin 
recognition sequence, Leu-Val-Pro-Arg-Gly-Ser, encoded by the 
thrombin mutant is shown on the left with the predicted site of 
cleavage arrowed.
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(c) Mutagenesis to create a Factor Xa recognition 
sequence in the proricin linker region.
A 28 base mutant oligonucleotide, MW03 (Table 
2.1.12), was designed to introduce an 8 base mismatch mutation, 
A814GGCCAGT821 to G814AAGGCCG821, and this was used in 
conjunction with the M13 template from (a) above. The method of 
Nakamaye and Eckstein (1986) was used and of the 3 putative 
mutagenic progeny sequenced all were found to contain the 
correct mutations. Figure 7.2.2.3 shows the sequence of the 
mutated linker region and the deduced amino acid sequence (with 
the I-E-G-R Factor Xa recognition sequence) from one of these 
clones. One mutant was sequenced further to check that no 
opportunistic mutations had occurred in the 552bp ricin-derived 
sequence.
This mutated linker will now be referred to as the 
'Factor Xa linker' and all proricin clones containing this 
linker will be suffixed ''Xa".
(d) Cloning of thrombin and Factor Xa linkers back into 
plNIIoiapA2pror icin .
RF M13 DMA was prepared from the mutated clones in 
(b) and (c) above. The 600bp EcoRI/Hindlll fragment from each 
was then cloned into the polylinker of pUC9. This step was 
necessary as M13mpl9 contains a Bglll restriction site and 
therefore the 552bp ricin-derived Belli fragment could not have 
been excised directly from the M13 mutants and cloned easily. 
In each case, pUC9 clones were screened by plating on colour 
selection plates. Mini prep DNA prepared from one of these 
colonies, containing a clone with the mutant linker, was cut 
with Bglll to release the 552bp ricin-derived region. This 
fragment was gel-isolated and cloned into the large 7kb Bglll 
fragment of pINIIIompA2proricin, which had first been 
phosphatased to minimise the recovery of religated vector. The 
orientation of the thrombin/Factor Xa linker in the
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FIGURE 7.2.2.3 DNA SEQUENCE ANALYSIS OF PRORICIN LINKER CODING 
REGION FROM A FACTOR Xa MUTANT.
DNA sequence of the linker region from a Factor Xa 
proricin mutant clone, with the 8 base mismatch mutation 
asterisked. The deduced amino acid sequence is shown alongside 
with the Factor Xa recognition sequence, Ile-Glu-Gly-Arg, 
marked. The predicted site of cleavage is arrowed. jjUco
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pINIIIompA2proricin vector was determined by digesting mini 
prep DNA with BamHI and Clal (not shown). Caesium chloride 
purified plasmid DNA was prepared from clones containing 
correctly-orientated mutant linkers and labelled 
pINIIIompA2proricinXa and pINIIIompA2proricinTh.
7.3 EXPRESSION IN E.COLI.
The constructs pINIIompA2proricin, 
pINIIIompA2proricinXa, and pINIIIompA2proricinTh were 
transformed into the E.coli strain JA221 (see Table 2.1.1 for 
genotype) and transformants were selected by streaking on L-Amp 
plates. This strain of E.coli was selected for this work 
because it has a modified cell membrane (lipoprotein minus 
phenotype) which has been shown to improve the yield of 
expressed proteins that are targeted to the periplasm (Takagi 
et al, 1988).
When transformants were grown on this medium, 
'patchy' growth was observed which was taken to be due to 
expression of recombinant proricin from a 'leaky' lpp/lac 
promoter. Expressed proricin, containing the ompA signal 
peptide, should be targeted across the cell membrane into the 
periplasmic space which could weaken the cells during cell 
growth and division. Therefore, all subsequent transformants 
were selected and grown on L-Amp plates made lOmM glucose/lOmM 
MgCl2/10raM MgSO^ (glucose is a metabolic repressor of the lac 
operon and magnesium strengthens cell wall formation). Colonies 
appeared to grow well on this medium.
Single colonies from these plates were used to 
inoculate JA221-minimal media (see Methods) which were then 
grown overnight at 37C/200rpm. These cultures typically reached 
an O.D.^00 of approximately 1.5units. They were then used to 
inoculate pre-warmed JA221-expression media (JA221/minimal 
media supplemented with 1Z Caseamino acids). Cultures were
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grown to mid-log phase (this took 2-3 hours with a l/50th 
dilution of an overnight culture) before inducing expression of 
proricin with IraM IPTG. Incubation was continued for a further 
3 hours. Figure 7.3.1 shows a typical growth curve for 
pINIIIompA2proricin-transformed JA221, compared to growth of a 
culture of untransformed JA221 under similar conditions (with 
the single exception that ampicillin was not included in the 
medium). The growth curve curves appear similar for both 
transformed and untransformed cultures. This would indicate 
that either there was no expression of recombinant proricin in 
the transformed cultures or the expression of proricin was not 
having any detectable effect on the growth of the 
pINIIIompA2proricin-transformed cells. The growth curves for 
JA221 cultures transformed with Xa/Th proricin mutants also 
appeared similar (not shown).
Cell fractions were prepared from cultures before 
and after induction with ImM IPTG and analysed for proricin 
expression. Total cell protein fractions, periplasmic protein 
fractions (the supernatant obtained after osmotic shock of 
cells) and cytoplasmic protein fractions (obtained from the 
cell pellet after osmotic shock) were taken at different time 
points, resolved by SDS-PAGE and proricin detected by western 
blotting techniques. Figure 7.3.2A shows the protein profile 
for such fractions from a JA221 culture expressing proricin. No 
protein bands were detected in lanes loaded with periplasmic 
fractions. In the total cell and shocked cell fractions a 
detectable protein profile was observed for each time point, 
which was similar to the protein profile obtained from 
fractions isolated from a culture of untransformed JA221.
The western blot analysis (Figure 7.3.2B) revealed 
that only fractions from the pINIIIompA2proricin-transformed 
culture contained any immunoreactive polypeptides. This 
indicated that proricin was being expressed from the
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FIGURE 7.3.1 GROWTH CURVES FOR pIIIompA2proricin-TRANSFORMED 
AND UNTRANSFORMED JA221 CULTURES y BEFORE AND AFTER INDUCTION 
WITH InM IPTG.
JA221 expression media (see Methods) was inoculated 
with 1/50 volume overnight cultures of pINIIIompa2proricin- 
transformed JA221 (Pr) and non-transformed JA221 (C). The 
cultures were incubated at 37C, 200rpm, and grown to mid-log 
phase before induction with ImM IPTG (arrowed). Aliquots were 
taken at 0, 1, 2, and 3 hours after induction and analysed for 
proricin expression (see Figure 7.3.2).
FIGURE 7.3.2 EXPRESSION OF RECOMBINANT PRORICIN IN 
pINIIIoapA2proricin-TRANSFORMED JA221, BEFORE AND AFTER 
INDUCTION WITH lmM IPTG.
SDS-PAGE (A) and Western Blot (B) analysis of total 
cell (T), periplasmic (P) and shocked cell (S) fractions from a 
culture of pINIIIorapA2proricin-transformed JA221, 0, 1, 2 and 3 
hours after induction with lmM IPTG. Cultures were grown at 
37C, 200rpra to mid-log phase before induction. All fraction 
volumes were adjusted to represent a cell concentration of 20 
O.D.**00 units/ml (the O.D. of the culture being measured 
immediately prior to fractionation) and 25ul of each fraction 
was loaded onto a 10% polyacrylamide gel. Lanes labelled 
'JA221' represent fractions from a non-transformed JA221 
culture after 3 hours IPTG induction. Protein bands were 
visualised by Coomassie staining (gel A). The nitrocellulose 
filter was probed with an IgG fraction of sheep anti-ricin A 
chain antisera and developed using the alkaline phospatase 
system. The upper and lower arrows represent the putative 
unprocessed and processed proricin forms respectively.
JA221
pINIIIompA2proricin plasmid. In the total cell and shocked cell 
fractions a doublet was detected at approximately 58kD, which 
were the predominant immunoreactive bands and which were taken 
to be the uncleaved (upper band) and signal peptide-cleaved 
(lower band) forms of the ompA2/proricin hybrid. Numerous 
immunoreactive bands were also detected below this doublet, 
which may represent breakdown products of proricin or premature 
termination events during translation of the proricin mRNA 
(similar to that described during the in vitro expression of 
proricin in wheat germ lysate).
No immunoreactive bands were detected in any 
periplasmic fractions. Since approximately 50% of the proricin 
was in the ompA-cleaved form in total cell fractions, 
indicating that 50% of the protein was reaching the periplasm 
(signal peptidase is localised in the periplasmic space), it 
was concluded that the method of osmotic shock was not 
efficiently releasing proteins from the periplasmic space. 
Another possible interpretation would be that the fusion 
protein becomes trapped in the cell membrane during 
translocation. This would allow the ompA signal to be cleaved 
(assuming this region of the protein was exposed on the 
periplasmic surface of the cell membrane) but would not allow 
release of the protein during osmotic shock.
A low level of proricin expression was detected in 
the total cell and (more clearly visible in Figure 7.3.2) in 
the shocked cell fractions from cells before IPTG induction. As 
the media used was a defined media, it was not likely that it 
contained any lac inducer, and therefore it was concluded that 
the lac/lpp promoter was not completely switched off in the 
absence of IPTG.
The levels of proricin expression in the culture 
appeared constant over the time period of the experiment 
(compare total cell fractions after 1, 2 and 3 hours
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induction). The fractions were all standardised to take account 
of the different cell densities at the three time points. This 
result indicates that once induced, the cells reach a steady 
state level of proricin synthesis. The maximum amount of 
proricin produced in a culture is therefore achieved when the 
cells reach stationary phase (2 to 3 hours). On this basis it 
was deemed sufficient in all future experiments to induce 
cultures for a 2-3 hour period before fractionation and 
analysis. A similar expression pattern was observed for JA221 
cultures transformed with the Factor Xa and thrombin proricin 
mutant clones.
In order to increase the resolution of the 
immunoreactive proricin doublet, fractions were loaded onto a 
10% acylamide/0.1% bisacrylamide polyacrylamide gel. Figure
7.3.3 shows the western blot of a gel loaded with fractions 
from cultures expressing the Factor Xa and thrombin proricin 
mutants. Two bands of approximately 58kD were clearly resolved 
and were most prominent in the tracks containing 
cytoplasmic/membrane protein from shocked cells (S). 
Surprisingly, the immunoreactive bands detected in the 
periplasmic fractions (P) were largely in the unprocessed form. 
It also appeared that the majority of the recombinant protein 
expressed was not released by osmotic shock and remained within 
the shocked cells.
In an effort to assess the effectiveness of the 
osmotic shock treatment to release the periplasmic protein from 
the cells, fractions from a JA221 culture expressing proricin 
were also assayed for beta-lactamase activity. The beta- 
lactamase gene is contained on the pINIIIompA2proricin plasmid 
and is normally used for antibiotic selection on ampicillin. 
The protein is periplasmically-localised and can be assayed 
spectrophotometrically (O'Callaghan et al. 1972). Figure 7.3.4
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FIGURE 7.3.3 RESOLUTION OF PUTATIVE PROCESSED AND UNPROCESSED 
RECOMBINANT PRORICIN BANDS USING 'LOW BIS' SDS-PAGE.
Western Blot analysis of total cell (T), periplasmic 
(P) and shocked cell (S) fractions from pINIIIorapA2proricinXa- 
transformed (Xa) and pINIIIompA2proricinTh-transformed (Th) 
JA221, incubated at 37C and after 3 hours induction with ImM 
IPTG. Protein bands were resolved using
lOZacrylamide/O.lZbisacrylamide SDS-PAGE and the amount of each 
fraction loaded represents protein from 0.5ml culture. 200ng of 
recombinant A chain (rA) was loaded as a control and the 
nitrocellulose blot was probed with an IgG fraction of sheep 
anti-A chain antisera.
shows the gel profiles, western blot of proricin products and 
the results of the beta-lactamase assay.
The beta-lactamase activity all appeared to be 
released from the cells in the first periplasmic fractionation 
(compare values for total cell and periplasm fractions) with 
negligible beta-lactamase activity being observed in the 
shocked cell fraction. The silver-stained gel showed the 
presence of a single strong polypeptide band of approximately 
35kD in the first periplasmic fraction (Gel A; lane PI) which 
is the predicted size for beta-lactamase. This gel also showed 
that there was selective release of beta-lactamase over other 
E.coli proteins (compare total cell fraction to periplasmic 
fraction). This indicates that the beta-lactamase activity 
recovered by osmotic shock was not caused by cell lysis and 
non-selective release of soluble E.coli proteins. There was no 
corresponding band observed in the second periplasmic fraction 
(Gel A; compare lanes PI and P2). It was concluded therefore, 
that the first osmotic shock treatment efficiently released the 
periplasmically-localised beta-lactamase.
However, when the fractions were analysed for 
immunoreactive recombinant proricin (Figure 7.3.4; gel B) very 
little full-length proricin was released in the first 
periplasmic fraction. Instead a lower molecular weight 
immunoreactive polypeptide appeared released in this fraction. 
More of the periplasraically-localised recombinant proricin was 
released after the second osmotic shock, and in this fraction 
there was no evidence of the lower molecular weight 
immunoreactive bands. However, the majority of the recombinant 
proricin remained associated with the shocked cell fraction 
(compare lanes T, P and S of gel B). The same profiles were 
observed with cultures expressing the Factor Xa proricin mutant 
(not shown).
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FIGURE 7.3.4 EFFICIENCY OF OSMOTIC SHOCK IN THE RECOYERY 
OF PERIPLASMICALLY-LOCALISED RECOMBINANT PRORICIN.
SDS-PAGE (A) and Western Blot (B) analysis of total 
cell (T), periplasmlc (PI, P2) and shocked cell (S) fractions 
from a culture of pINIIIompA2proricln-transformed JA221 after 
Induction for 2 hours at 37C with lmM IPTG. Each lane 
represents protein from 0.2ml culture. An aliquot of the total 
cell fraction was sonicated in lOmM PMSF to determine whether 
the bands observed below the full length proricin product were 
due to proteolysis during fractionation. During the preparation 
of the periplasm fractions, the cells were shocked twice by 
successive suspensions in l/100th volume ice cold O.lmM MgCl2: 
lanes PI and P2 refer to the supernatant from the first and 
second osmotic shock respectively. lOOng of recombinant A chain 
was loaded as a control (rA), the nitrocellulose blot probed 
with an IgG fraction of sheep anti-A chain antisera and the 
immunoreactive bands detected by the alkaline phosphatase 
protocol described in Methods. Protein bands in A were 
visualised by silver stain. Fractions were also assayed for B- 
lactamase activity (shown in table) using the method of 
O'Callaghan e_t al (1978). The activity in the culture medium 
was also determined (M).
From this data it was concluded that the method of 
osmotic shock was effective for selective release of some 
periplasmically-localised proteins, but did not mediate the 
efficient release of the recombinant proricin from expression 
cultures of pINIIIompA2proricin-transformed JA221.
Total cell fractions were also prepared in the 
presence of lOmM PMSF (Figure 7.3.4) to determine whether the 
low molecular weight immunoreactive bands, seen in fractions 
from cultures expressing proricin, were caused by serine 
protease activity released during fractionation. However, there 
was no detectable difference between the fractions when 
analysed by SDS-PAGG and Western Blot which suggested that this 
was not the cause of the bands observed.
The solubility of recombinant proricin (and proricin 
mutants) recovered in the periplasm fractions was determined by 
centrifugation at 100,000xg for 30min at 4C. The supernatant 
after this step was taken to contain soluble protein. When 
supernatants and pellets were analysed by SDS-PAGE and Western 
blot analysis however, all immunoreactive proricin was found in 
the pellet (not shown).
An increase in the levels of expression of soluble 
recombinant proteins by a reduction of the expression 
temperature have been reported (O'Hare «it al, 1988, for 
expression of recombinant ricin A chain: Hussain et al, 1989, 
for expression of recombinant B chain: also see general review 
by Schein, 1989). Takagi et al (1988) have reported that 
incubation of induced E.coli cultures at 23C increased the 
level of expression of active substilisin E from a pIIIompA- 
derived vector. Hussain £t al (1989) found that ricin B chain 
expression was increased by overnight expression at 18C. The 
facilities were not available for routine incubation of 
cultures at 18C, but one experiment was possible. Figure 7.3.5 
shows the results from this experiment.
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FIGPRE 7.3.5
A« EFFECT OF LOWERING THE INCUBATION TEMPERATURE TO 18C ON THE 
SOLUBILITY OF PERIPLAMSIGALLY-LOCALISED RECOMBINANT PRORICIN.
Western Blot analysis of periplasmic fraction 
isolated from a culture of pINIIIorapA2proricin-transformed 
JA221, after incubation overnight at 18C in the presence of ImM 
1PTG. The periplasmic fraction was concentrated lOx fold in an 
Amicon Centricon filtration unit and then centrifuged at 
100,000xg, 30min, 4C, to pellet the insoluble protein. Proteins 
from 10, 20 and 40jil of the soluble periplasmic fraction
(representing soluble periplasmic protein from 10, 20 and 40ml 
of culture: labelled SP) and all of the insoluble fraction 
(representing 500ml of culture: lane I) were resolved by SDS- 
PAGE and blotted onto nitrocellulose. 2jig ricin (Sigma) was run 
as a control. The blot was probed with an IgG fraction of sheep 
anti-A chain antisera and developed using the alkaline 
phosphatase system.
B: EVIDENCE FOR SOME DEGREE OF DISULPHIDE BONDING WITHIN 
SOLUBLE PERIPLASMICALLY-LOCALISED RECOMBINANT PRORICIN.
Western Blot of soluble periplasmic fraction (P), 
resolved by SDS-PAGE under reducing (R) and non-reducing (NR) 
conditions. Protein loaded represents the soluble periplasmic 
protein recovered from 80mls of the overnight culture (shown in 
A, above). The protein in lane S represents the shocked cell 
fraction from 4mls of culture; lane rA contains 500ng 
recombinant ricin A chain; and lane R is ricin run under non­
reducing conditions (NR).

The western blot analysis showed that approximately 
90% of the recombinant proricin expressed at 18C was recovered 
as soluble material in the periplasm fraction (Figure 7.3.5, 
blot A: compare lanes SP-40 and I). Furthermore, the majority 
of the soluble recombinant proricin recovered was in the ompA- 
cleaved form. Another immunoreactive band of lower molecular 
weight (approximately 30kD) was also visible in the soluble and 
insoluble periplasmic fractions.
The migration of the soluble recombinant proricin in 
the periplasm fraction was also compared under reducing and 
non-reducing conditions (Figure 3.7.4, blot B). The proricin 
migrated further under non-reducing conditions (compare lanes 
P-R and P-NR), indicating that the periplasmic proricin 
expressed under these conditions has a conformation maintained 
by disulphide-bonds. It is not possible from this data however, 
to determine whether the correct pairings of cysteine residues 
exists in the recombinant product. The effect of disulphide 
bond formation on the migration of proteins under non-reducing 
conditions is illustrated by ricin (R), which appears as a 
single band of approximately 58kD under non-reducing conditions 
in contrast to its characteristic heterodimeric profile under 
reducing conditions (compare lane R in blots A and B).
There were two additional bands of lower molecular 
weight detected by the anti-A chain antisera in the soluble 
periplasm fraction. The higher band appeared to be exactly the 
same size as recombinant ricin A chain (compare lanes rA and P: 
Figure 7.3.5B) and was more intense than the lower band. A 
possible explanation for the presence of these bands was that 
they represented processed A and B chain-related polypeptides 
cleaved from the mature proricin. Such a proteolytic step would 
have to occur in the periplasm, since cytoplasmic proteolysis 
would trap B chain, lacking a signal peptide region, in the 
cytosol. Furthermore, cross-reaction of the sheep anti-A chain
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antisera with B chain polypeptides is seen with whole ricin 
(gel A; lane R). However, the size of the lower band is less 
than expected for B chain and both immunoreactive bands remain 
visible in the soluble periplasm fraction under non-reducing 
conditions suggesting that these immunoreactive polypeptides 
were not linked by a disulphide bridge. Alternatively, the 
bands may both represent A chain-like fragments (full-length 
and partial), produced by premature termination events during 
translation of proricin mRNA or proteolysis of the recombinant 
proricin in the cytoplasm. The orapA signal peptide would target 
both to the periplasm.
Finally, it was estimated that only 0.03mg/l of 
soluble recombinant proricin was recovered from the periplasm 
of JA221 cultures transformed with pINIIIompA2proricin and 
induced overnight at 18C. Over 902 of the recombinant proricin 
expressed in these cultures still remained trapped in the 
shocked cell fractions (0.25mg/l).
7.4 DISCUSSION.
Proricin clones with linkers encoding Factor Xa and 
thrombin recognition sequences, were made successfully. 
Proricin and Factor Xa/thrombin mutant clones were expressed in 
E.coli as fusion proteins with the ompA signal peptide, using 
the periplasmic secretion vector pINIIIompA2. Expression of the 
fusion protein was inducible with 1 mM IPTG. However, the 
lpp/lac promoter could not be completely switched off under the 
conditions used, and low levels of recombinant protein were 
detected even in the absence of IPTG.
Cultures transformed with pINIIIompA2proricin, 
pINIIIompA2proricinXa and pINIIIompA2proricinTh all expressed 
an immunoreactive product of the predicted size for proricin 
(58kD). Using 'low bisacrylamide' SDS-PAGE it was possible to 
clearly resolve this 58kD proricin into two bands, which were
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taken to represent the signal peptide processed and unprocessed 
forms of the recombinant fusion protein. All fractions also 
were shown to contain many immunoreactive bands of lower 
molecular weight than the 58kD doublet. These polypeptides did 
not arise by the action of serine-specific proteases during 
fractionation. Other possible explanations for their presence 
is that they are caused by premature termination events during 
translation of the recombinant proricin mRNA or by other 
classes of proteases.
Efforts to recover the recombinant proricin from the 
periplasm of expression cultures using osmotic shock only 
succeeded in recovering approximately 10% of the total 
immunoreactive protein. This method however, successfully 
recovered all of the co-expressed and periplasmically-localised 
beta-lactamase from the same cultures. There are two possible 
reasons for the poor recovery of recombinant proricin from 
osmotically-shocked cells. One is that the ompA2/proricin 
fusion protein cannot easily cross the cell membrane and 
becomes trapped within the membrane. Schein (1989) reports that 
the structure of the recombinant protein is important for 
secretion. Alternatively, the recombinant proricin may become 
correctly segregated into the periplasm, but it cannot easily 
be drawn through the cell wall during osmotic shock because, 
for example, it exists in the form of large insoluble 
aggregates or simply because it is too bulky to pass through 
the gaps in the wall. Evidence in support of this was presented 
in Figure 7.3.4, where the majority of the proricin recovered 
during osmotic shock was recovered in the second fraction. 
Furthermore, the small quantity of proricin that was recovered 
in periplasmic fractions was found to be insoluble.
By lowering the expression temperature from 37C to 
18C it was possible to recover a small amount of soluble 
periplasmically-localised recombinant proricin (0.03mg/l). This
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recombinant proricin product was mostly in the processed (ompA- 
cleaved) form with some evidence of disulphide bonding. Over 
90% of the recombinant proricin however, remained within the 
shocked cell fraction. The optimal total amount of recombinant 
proricin that was synthesised (0.28mg/l) was from an overnight 
culture incubated at 18C. Other workers have demonstrated the 
significance of the expression temperature on the yield of 
recombinant proteins. In particular, Takagi et a_l (1988), who 
were using a similar expression system to target recombinant 
substilisin E to the periplasm of E.coll. found that expression 
at 23C increased the yield significantly. They also found that 
low inducer concentrations improved the yield of substilisin E. 
However, the effects of different IPTG concentrations on 
proricin yield were not investigated in this study.
The recombinant proricin recovered in the 
periplasmic fraction from the culture grown at 18C, also 
contained significant amounts of ' two immunoreactive 
polypeptides that were not linked by a disulphide bridge, but 
one of which was exactly the same size as recombinant A chain. 
It is possible that these may represent A chain and B chain­
like fragments which are cleaved from the mature recombinant 
proricin during periplasmic expression.
From the results presented it is clear that the 
problems with low yield and insolubility of recombinant 
proricin would make large scale purification impractical. The 
low molecular weight immunoreactive bands might also make 
interpretation of any toxicity studies difficult (using the RNA 
RNA N-glycosidase assay for example) with respect to the 
biological activity full-length recombinant protein. These 
problems have been discussed already with regards toxicity 
studies on recombinant proricin synthesised in Xenopus oocytes 
(Chapter 5). Although lowering the expression temperature did 
increase the amount of periplasmically-localised recombinant
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protein, it was not possible to perforin such experiments 
routinely at Warwick under the necessary Category IV conditions 
required by the Health and Safety Executive (HSE). Furthermore, 
at this lower incubation temperature, two immunoreactive bands 
were detected. These might mask results of the intended in 
vitro proteolytic experiments using the Factor Xa and thrombin 
mutants. It was therefore concluded that this system was not 
suitable for the expression of recombinant proricin and the 
Factor Xa/thrombin proricin mutants.
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CHAPTER 8
EXPRESSION OF PRORICIN AND PRORICIH MUTANTS IW VITRO 
USING A XBNOPUS EGG CELL-FREE TRANSLATION SYSTEM.
Contents:
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8.2 Resultsr-4•CM•00 Cloning of Xa and Th mutant linkers into 
pGEMppRCL617.
8.2.2 In vitro expression of preproricin and 
preproricin mutants.
8.2.3 Proteolytic cleavage of in vitro synthesised 
preproricin and preproricin mutants.
8.2.4 Cloning of preproricin and preproricin 
mutants into pSP64T.
8.2.5 Expression of preproricin and mutants in 
Xenopus egg-free extract translation system
8.2.6 Glycosylation and lectin activities of 
recombinant proricin and proricin mutants.
8.2.7 Specific proteolytic cleavage of recombinant 
proricin Xa mutant.
8.3 Discussion.
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8.1 INTRODUCTION
The low yield of soluble recombinant proricin from 
E.coli was discussed in Chapter 7. It was concluded that the 
bacterial expression system was not suitable for expression and 
analysis of proricin and proricin mutants. The greatest success 
obtained in expression of recombinant proricin during this 
study was when preproricin transcripts were injected into 
Xenopus oocytes (Chapter 5). Using this system it was possible 
to synthesise a soluble, radiolabelled, immunoreactive product 
which could be assayed for its biological activities.
Although the technique of oocyte injection requires 
considerable experience to perform it successfully, an 
alternative expression system has recently been developed which 
uses an extract from Xenopus eggs to synthesise recombinant 
radiolabelled protein iji vitro. The egg-free extract is 
prepared from freshly laid eggs and is stored under liquid 
nitrogen until use. Immediately before use it is thawed, 
supplemented (with creatine phosphate, spermidine, tRNA and an 
S-100 preparation from rabbit reticulocyte lysate) and mixed 
with the transcript. ^S-methionine is added to radiolabel 
proteins synthesised during the incubation period and standard 
immunoprécipitation procedures identify immunoreactive 
products.
The aims of the work described in this chapter 
therefore were to assess the uses of this expression system for 
the synthesis of recombinant proricin and proricin mutants so 
that the biological activities of the mutants could be analysed 
before and after proteolytic cleavage. In this way, the 
accessibility of the new linkers to their proteases, the 
substrate specificity of the proteolytic reaction and the 
structure of the A and B subunits (assessed by their biological 
activities and disulphide bonding) can be ascertained.
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8.2
8 .2.1
RESULTS
CLONING OF Xa AND TH MUTANT LINKERS INTO 
pGEMppRCL617.
The pINIIIompA2proricin (wild-type and mutant) 
constructs used in the E.coli expression study in the previous 
chapter, encoded fusion proteins between the bacterial ompA 
signal peptide and the incomplete proricin clone, pRCL617oxl6. 
This meant that the proricin-derived portion of the chimeric 
gene in each case lacked a 5'ATG initiation codon. In order to 
express the Factor Xa/thrombin mutant linkers in a preproricin 
clone containing a eukaryotic signal peptide, it was necessary 
to isolate the 552bp Bglll fragments from the
pINIIIompA2proricinXa and Th mutants and to re-clone these into 
the large Bglll fragment isolated from a full-length
preproricin clone. The construct pGEMppRCL617 (Richardson e£ 
al. 1989), containing the full ricin presequence and which was 
used as the expression vector for the oocyte work described in 
Chapter 5, was therefore cut with Bglll, the large fragment 
phophatased, gel-isolated and ligated with the 552bp Bglll Xa 
and Th mutant linker fragments. Mini prep DNA was prepared from 
ampicillin-resistant colonies and digested with BamHI to 
orientate the Bglll mutant linker fragment (Figure 8.2.1).
Factor Xa and thrombin preproricin mutants were 
identified and large scale caesium chloride purified DNA 
prepared. This DNA was finally sequenced in the region encoding 
the linker in order to confirm the presence of the substituted 
mutations in each case.
8.2.2 IN VITRO EXPRESSION OF PREPRORICIN AND MUTANT
PREPRORICIN CLONES.
The preproricin and mutant preproricin constructs 
described above were orientated in the pGEM-derived vector such 
that transcription was initiated from the T7 promoter. The DNA
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FIGURE 8.2.1 ORIENTATION OF THE 552bp Bglll FRAGMENT IN
pGEMppRCL617Xa and pGEM617PPRCL617Th MUTANTS.
Restriction digest analysis of mini prep DNA 
isolated from colonies transformed with pGEMppRCL617, after 
substituting the 552bp Bglll wild type linker fragment with the 
552bp Bglll Factor Xa and thrombin mutant linker fragments, lug 
DNA was digested with BamHI and fragments were resolved on a 
1.2% agarose (lxTBE) gel. Bands were identified by ethidium 
bromide staining and visualised on a UV transilluminator. Lanes 
1-7 contain DNA from Factor Xa mutants; lanes 8-12 contain DNA 
isolated from thrombin mutants, lug wild-type pGEMppRCL617 DNA 
was also digested with BamHI as a control (C). Lambda markers 
were used to size the fragments (M): sizes are shown in bp. The 
predicted sizes of the DNA fragments from preproricin clones 
with the Bglll fragment inserted in the correct orientation 
(tick) or incorrect orientation (cross) are also shown 
opposite. Clones in lanes 4, 5, 6, 9 and 12 contain the Bglll 
fragment in the correct orientation. Digestions shown in lanes 
1, 10 and 11 have an extra band of approximately 500bp and 
therefore these clones contain two Bglll fragments.
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was first linearised and then each construct was transcribed 
using T7 RNA polymerase. Incorporation of 3H-UTP into RNA 
standardly gave estimated amounts of RNA synthesised of between 
6-8pg per 20jil transcription reaction.
Transcripts encoding preproricin and preproricin 
mutants were then translated in rabbit reticulocyte lysate and 
wheat germ lysate systems (see Figure 8.2.2). All preproricin 
and mutant clones encoded a full-length polypeptide of 64kD 
when translated in wheat germ lysate, confirming that the 
substituted 'Factor Xa' and 'thrombin' fragments had not 
destroyed the reading frame or introduced any opportunistic 
termination codons. The control (preB), consisting of the ricin 
presequence fused to the B chain, also encoded a polypeptide of 
the expected size (32kD) in wheat germ. When translated in 
rabbit reticulocyte lysate a preB chain band of 32kD was 
observed. However, when preproricin transcripts or transcripts 
encoding the preproricin mutants were translated in rabbit 
reticulocyte lysate, no bands were observed in any tracks. This 
result agrees with the results of May (1988) who reported that 
translation of proricin transcripts in reticulocyte lysate was 
toxic: this toxicity is likely to be due to the synthesis of 
small amounts of active A chain-like fragments from the 
preproricin transcript or results from the fortuitous cleavage 
of the preproricin product to yield a proportion of active A 
chain fragments capable of inactivating the rabbit ribosomes. 
Wheat germ ribosomes are 1000 fold less sensitive than 
mammalian (and other non-plant) ribosomes to ricin and 
therefore are capable of translating active A chain 
polypeptides (Rupert Osborn, PhD thesis, Warwick)
This result might suggest that expression of 
proricin in any animal system, including Xenopus sp., would be 
unsuccessful, as the release of active A chain fragments during 
translation of the proricin transcript would arrest further
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FIGURE 8.2.2 IN VITRO EXPRESSION OF FACTOR Xa AND THROMBIN
PREPRORICIN MUTANTS.
Preproricin transcripts and transcripts encoding 
Factor Xa and thrombin preproricin mutants were translated in 
rabbit reticulocyte lysate (lanes 1-5) and wheat germ lysate 
(lanes 6-10) in the presence of ^^S-Methionine. Labelled 
protein was resolved by SDS-PAGE and visualised by 
fluorography.
Lanes 1 and 6: preproricin
, 2 and 7: Factor Xa preproricin mutant
3 and 8: Thrombin preproricin mutant 
U and 9: translation of transcript preB*
5 and 10:no RNA control translation
* - gift from Dr.Richard Wales (Warwick)
expression. However, the results presented in Chapter 5 clearly 
show that expression is successful in systems where the active 
A chain fragments can be segregated away from the ribosomes: in 
the Xenopus oocytes it was assumed that the preproricin signal 
peptide mediated the translocation of any active polypeptide 
species across the ER membrane, where they became sequestered 
in the ER lumen. It was hoped therefore, that any active 
fragments synthesised in the Xenopus egg cell-free would be 
targeted and sequestered into microsomes in a similar way, thus 
enabling further preproricin/mutant expression.
8.2.3 PROTBOLYTIC CLEAVAGE OF IN VITRO SYNTHESISED 
PREPRORICIN AND PREPRORICIN MUTANTS.
Radiolabelled preproricin and mutant preproricin 
synthesised in vitro in wheat germ lysate were then incubated 
with various quantities of Factor Xa and thrombin enzymes, to 
determine whether specific cleavage could be demonstrated in 
vitro. The activity of the Factor Xa enzyme was first checked 
by incubation of an aliquot with its physiological substrate 
prothrombin, followed by SDS-PAGE analysis. This confirmed that 
the enzyme was active. It was not possible to check the 
activity of the thrombin enzyme however, as SDS-PAGE analysis 
revealed that the commercially-available fibrinogen (the 
physiological substrate of thrombin) was heavily contaminated 
with processed fragments. The thrombin e n z y m e  was therefore 
purchased, stored and used exactly as described by Smith and 
Johnson (1988).
Figure 8.2.3A shows the result of incubating 
preproricin, preproricinXa and preproricinTh with increasing 
amounts of the appropriate proteolytic enzyme. When preproricin 
and preproricinXa were digested with Factor Xa, two bands 
appeared which matched the sizes of fragments predicted for the 
specific cleavage of the linker (i.e. 34.5kD and 29.4kD). This
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FIGURE 8.2.3 PROTEOLYTIC CLEAVAGE OF IN VITRO SYNTHESISED 
PREPRORICIN MUTANTS.
A/ 3^S-Methionine labelled Factor Xa (Xa) and thrombin 
(Th) preproricin mutants, synthesised in vitro in a wheat germ 
lysate, were incubated with different amounts of the 
appropriate enzyme for 60min at 26C in lx TEN buffer. Wild type 
preproricin (ppr) was used as a control. Fragments were 
resolved by SDS-PAGE and visualised by fluorography.
B/ -*!>S-Methionine labelled preproricin and Factor Xa 
preproricin mutant, synthesised Ln vitro in wheat germ lysate, 
were digested with 0.1 vol (lanes 2-4) or 0.05 vol (lanes 5-7) 
Factor Xa at 26C in lx TEN buffer, for lOmin (lanes 2 and 5), 
30min (lanes 3 and 6), or 60min (lanes 4 and 7). Control 
digestions were performed in lx TEN for Omin (lane 1) or 60min 
(lane 8)in the absence of Factor Xa in the absence of Factor 
Xa. Arrows refer to proteolytically-cleaved products.
was as expected for the mutant containing the Factor Xa 
recognition sequence. However, the wild-type control should not 
have been cleaved in the linker region. The predicted amino 
acid sequence of wild-type preproricin was then inspected 
around the linker region (see Appendix A), to identify arginine 
residues which may be cleaved 'non-specifically' by Factor Xa. 
These are listed below with the predicted sizes of the 
fragments produced by cleavage at each position.
Arg274_vai// 34,500 + 29,500
Arg258-Cys 32,500 + 31,600
Arg2^2-Pro 34,300 + 29,700
Arg291_ne 36,800 + 27,300
Arg2^^-Asn 37,300 ♦ 26,800
(# = predicted site of Factor Xa cleavage in Xa mutant)
Cleavage at only one of these sites would result in
fragments of the sizes seen in Figure 8.. 2.3A. However,
trypsin-like proteases do not usually cleave peptide bonds
where the carboxyl residue is proline. It is therefore unlikely 
that non-specific cleavage occurs at this position. 
Furthermore, cysteine, proline and asparagine residues are not 
found on the carboxyl side of known Factor Xa cleavage sites 
(see Nagai and Thogerson, 1984). Wearne (1990) has reported 
non-specific Factor Xa cleavage of Lys-X peptide bonds in 
fusion proteins. However, there are no lysine residues within 
30 amino acid residues of the linker in either direction.
Factor Xa digestion of the wild-type and mutant was 
then followed over a time course to determine whether the 
specific cleavage at the Factor Xa recognition site in the 
mutant and the non-specific cleavage of the wild-type could be 
resolved (Figure 8.2.3B). However, there was no distinguishable 
difference between the rates of appearance of the fragments in 
either the wild-type or the mutant. This observation therefore 
remains unexplained.
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When thrombin digestions were studied, no specific 
cleavage of the wild-type or thrombin mutant was observed at 
any concentration of the enzyme (Figure 8.2.3A). In tracks were 
relatively large amounts of the enzyme were used, deformation 
of the 64kD preproricin (or mutant preproricin) band was seen 
due to the high amounts of bovine serum albumin (66kD) present 
in the Sigma thrombin preparation.
In the highly reducing, membrane-free wheat germ in 
vitro expression system the proricin synthesised is 
unglycosylated, and has no disulphide bonding. It is likely 
therefore that its conformation is unlike native proricin from 
the plant. The linker region in the wheat germ-synthesised 
products may not be accessible to the protease enzymes. This 
may explain why the results obtained above were not as expected 
and why expression in Xenopus egg cell-free extract, where the 
preproricin should be glycosylated, disulphide-bonded and 
segregated into ER-derived microsomes, was desirable.
8.2.4 CLONING OF PREPRORICIH AND PREPRORICIN MUTANTS INTO 
pSP64T.
When preproricin transcripts, synthesised iii vitro 
from pGEMPPRCL617, were translated in the Xenopus egg-free 
translation system, immunoprecipitated recombinant proricin was 
only visible as faint bands on autoradiographs after long film 
exposures ( > one month at -70C). The fluorograph showing the 
optimisation of the egg cell-free translation system for the 
preproricin transcript (Figure 8.2.5A) is an example of the 
long exposures necessary to visualise bands when using 
pGEMppRCL617-derived transcripts (1 month exposure).
It was therefore decided necessary to re-clone the 
preproricin and preproricin mutant genes from the pGEM-derived 
constructs into the high expression transcription vector, 
pSP64T (Krieg and Melton, 1984: Appendix C for map). This
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vector was introduced in Chapter 6, where the pSP64T-derived 
construct, pSP64Tproricin, was used to synthesise proricin in 
vitro. The vector has 5' and 3' untranslated regions of Xenopus 
beta-globin DNA that have been shown to increase the level of 
expression of genes cloned into the Bglll site situated between 
them (Krieg and Melton, 1984).
In each case a 1.7kb Xhol / EcoRI fragment, 
containing the wild-type/mutant preproricin clone, was isolated 
from its pGEM-derived construct and the 5' and 3' cohesive 
termini blunted using the Klenow fragment of DNA polymerase. 
This fragment was then cloned into pSP64T, after Bglll 
restriction and blunt-ending of the vector. Mini prep DNA was 
prepared from ampicillin-resistant colonies and a clone was 
selected which contained a single copy of the preproricin gene 
in the correct orientation for SP6 transcription. The 
restriction digest of a pSP64Tpreproricin clone is shown in 
Figure 8.2.4.
Finally, large scale caesium chloride purified 
plasmid preparations of each clone were prepared and plasmid 
sequenced to confirm the presence of the correct (wild-type or 
mutant) linker sequence.
8.2.5 TRANSLATION OF TRANSCRIPTS ENCODING PREPRORICIN AND
PREPRORICIN MUTANTS IN XENOPPS EGG-FREE EXTRACT.
Transcripts were prepared from SP6 in vitro 
transcription of (EcoRI) linearised pSP64Tpreproricin/mutant 
constructs. These were then translated in egg cell-free 
extracts and, in each case, a radiolabelled recombinant product 
of the predicted size was identified after immunoprécipitation, 
SDS-PAGE and 1 week exposure to film (Figure 8.2.5). From this 
it was concluded that all constructs expressed a full-length 
polypeptide which could be visualised after relatively short 
exposure to film.
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FIGURE 8.2.4 CORRECT ORIENTATION OF PREPRORICIN CLONE 
PPRCL617, IN pSP64T.
Restriction digest analysis of pSP64Tpreproricin 
(lanes 1-4) and pSP64T (lanes 5-8). ljjg of DNA was digested 
with Hindlll (lanes 2 and 6), Hindlll and Clal (lanes 3 and 7), 
or EcoRI (lanes 4 and 8). Fragments were resolved on a 1 % 
agarose (lx TBE) gel, identified by ethidium bromide staining 
and visualised on a UV-transilluminator. lug of uncut DNA was 
run as a control (lanes 1 and 5).
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FIGURE 8.2.5 SYNTHESIS OF PRORICIN AND FACTOR Xa/THROMBIN 
PRORICIN MUTANTS IN XENOPUS EGG CELL-FREE TRANSLATION SYSTEM.
A/ Optimisation of system for transcript.
Preproricin transcript was translated in 30jil egg 
cell-free extract for 2 hours at 21C in the presence of 25uCi
O C  'JJS-methionine. Recombinant proricin was immunoprecipitated 
using rabbit anti-B chain antisera. Immunoprecipitated (lanes 
1-5) and non-immunmoprecipitated (lanes 6-10) proteins were 
resolved by SDS-PAGE and visualised by fluorography.
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B/ Egg cell-free translation of preproricin, Factor Xa
and thrombin preproricin mutant transcripts.
lug of transcripts, synthesised in vitro and 
encoding preB (lane 1), preproricin (lane 2), Factor Xa mutant 
preproricin (lane 3) and thrombin mutant preproricin (lane 4), 
were translated for 2 hours at 21C in 30jil egg extract in the 
presence of 25pCi ^S-methionine. Proricin was
immunoprecipitated using rabbit anti-B chain antisera; bands 
were resolved by SDS-PAGE and visualised by fluorography.
A
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Although the same amount of RNA was added to each 
translation reaction, the levels of expression of the wild- 
type, the mutants and the preB control appeared different 
(compare intensities of bands in lanes 1,2,3 and 4 in Figure 
8.2.5B). Since the lpg of the preB transcript (l.Okb) contains 
almost twice as many molecules as the same amount of 
preproricin RNA (1.8kb) and also, as the rate of synthesis for 
a 30kD protein should be twice as fast as the the rate of 
synthesis for a 60kD protein, it is possible to account for the 
difference between the intensities of the preB and proricin 
bands. However, the order of expression, PPR > Xa > Th, could 
not be easily explained. In all further experiments, using 
different DNA and RNA preparations, this order of expression 
was maintained.
Another observation made when translating these RNAs 
in egg cell-free extracts, was that two immunoreactive bands of 
similar molecular weight were resolved (seen clearly in Figure 
8.2.5A). This could either represent signal peptide-processed 
and unprocessed forms of preproricin or two different 
glycosylated forms of microsome-segregated proricin. This was 
investigated in more detail in the next section.
8.2.6 GLYCOSYLATION AND LECTIN ACTIVITY OF PBOKICIN AND 
PRORICIN MDTANTS.
The preproricin and preproricin mutant transcripts 
encode proteins with a signal peptide which, in the case of 
wild-type preproricin expressed in Xenopus oocytes (Chapter 5), 
mediates its co-translational translocation across the ER- 
membrane where asparagine-linked glycosylation takes place, on 
the glycosylation sites in the A and B chains. The signal 
peptide is cleaved and the glycosylated proricin is sequestered 
in the ER-lumen. In this form, the oocyte-synthesised 
recombinant proricin was shown to possess lectin activity.
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In order to determine whether the egg cell-free 
translation system co-translatlonally glycosylates the 
preproricin and preproricin mutants, one aliquot of the 
immunoprecipitated protein in each case, was digested with N- 
acetylglucosaminidaseH (endoH). This enzyme specifically 
removes all but the N-acetylglucosamine moiety from asparagine- 
linked core oligosaccharide side chains on glycoproteins such 
as those sequestered in the ER lumen. When the endoH-treated 
immunoprecipitated protein was analysed by SDS-PAGE and 
compared to untreated protein, a shift was observed (see lanes 
7 and 8: Figure 8.2.6). As was observed in section 8.2.5 above, 
the immunoprecipitated protein translated from the preproricin 
(mutant) transcript could be resolved into two bands. However, 
in endoH-treated tracks, a single band was observed. This band 
was lower in molecular weight than the bands in the untreated 
sample, indicating that the latter represented different 
glycosylated forms of proricin and not, as was suggested above, 
processed versus unprocessed forms of preproricin. The wild- 
type, Factor Xa and thrombin mutants appear to be co- 
translatlonally translocated across the ER-membrane and N- 
glycosylated in this system. Protease protection experiments 
would have been necessary to confirm this.
In order to test the lectin activity of the proricin 
and proricin mutants synthesised in the egg cell-free extract, 
the translation mix was diluted in oocyte homogenisation buffer 
(to solubilise the microsomal membranes) before loading onto a 
SeLectin™ column. This column contains lactose immobilised 
onto polyacrylamide beads and was used for the single-step 
purification of recombinant proricin synthesised in oocytes 
(Chapter 5). Unbound proteins were eluted and the column washed 
thoroughly in buffer, before eluting any bound protein with 
lOOmM lactose.
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FIGDRE 8.2.6 LECTIN ACTIVITY AND GLYCOSYLATION OF 
RECOMBINANT PRORICIN AND PRORICIN MUTANTS SYNTHESISED IN 
XENOPUS EGG CELL-FREE EXTRACT.
Labelled protein from a 60}il egg-free translation 
reaction, containing 2pg transcript and 50jiCi ^^S-methionine, 
was diluted in oocyte homogenisation buffer and passed three 
times down a 2ml SeLectin™ column. The column was then washed 
with 3x 0.5ml oocyte homogenisation buffer before eluting the 
bound protein with 2x 0.5ml lOOmM lactose. Proricin (gel A), 
Factor Xa mutant proricin (gel B), and thrombin mutant proricin 
(gel C) was immunoprecipitated from each fraction using rabbit 
anti-B chain antisera, resolved by SDS-PAGE and visualised by 
fluorography (lanes 1- 10% of total unbound protein, before 
immunoprécipitation; 2- 90% of total unbound protein, after 
immunoprécipitation; 3“ 1st fraction of wash; 4- 2nd fraction 
of wash; 5- 1st fraction of lOOmM lactose wash; 6- 2nd fraction 
of lactose wash). Also, immunoprecipitated recombinant proricin 
from a 30jil egg-free translation was divided into two equal 
aliquots and half was incubated overnight with 2.5mU endoH 
before loading on the gel (lanes 7-untreated; 8-endoH treated). 
An aliquot of immunoprecipitated recombinant B chain was also 
endoH treated as a control (gel B: lanes 9-untreated; 10-endoH 
treated).
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Figure 8.2.6 shows the total unbound protein (lanel) 
and the proricin immunoprecipitated from each of the fractions 
eluted from the column (lanes 2-6). In each case, approximately 
50% of the total immunoprecipitated (mutant) proricin did bind 
to the column and was eluted in the lOOmM lactose. It was 
therefore concluded that 50% of the proricin, Factor Xa mutant 
and thrombin mutant synthesised in the egg-free extract 
possessed a functional B chain with sugar-binding (lectin) 
properties.
8.2.7 SPECIFIC PROTEOLYTIC CLEAVAGE OF RECOMBINANT
PRORICIN Xa MUTANT.
Sufficient amounts of the radiolabelled recombinant 
proricin Xa mutant were synthesised in the egg cell-free 
translation system to enable a digestion of the 
immunoprecipitated protein with Factor Xa. Therefore, both 
wild-type and Xa mutant were digested for'60min with various 
amounts of Factor Xa. Figure 8.2.7 shows that the mutant Xa 
proricin was specifically cleaved into two fragments, one of 
which was the same size as glycosylated B chain (Figure 8.2.7: 
lane 9). Some non-specific cleavage was identified in both 
wild-type and mutant tracks, but the two strongest bands in the 
Xa mutant tracks were unique to this mutant, of the predicted 
size for ricin A and B chains, and were therefore caused by 
specific cleavage at the Factor Xa recognition site in the 
mutated linker region.
Time did not allow for any further investigations.
8.3 DISCUSSION.
The Factor Xa and thrombin mutant linkers were 
cloned successfully into a full-length preproricin clone, and 
wild-type/Xa/Th preproricin were all expressed in vitro. 
Translation in rabbit reticulocyte lysate was not successful,
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FIGURE 8.2.7 SPECIFIC CLEAVAGE OF IMMUNOPRECIPITATED 
RECOMBINANT FACTOR Xa MUTANT PRORICIN.
Immunoprecipitated recombinant proricin (lanes 1-4) 
and Factor Xa mutant proricin (lanes 5-8), synthesised in a 
Xenopus egg-free system, was incubated with O.lx volumes (lanes 
2 and 6), 0.2x volumes (lanes 3 and 7) or 0.5x volumes (lanes 4 
and 8) Factor Xa, for 60min. at 26C in lx Factor Xa buffer. 
Immunoprecipitated protein was also incubated as above but in 
the absence of any enzyme (lanes 4 and 8). Fragments were 
resolved by SDS-PAGE and were visualised by fluorography. 
Immunoprecipitated recombinant ricin B chain synthesised in the 
same system (lane 9) and an aliquot of non-immunoprecipitated 
proteins from the factor Xa translation (lane 10) was also 
loaded.
presumably due to the release of active A chain-like fragments 
during the translation of the preproricin transcripts, which 
inactivated the rabbit ribosomes. Translation in wheat germ 
lysate was successful however, as wheat germ ribosomes are 
known to be lOOOx fold more resistant to RIPs than mammalian 
ribosomes. In the wheat germ lysate wild-type and mutant 
preproricin polypeptides, all identical in size, were 
synthesised. This confirmed that the cloning and mutagenesis 
steps had not introduced any opportunistic stop codons in the 
mutants.
When the preproricin mutants were incubated in vitro 
with the appropriate endoprotease (Factor Xa or thrombin), only 
in the preproricin Xa mutant was any proteolysis observed. 
Bands of the predicted size for cleavage of the linker region 
(34kD and 29kD) were observed. However, Factor Xa cleavage of 
the wild-type preproricin was also observed under the same 
conditions which yielded fragments indistinguishable in size 
from the fragments released from the Factor Xa digestion of the 
Xa mutant. It was suggested that non-specific Factor Xa 
cleavage of the wild-type preproricin was caused because the 
conformation of the wheat germ synthesised product is likely to 
differ to the native precursor, possibly occluding access of 
the enzyme to the linker and exposing other regions of the 
protein. It was hoped that translation of preproricin mRNA in 
an expression system containing ER-derived membranes, such as 
the Xenopus egg cell-free extract, would produce a proricin 
protein that was folded into a more native-like conformation.
Expression of the wild-type preproricin transcript 
in a Xenopus egg cell-free translation system produced a 
labelled polypeptide of the expected size for glycosylated 
proricin. However, the levels of expression were very low. It 
is possible that this was due to the release of active A chain 
moieties which inactivated the Xenopus ribosomes. However,
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other workers have reported dramatic increases in gene 
expression in Xenopus systems by re-cloning of genes from pGEM- 
derived vectors into pSP64T (Krieg and Melton, 1984). This 
vector contains the 5' and 3' untranslated regions from Xenopus 
beta-globin, which are thought to stabilise transcripts of 
foreign genes cloned into the vector. It was therefore decided 
to re-clone the wild-type/Xa/Th preproricln genes from 
pGEMppRCL617 into pSP64T.
The wild-type and mutant preproricin clones were 
successfully re-cloned into pSP64T. They were plasmid sequenced 
to confirm the sequences of the linkers in each construct. 
Transcripts were synthesised In vitro and translated 
successfully in the egg cell-free extract. As predicted, the 
proricin immunoprecipitated from this experiment could be 
visualised after 1-7 days exposure, as opposed to the one month 
exposures required for visualisation of the immunoprecipitated 
products encoded by pGEM-derived transcripts. No direct 
comparisons were made between the levels of proricin expression 
from the two types of transcript, however.
In the egg cell-free system experiments the bands 
visualised for the wild-type and mutant proricin polypeptides 
were identical in size, but not intensity. The 
immunoprecipitated Xa preproricin mutant was more intense than 
the Th preproricin mutant, but was less intense than the wild- 
type. However, both the wild-type and the mutants were N- 
glycosylated and possessed B chain lectin activity. This is 
evidence that the amino acid sequence of the Xa and Th mutant 
linkers did not disrupt the functional folding of the B chain.
Only in the case of the Xa preproricin mutant was 
expression sufficient to enable a preliminary investigation of 
the specific Factor Xa cleavage of the mutant linker. The 
mutant was cleaved into two fragments of approximately 34kD and 
32kD by Factor Xa digestion with two out of the three enzyme
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volumes used. In the Factor Xa digestions where fragments were 
visualised, the 34kD fragment appeared the same size as B chain 
translated from the preB transcript in the same egg cell-free 
system. At the highest enzyme concentration used (0.5volumes 
added) no fragments were seen after one hour's incubation. No 
explanation for this result has been given.
No corresponding fragments of 32kD and 34kD were 
visualised when the immunoprecipitated wild-type proricin was 
digested with Factor Xa under the same conditions. From this it 
was concluded that the fragments were produced by specific 
cleavage of the Xa proricin mutant. This result also shows that 
the non-specific cleavage of the wild-type proricin observed in 
the protease digestions of the wheat germ-synthesised 
polypeptide, can be resolved from the specific cleavage of the 
Xa proricin mutant in this system. This lends weight to the 
argument that the conformation of proricin synthesised is 
different in the two systems.
The problems encountered with the low levels of 
expression of the wild-type/mutant preproricin transcripts in 
this system, requiring time-consuming re-cloning of the clones 
from pGEMl into an alternative iji vitro transcription vector 
(pSP64T), restricted the endoprotease studies to the single 
experiment shown in Figure 8.2.7. The Factor Xa specific 
cleavage of the Xa proricin mutant needs further 
characterisation. For instance, there is currently no direct 
evidence to support the assumption that the fragments observed 
by digestion of the mutant are indeed the A chain and B chain 
subunits. Furthermore, it is desirable to show that these 
fragments are disulphide-linked, as is the case in mature, 
native ricin. Also, the protease digestion was performed on 
immunoprecipitated protein: the bound antibody molecules may in 
fact hinder the access of the enzyme to the linker region and 
so limit the rate of cleavage. It may be preferable to digest
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the proricin mutant before immunoprecipitating any of the 
fragments produced.
A possible strategy for investigating these 
questions is to pass the crude egg cell-free translations down 
a SeLectin™ (as in Section 8.2.6). In this way the bound Xa 
mutant proricin is purified from the other labelled proteins 
and can be eluted in lx TEN buffer made lOOmM lactose. The 
purified mutant can then be digested with Factor Xa, before 
dividing the reaction in three. Two aliquots are reduced by 
addition of beta-mercaptoethanol before immunoprecipitating 
with either anti-A chain or anti-B antisera. The 
immunoprecipitated polypeptides could then be resolved by SDS- 
PAGE. The third aliquot is imraunoprecipitated with a mixture of 
anti-A chain and anti-B chain antisera and then aliquots of the 
immunoprecipitated protein resolved by SDS-PAGE under reducing 
and non-reducing conditions.
Such an approach would identify the fragments 
produced as A chain-like or B chain-like, since each antiserum 
should only immunoprecipitate its corresponding fragment. Also, 
by running immunoprecipitated aliquots under reducing and non­
reducing conditions, any fragments which are linked by a 
disulphide bond will only be resolved from the full-length 
uncleaved proricin, under reducing conditions.
This approach might also enable an investigation 
into the thrombin-specific cleavage of the Th proricin mutant 
synthesised in the egg cell-free system. This mutant was only 
expressed at very low levels (compare Figure 8.2.6; A and C). 
However, selective binding to a SeLectin™ column would enable 
the Th proricin mutant protein synthesised from a number of 
translations to be concentrated. This would allow further 
investigations to be performed.
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Intracellular protein sorting has been an area of 
Intense study for cell biologists In recent years. The yeast 
Saccharomyces cerevlsae has been the model system, with its 
useful genetics enabling the identification and 
characterisation of components of the sorting pathway such as 
BiP, ER retention signals and vacuolar targeting signals. This 
raised the possibility of looking for a plant vacuolar 
targeting signal by expression of a plant storage protein in 
transgenic yeast. However, work by Chrispeels and his 
colleagues on the targeting of PHA/invertase hybrids in 
transgenic yeast suggests that the sorting machinery in higher 
plants has evolved such that the two systems are not 
compatible. The answer has been to use transgenic tobacco to 
delineate the elusive plant vacuolar targeting signal.
Two regions of plant proteins have been focussed on. 
Chrispeels and Tague (1990) suggest that regions within the 
mature domains of some plant storage proteins which resemble 
the tetrapeptide QRPL yeast vacuolar targeting signal may be 
involved in targeting to the vacuole. In support of this, 
Sabastiani ej: ¿1 (1991) have most recently identified 9 regions 
of primary sequence homology within the mature domains of the 
7S-lectins (one of which was the region identified by 
Chrispeels and Tague) which, they suggest, may combine in the 
folded protein to form a 3D signal patch.
On the other hand, the precursor forms of sporamin 
(Matsuoka and Nakamura, 1991), barley lectin (Bednarek ejt al. 
1990), wheat germ agglutinin (Chrispeels and Raikhel, 1991) and 
the basic isoforms of B-l,3-glucanases from tobacco (Shinshi et 
al, 1988) all have propeptides vhich have been implicated in 
vacuolar targeting. This would suggest that the vacuolar 
targeting signal is not held within the mature domain of these 
proteins. Interestingly, work at Warwick and in Milan on the
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type I RIPs dianthin-30 (from carnation leaves) and saporin S0- 
6 (from the leaves of Saponaris officialis) has recently 
identified C-terminal propeptides which bear a striking 
resemblance to the propeptides of barley lectin and tobacco B- 
1,3-glucanase (Giuseppe Legname and Marco Soria, personal 
communications). It has yet to be established whether dianthin- 
30 and saporin SO-6 are localised in the vacuole, but it is 
tempting to speculate that their C-terminal extensions contain 
vacuolar targeting information.
Ricin and other type II RIPs have evolved by 
association of ancestral genes encoding a type I RIP and a 
lectin-like protein. The homology comparisons of Chrispeels' 
and Sebastiani's groups on plant storage proteins would suggest 
that the vacuolar targeting information is held within the 
mature protein. However, the close homologies of type I RIPs 
(to which ricin A chain is evolutionarily related) to other 
vacuolar proteins favours a propeptide-localised signal. 
Evidence for the presence of an N-terminal propeptide on 
proricin has been presented in this thesis. Furthermore, 22aa 
residues of the N-terminal presequence from preproricin were 
sufficient to function as an ER-signal peptide when fused to 
npt2 and expressed in vitro. However, the full 35aa residue 
ricin presequence did not cause retention of npt2 when 
ricin/npt2 chimeras were expressed transiently in tobacco plant 
protoplasts. This data would suggest that the ricin presequence 
alone does not function as a vacuolar targeting signal. 
Transient expression studies are currently underway at Warwick 
using presequence-A chain constructs to determine whether the 
vacuolar targeting signal is held within the A chain domain of 
proricin.
Plant storage proteins are transported through the 
endomembrane system in a precursor form, maturation only
236
occurring after deposition at their final subcellular 
destination - the protein bodies. The processing of many plant 
storage protein precursors is thought to involve asparagine- 
specific proteolytic cleavage. An assay was therefore designed 
to enable purification of the proricin processing enzyme from 
castor bean. The results showed that purification of the enzyme 
using this system was not possible however; the dry castor bean 
seeds containing low levels of activity and high levels of 
toxic endogenous ricin (which was co-purified with the enzyme 
activity in the protein body matrix fraction). The in vitro 
synthesised proricin also was sub-optimal for use as an enzyme 
substrate. SDS-PAGE analysis showed that it contained 
radioactive bands covering the whole range of molecular weights 
up to the full-length proricin polypeptide.
Questions were also raised as to the use 
unglycosylated, non-covalently folded proricin as a substrate 
for the processing enzyme. It is unlikely that the conformation 
of proricin synthesised in this way resembles the conformation 
of native proricin, which folds in the oxidising environment of 
the ER lumen. Support for this comes from another area of the 
thesis. The Factor Xa proricin mutant, synthesised in wheat 
germ lysate, appeared to be cleaved non-specifically when 
digested with Factor Xa (both the wild-type and mutant proricin 
were cleaved: see Figure 8.2.3). However, when the wild-type 
proricin and Factor Xa mutant were synthesised in Xenopus egg 
cell-free extract, preliminary data showed Factor Xa-specific 
cleavage of the mutant only. This demonstrates that the 
synthesis of the same polypeptide in different systems can 
alter its use as an enzyme substrate.
Nishimura and colleagues have reported the 
purification of a storage protein processing enzyme (Nishimura 
and Nishimura, 1991). The publication of a purification
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strategy and details of the characteristics of this enzyme are 
eagerly awaited.
Expression of a recombinant proricin in heterologous 
systems was hindered by the potent toxicity of ricin. Although 
recombinant proricin per se was shown to possess no RNA N- 
glycosidase activity when expressed in Xenopus oocytes (the B 
chain was shown, on the other hand, to be biologically active), 
A chain-sized fragments were produced which were active and 
depurinated rabbit reticulocyte ribosomes. The inability to 
express preproricin/proricin transcripts successfully in rabbit 
reticulocyte lysate has been attributed to the inadvertent 
synthesis of toxic A chain-like fragments from the 
(pre)proricin message which inactivate the ribosomes and 
prevent further translation of the full-length precursor 
moiety. Finally, the potential for the release of active forms 
of a recombinant type II RIP, restricted the E.coli expression 
studies of proricin to HSE Category IV conditions. This 
ultimately prevented a thorough study into the potential of 
E.coli periplasmic expression for production of recombinant 
proricin and mutant proricin proteins.
The ability of the A chain to stabilise the B chain 
in aqueous solution made expression of a recombinant, linker- 
cleavable proricin desirable. Expression of preproricin in 
Xenopus oocytes provides a system whereby the recombinant 
protein can be N-glycosylated and segregated into the oxidising 
environment of the ER-lumen. Using expression in a Xenopus egg 
cell-free extract it was possible to synthesise proricin 
mutants, with linkers containing either a Factor Xa or thrombin 
recognition sequence. These proteins were glycosylated in a 
similar way to wild-type proricin and the B chain domains of 
both mutants possessed lectin activity. Unfortunately, in order 
to increase the expression of the preproricin and preproricin
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mutant clones in this system to a workable level, it was 
necessary to perform time-consuming cloning steps to transfer 
the preproricin (mutant) clone from a pGEM-derived vector into 
the high expression vector pSP64T. However, a preliminary 
experiment on the recombinant Factor Xa proricin mutant 
synthesised in the egg cell-free system suggests that specific 
proteolytic cleavage of the linker is possible. Further 
experiments are in progress to further characterise these 
proricin mutants in order to assess their potential use for the 
synthesis of recombinant toxins.
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APPENDIX A
cDNA SEQUENCE AND DEDDCED PROTEIN SEQOENCE OF PREPRORICIN.
(original sequence from Lamb a^, 1985)
The cDNA sequence of preproricin, published by Lamb £t al^  
(1985), was found to be an incomplete clone upon comparison of 
the sequence to that of a preproricin genomic clone (Hailing 
al, 1985). The cDNA clone lacked a single methionine 
(initiation) codon at its 5' end.
The amended cDNA sequence, shown opposite, encodes a 
single polypeptide precursor form of ricin (preproricin). The 
deduced primary amino acid sequence is shown below the DNA 
sequence. This precursor consists of a 35 amino acid residue N- 
terminal region, a 267 amino acid residue A chain region, 12 
residue linker peptide and a 241 amino acid residue region 
corresponding to the mature B chain. The N-terminal region and 
12 amino acid linker peptide (both highlighted by dashed lines 
in parentheses) are not present in the mature protein. 
Potential sites for Asparagine-linked glycosylation are boxed.
All clones described in the text as "preproricin" 
contain the full-length gene described here and thus 
translation is initiated from the ATG codon at position -105. 
The construct, pSP64Tproricin (used as a source of substrate 
for the protein body-localised castor bean endoprotease) 
contains an incomplete 5' region beginning at position -75 and, 
therefore, expression of this derivative of preproricin uses 
the ATG codon at position -72 to initiate translation. The 
construct pINIIIompA2proricin (used for E.coli expression of 
proricin) contains an incomplete cDNA clone beginning at 
position +10. It therefore lacks the entire N-terminal region 
and the first 3 residues of the A chain.
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-105 -100
-CTCGACC ATG AAA £CG
GCA AGA AAT ACT ATT GTA ATA TGG ATG TAT GCA OTC GCA ACA TGG CTI TGT l'i'1 GGA -CC ACC TCA GGC TGC TCT TTC ACA i *A uAo 
Gly Gly Asn Thr II« V»1 11« Trp 'tec Tvr Ala Val Ala Thr Trp Leu Cys Phe Cly Ser Thr Ser Gly Trp Set Phe Thr Leu G.u
GAT AAC 
ASP Asn
<rrr ogc
Val Arg
Atr TTA 
lie Ceu
AAT ACC 
Asn Set
GCC ITT 
Ala Phe
AAC ATA TIC CCC AAA CAA TAC CCA ATT ATA AAC TTT ACC ACA GOG GGT GCC ACT CTC CAA ACC TAC ACA AAC TTT ATC ACA GCT 
Asn lie Phe Pro Lys Gin Tyr Pro lie lie AjSn Phe ffirlThr Ala Gly Ala Thr Val Gin Ser Tyr Thr Asn Phe lie Arg Ala
GCT OCT TTA ACA ACT GGA GCT GAT CTG 
Gly Arg Leu Thr Thr Gly Ala Asp Val
30
200
GTT GAA CTC TCA AAT CAT GCA GAG CIT 
Val Glu Leu Ser Asn His Ala Glu Leu 
40 Gin
GCA TAT ITC TTT CAT CCT GAC AAT CAC 
Aja Tyr Phe Phe His Pro Asp Asn Gin
GGT GGT AAT TAT GAT AGA CIT GAA CAA 
Gly Gly Asn Tyr Asp Arg Leu Glu Gin
tfC TCA 
[le Ser
GOG CTT TAT TAT TAC AGT ACT GGT GGC 
Ala Leu Tyr Tyr Tyr Ser Thr Gly Gly
ACA CAT GAT ATA CCA GTG TTG CCA AAC AGA GTT GGT TTG CCT ATA AAC CAA GGG TTT
Arg His Asp lie Pro Val Leu Pro Asn Arg Val Gly Leu Pro lie Asn Gin Arg Phe
40 Glu 40 ISO
TCT GTT ACA TTA GCC CTG GAT GTC ACC AAT GCA TAT GTG GTC GGC TAC OCT GCT GGA
Ser Val Thr Leu Ala Leu As d  Val Thr A sn  Ala Tyr Val Val Gly Tyr Arg Ala Gly
^ Ser •<>
300 3SO
GAA GAT GCA GAA GCA ATC ACT CAT CTT TTC ACT GAT GTT CAA AAT OGA TAT ACA TTC
Glu Asp Ala Glu Ala lie Thr His Leu Phe Thr Asp Val Gin Asn Arg Tyr Thr Phe,0 "•.  .CTT GCT GGT AAT CFG AGA GAA AAT ATC GAG TTG GGA AAT GGT CCA CIA GAG GAG GCT
Leu Ala Gly Asn Leu Arg Glu Asn He Glu Leu Gly Asn Gly Pro Leu Glu Glu Ala
500
ACT CAG CTT CCA ACT CTG GCT OGT TCC TTT ATA ATT TGC ATC CAA ATG ATT TCA GAA
Thr Gin Leu Pro Thr Leu Ala Arg Ser Phe He He Cys He Gin Met lie Ser Glu
OCA GCA AGA TTC CAA TAT ATT GAG GGA GAA ATG OGC AOG AGA ATT AGG TAC AAC OGG AGA TCT GCA CCA GAT OCT ACC GTA ATT ACA CT7
Ala Ala Arg Phe Gin Tyr He Glu Gly Glu Met Arg Thr Arg lie Arg Tyr Asn Arg Arg Ser Ala Pro Asp Pro Ser Val He Thr Leu
,•0 ,4°  200
•SO  POO
GAG AAT ACT TGG GGG AGA CIT TCC ACT GCA ATT CAA GAG TCT AAC CAA GGA GCC TTT GCT ACT OCA ATT CAA CTG CAA AGA OGT AAT GGT
Glu Asn Ser Trp Gly Arg Leu Ser Thr Ala He Gin Glu Ser Asn Gin Gly Ala Phe Ala Ser Pro He Gin Leu Gin Arg ArglAsn Gly**° 2,0 —  A«»
r?° . . . too
TCC AAA TTC AGT GTC TAC GAT (JIG ACT ATA TTA ATC CCT ATC ATA GCT CTC ATG GTG TAT AGA TGC GCA CCT OCA OCA TGC TCA CAC TIT
- ¿¿g Lys Phe Ser Val Tyr Asp Val Ser He Leu He Pro lie He Ala Leu Met Val Tyr Arg Cys Ada Pro Pro Pro Ser Ser Gin Phe
ISO
TCT TTG CTT ATA AGG CCA GTG GTA CCA AAT ITT AAT GCT GAT CTT TGT ATG GAT CCT GAG CCC ATA GTG CGT ATC CTA GGT OGA AAT GGT
Ser Leu Leu lie Arg Pro Val Val Pro Asn Phe Asn Ala Asp Val Cys Met Asp Pro Glu Pro He Val Arg He Val Gly Arg Asn Gly......................................................................... . **° 240
90°  990
CTA TCT GTT GAT GTT AGG GAT GGA AGA TTC CAC AAC GGA AAC GCA ATA CAG TTG TGG CCA TGC AAG TCT AAT ACA GAT GCA AAT CAG CTC
i Cys Val Asp Val Arg Asp Gly Arg Phe His Asn Gly Asn Ala lie Gin Leu Trp Pro Cys Lys Ser Asn Thr Asp Ala Asn Gin Leu
—  —  Asn His ** ”°leu ( joo Asn
TOG ACT TTG AAA AGA GAC AAT ACT ATT OGA TCT AAT GGA AAG TGT TIA ACT ACT TAC GGG TAC ACT COG GGA GTC TAT GTG ATG ATC TAT
Trp Thr Leu Lys Arg Asp Asn Thr He Arg Ser Asn Gly Lys Cys Leu Thr Thr Tyr Gly Tyr Ser Pro Gly Val Tyr Val Met lie Tyr
330 mo Pro Ser
u p o  # # # .  11«0
GAT TGC AAT ACT GCT GCA ACT GAT GCC ACC OGC TGG CAA ATA TGG GAT AAT OGA ACC ATC ATA AAT CCC AGA TCT AGT CTA GTT TTA GCA
Asp Cys Asn Thr Ala Ala Thr Asp Ala Thr Arg Trp Gin lie Trp Asp nsn uiv lhrl lie lie Asn Pro Arg Ser Ser Leu Val leu Ala340 Thr Asp —  ciu Asn
r r r  ACA TCA GGG AAC PCI GCT AGC ACA CTT AOG GIG CM AGC AAC ATT TAT GOC GIT ACT CAA OCT TOG CTT OCTSi SS 5Ti ihr L  Thr V.1 Cln Thr A«n 11« Tyr Al. V«1 S«r Cln Gly Trp Uu Pro Thr G E H I S  GinPro PheAla Thr Ser Gly Asn Ser Gly Thr Thr leu Thr Val Gin3*0 400
CCT TTT GTT ACA ACC ATT GTT GGG CTA TAT GGT CTG TGC TTG CAA GCA AAT AST GGA CAA GTA TOG ATA GAG GAC TGT AGC ACT GAA AAG 
Pro Phe Val Thr Thr He Val Gly leu Tyr Gly leu Cys Leu Gin Ala Asn Ser Gly Gin Val Trp lie Glu Asp Cys Ser Ser Glu LysVal 440 Ser CysTrp ’33° . . .  . . .
GCT GAA CAA CAG TOG GCT CIT TAT GCA GAT GGT TCA ATA OGT OCT CAC CAA AAC OGA GAT AAT TCC CTT ACA AGT GAT TCT AAT ATA OX
Ala Glu Gin Gin Trp Ala Leu Tyr Ala Asp Gly Ser lie Arg Pro Gin Gin Asn Arg Asp Asn Cys Leu Thr Ser Asp Ser Asn lie Arg
440 Ser Asn* Asn Arg14*0 1*00
GAA ACA GTT GTT AAG ATC CTC TCT TGT GGC CCT GCA TCC TCT OGC CAA OGA TOG ATG TTC AAG AAT GAT GGA ACC ATT TTA AAT TIG TAT
Glu Thr Val Val Lys He Leu Ser Cys Gly Pro Ala Ser Ser Gly Gin Arg Trp Met Phe Lys Asn Asp Gly Thr lie leu Asn leu Tyr
«•o 440 Glu 400• M O  i*00
ACT GGA Tr6 C7TC TTA GAT GTC AGG OCA TOC CAT COG ACC CIT AAA CAA ATC ATT CIT TAC CCT CIC CAT OCT GAC CCA AAC CAA ATA TOC
Ser Gly L»u Val Leu Aap Val Arg Arj Ser Aap Pro Scr Leu Lya Cln 11« 11« Leu Tyr Pro Leu Hie Gly Aap Pro Aan Gin 11« TrpAla *" Trp * .....
•«to
TTA CCA TTA TTT TGA TAGACACATT ACltlCTTGC ACTCICTCIG TCCTGCCATC AAAATAGATG GCTTAAATAA AAAOCACATT CTAAATTTTC TAACTGAAAC 
leu Pro Leu Phe ***
*Leu Pro •>*>
GACAGCAACT TATlCCACTC CACtATCTAA TAACAGCACA ACTATTCTCT TCTCCATTCT AAATTT-Poly(A)
APPENDIX B
RESTRICTION MAP OF pPRCL617
The construct, pPRCL617, contains the amended preproricin cDNA 
sequence shown in Appendix A (Richardson et al, 1989). This 
clone was used for the source of preproricin cDNA. The position 
of restriction sites are shown by numbers which correspond to 
the nucleotide numbering of Lamb et al (1985) (see Appendix A).
KEY.
N - 35 amino acid residue N-terminal coding region
A - mature A chain coding region
L - 12 amino acid residue coding region
B - mature B chain coding region
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APPENDIX C
VECTORS.
A. pSP64T (Krieg and Melton, 1984)
This vector is used for ¿n vitro expression of 
cloned genes. The gene of interest is cloned into the unique 
Bglll restriction site (in a clockwise orientation with 
reference to the map opposite). The DNA is then linearised 
using a suitable restriction enzyme site in the multiple 
cloning region (MCS) and transcription fired from the SP6 
promoter (SP6). The 5' and 3' untranslated regions of Xenopus 
B-globin mRNA (shaded) stabilise the transcript and result in a 
high expression of the cloned gene. This can dramatically 
improve expression of genes in Xenopus oocyte/egg-free extract 
translation systems. The vector carries the B-lactamase gene 
for Ampicillin resistance (AmpR).
This vector was used to create the constructs 
'pSP64Tpreproricin', 'pSP64TXa', and 'pSP64TTh'. May (1988) 
also used this vector to create 'pSP64Tproricin' which was used 
by this author as a source of proricin substrate to assay for 
the protein body-localised castor bean endoprotease.
B . pINIIIompA2 (Ghrayeb £t aj., 1984)
This vector is used for expression of foreign 
proteins in E.Coli. It contains a region encoding the signal 
peptide of the E.coli ompA protein followed by three unique 
restriction sites. The gene of interest is cloned in-frame with 
the ompA signal sequence by insertion at one of these three 
unique restriction sites to create a chimeric gene. The 
expression of this chimera is under the control of the 
lipoprotein promoter/lactose operon (lpp/lac PO) and, when 
expression is induced by IPTG, the fusion protein produced will 
be secreted into the periplasmic space. Khalid Hussain 
(Warwick) cloned an incomplete proricin clone, pRCL617oxl6, 
beginning at the fourth codon of the mature A chain (and hence 
lacking the entire N-terminal region and first 3 residues of A 
chain) into the EcoRI site to create the construct
pINIIIompA2proricin. This construct was used by this author to 
investigate expression of proricin in E.coli.
C. pIC20H (Marsh et al, 1984)
This vector contains a unique Bglll restriction site 
in the multiple cloning site. This vector was used as part of 
the cloning strategy for mutation of the proricin linker 
peptide to create Factor Xa and thrombin recognition sequences.
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BV
I ompA signal peptide
I
EcoRI Hindi 11 BamHI
— GTA GCG CAG GCC I GCTGAATTCCAAGCTTGGATCC-
1 tI____________ __ signal qeptUtecleayajje site_______
APPENDIX D
COMPUTER PROGRAMME FOR FINDING LIKELY SITES OF SIGNAL PEPTIDE 
CLEAVAGE
The computer programme shown opposite was written in BBC Basic 
language and it was run on a BBC microcomputer. The programme 
allows the user to enter a sequence of amino acid residues 
using either the one or three-letter codes, beginning at the N- 
terminal methionine residue of the protein. Signal peptides 
described in the literature to date have been between 20 and 35 
residues long (von Heijne, 1990) and therefore it is usually 
sufficient to enter the first 35-40 N-terminal residues. Upon 
the command [return key], the programme will assign values to 
each residue entered using the von Heijne algorithm (von 
Heijne, 1986). The programme calculates this value by reference 
to the two-dimensional array, z(15,20), which stores a 
probability table assembled from von Heijne's paper (von 
Heijne, 1985) and given to this author by Dr Les Dale, 
University of Birmingham. The final value assigned to each 
residue is a summation of 15 separate probabilities and values 
are only assigned to residues from residue^ onwards. Residues 
assigned high positive values are considered good candidates 
for the sites of signal peptide cleavage, and visa versa.
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APPENDIX E
SUPPLIERS: NAMES AND ADDRESSES
All chemicals and reagents were obtained form BDH 
Chemicals Ltd, Poole, Dorset, UK and were of AnalaR grade, 
except for those listed below.
Amersham International pic, Aylesbury, Bucks., UK.
Radiochemicals; Amplify; biotin-steptavidin blotting kit; 
Hybond-C nitrocellulose membranes; restriction enzymes; T4 DNA 
ligase; T4 polynucleotide kinase; T4 DNA polymerase; E.coli 
polymerase 1 (Klenow fragment); lambda DNA; T7 RNA polymerase.
BDH Chemicals Ltd, Poole, Dorset, UK.
1-Naphthyacetic acid (NAA).
Beckman RIIC Ltd., High Hycombe, Bucks., UK.
Ready-solv EP liquid scintillation fluid and quickseal vials.
Biorad Laboratories Ltd., Watford, Herts., UK.
Low molecular weight protein standards for SDS-PAGE.
Boehringer Mannheim (BCL), Lewes, East Sussex, UK.
Deoxy- and dideoxy-nucleotides; ribonucleotides; calf 
intestinal alkaline phosphatase (cip); creatine kinase; 
creatine phosphate; SP6 polymerase; 4-morpholinethansulfonsaire 
(MES).
BRL (Bethesda Research Laboratories) Ltd., Paisley, UK.
Restriction enzymes; cloning manual
Difco Laboratories, Detroit, USA 
Bacto-agar; Bacto-tryptone; yeast extract.
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Fisons pic (Services), Crawley, Sussex, UK.
Acrylamide (electrophoresis grade); butan-l-ol; chloroform; 
diethyl ether; dimethyl sulphoxide; formamide; formaldehyde; 
glycine; glycerol; hydrogen peroxide; trichloroacetic acid; 
Urea
Flow Labs, Irvine, Ayrshire, UK.
Gamborg medium (B5 salts), MS medium, gibberelic acid (GA3).
Fluka Chemicals, Glossop, Derbyshire, UK.
N6-Benzyledenine (6-BAP).
Fuji Photo film Co. (UK) Ltd., London, UK
RX medical X-ray film
Gibco BRL, Uxbridge, Middlesex, UK.
Low melting-point agarose (ultra-pure)
Kodak Chemicals Ltd., Kirby, Liverpool, UK
N'N-methylene bis-acrylamide
May and Baker Ltd., Ecdes, Manchester, UK
Acetic acid (glacial); ethanol; hydrochloric acid; methanol
Promega Biotec. Ltd., Maidstone, Wisconsin, USA.
RNasin; SP6 RNA polymerase; alkaline phosphatase detection kit; 
rabbit reticulocyte lysate.
Sigma Chemical Company, Poole, Dorset, UK
Agarose type II medium EEO; Bovine serum albumin (BSA); 
ethidium bromide; lysozyme; PMSF; ribonucléase A; Tween 20; 
Triton X 100; Nonidet P40; L-amino acids; EDTA; silver nitrate; 
Coomassie Brilliant Blue R; spermine; spermidine;
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dithreothreitol (DTT); ATP; 5-bromo-4-chloro-3-indolyl-B-D- 
galactopyranoside (X-Gal); isopropyl-B-D-thio galactucanoside 
(IPTG); B-glucuronidase (EC 3.2.1.31: GUS); 4-methyl
umbelliferryl glucoronide (MUG); 4-methyl umbelliferrylate 
(MU); thrombin; xylene cyanol; MOPS; HEPES; fluorescein 
diacetate (FDA); thrombin.
United States Biochemical Corp., Cleveland, Ohio, USA.
Sequenase kit
Whatman Labscales Ltd., Maidstone, Rent, UK.
Filter paper (3MM; Nol; P81; DE81).
Yakult Hosha Co Ltd., Tokyo, Japan.
Cellulase "Onozuka RS"; maceroenzyme RIO.
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